WO2020002187A1 - Laccase-containing detergent having improved cleaning power - Google Patents
Laccase-containing detergent having improved cleaning power Download PDFInfo
- Publication number
- WO2020002187A1 WO2020002187A1 PCT/EP2019/066589 EP2019066589W WO2020002187A1 WO 2020002187 A1 WO2020002187 A1 WO 2020002187A1 EP 2019066589 W EP2019066589 W EP 2019066589W WO 2020002187 A1 WO2020002187 A1 WO 2020002187A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- laccase
- amino acid
- seq
- acid sequence
- laccases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0061—Laccase (1.10.3.2)
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38654—Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase
Definitions
- the invention is in the field of enzyme technology.
- the invention relates to laccases, which can be used in particular with a view to their use in detergents and cleaning agents, all sufficiently similar laccases with a sequence similar to SEQ ID NO: 1 and nucleic acids coding for them.
- the invention further relates to their production and methods for using these laccases, their use as such and agents containing them, in particular detergents and cleaning agents.
- Laccases (EC 1.10.3.2) are copper-containing, "blue" enzymes that are found in many plants, fungi and microorganisms. Laccases are among the oxidoreductases. The catalytically active center contains four copper ions, which can be differentiated according to their spectroscopic properties. The "blue" type 1 copper is involved in the substrate oxidation, one type 2 and two type 3 copper ions form a trinuclear cluster that binds oxygen and reduces it to water. Laccases are also known as p-diphenol oxidases. In addition to diphenols, laccases oxidize many other substrates such as methoxy substituted phenols and diamines. With regard to their substrates, laccases are surprisingly unspecific.
- laccases Because of their broad substrate specificity and ability to oxidize phenolic compounds, laccases have aroused great interest in industrial applications. Promising areas for the use of laccases include, for example, the delignification and gluing of fiberboard in the wood industry, the dyeing of substances and the detoxification of dyeing waste in the textile industry, and the use in biosensors.
- laccases can also oxidize substrates that they would otherwise not be able to oxidize.
- the mediators are typically "small molecule compounds" that are oxidized by laccases. The oxidized mediator then in turn oxidizes the actual substrate.
- the first laccase was found in the Japanese lacquer tree (Rhus vernicifera) in 1883. Laccases can be found in many plants such as peach, tomato, mango and potato; Laccases are also known from some insects.
- the most commonly used laccases come from mushrooms, for example from the species Agaricus, Aspergillus, Cerrena, Curvularia, Fusarium, Lentinius, Monocillium, Myceliophtora, Neurospora, Penicillium, Phanerochaete, Phlebia, Pleurotus, Podospora, Schizophyllum, Stagonosporyllum, Sporotosporus.
- laccases In nature, the function of laccases is, among other things, to participate in the decomposting of lignocellulose, the biosynthesis of cell walls, the browning of fruits and vegetables, and the prevention of microbial attacks on plants. It is often difficult to effectively remove colored stains / stains from soiled laundry or from a soiled object. Strongly colored stains and soiling, ie stains from fruit and / or vegetables, are a particular challenge when removing them. These stains and soiling contain color bodies based on carotenoid compounds, such as a-, b- and g-carotene and lycopene, on porphyrins, such as chlorophyll, and on flavonoid pigments and dye components.
- This latter group of dye components based on natural flavonoid comprises the strongly colored anthocyanin dyes and pigments based on pelargonidine, cyanidine, delphidine and their methyl esters and the anthoxanthines.
- These compounds are the origin of most orange, red, purple and blue colors in fruits and are found in all berries, cherries, red and black currants, grapefruits, passion fruit, oranges, lemons, apples, pears, pomegranates, red cabbage, beetroot and also abundant in flowers.
- Derivatives of cyanidine are present in up to 80% of the pigmented leaves, in up to 70% of the fruits and in up to 50% of the flowers.
- soiling examples include soiling from tea, coffee, red wine, spices such as curry and paprika, orange, tomato, banana, tea, mango, broccoli, carrot, beetroot, spinach and grass.
- Ballpoint pen ink is also known as very difficult to remove colored stains.
- These strongly colored flavonoid and carotenoid dyes are often polycyclic and heterocyclic compounds with conjugated double bond systems. This chemical structure is often responsible for the clear color of the compounds.
- the invention therefore relates to a laccase comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, or variants thereof.
- the variants according to the invention are characterized in that they consist of a laccase which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, as the starting molecule by one or more conservative ones Amino acid substitution are available.
- the variants according to the invention are characterized in that they start from a laccase which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, by fragmentation, Deletion, insertion or substitution mutagenesis are available and comprise an amino acid sequence which has a length of at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 445, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 connected amino acids matches the starting molecule.
- Another object of the invention is a method for producing a laccase, comprising providing a starting laccase which has at least 70% sequence identity to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length or variants of the starting laccase, wherein the variants are as defined above.
- a laccase in the sense of the present patent application therefore includes both the laccase as such and a laccase produced by a method according to the invention. All statements on laccase therefore relate both to laccase as a substance and to the corresponding processes, in particular laccase production processes.
- a nucleotide sequence corresponding to the amino acid sequence according to SEQ ID NO: 1 or SEQ ID NO: 2 is given in SEQ ID NO: 3 or SEQ ID NO: 4.
- the invention further relates to agents comprising laccases, in particular detergents and cleaning agents, washing and cleaning processes, and uses defined by the laccases described herein, the laccases used here having at least 70% sequence identity with the one in SEQ ID NO: 1 or SEQ ID NO: 2 indicated amino acid sequence over their total length or are variants thereof.
- the variants used here are characterized in that they consist of a laccase, which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, as a starting molecule by one or more conservative amino acid substitution are available.
- Variants are alternative or supplementary Variants used, characterized in that it consists of a laccase which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, as the starting molecule by fragmentation, deletion, insertion or substitution mutagenesis are available and comprise an amino acid sequence that is at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487 in length , 488, 489, 490, 491, 492, 493, 494 or 495 connected amino acids matches the starting molecule.
- the present invention is based on the surprising finding of the inventors that a basidiomyceta laccase according to the invention, in particular Marasmiellus palmivorus, which comprises an amino acid sequence which is at least 70% identical to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2, the removal of colored stains and soiling, in particular soiling containing anthocyanins, under standard washing conditions.
- a basidiomyceta laccase according to the invention in particular Marasmiellus palmivorus
- This is particularly surprising insofar as the use in detergents or cleaning agents has not been described for any of the basidiomyceta laccases, in particular Marasmiellus palmivorus.
- laccases according to the invention have high stability in detergents or cleaning agents, for example with respect to surfactants and / or bleaching agents and / or with respect to temperature influences and / or with respect to acidic or alkaline conditions and / or with respect to pH changes and / or with respect to denaturing or oxidizing agents Agents and / or against proteolytic degradation and / or against a change in the redox ratios. Consequently, particularly preferred embodiments of the invention provide performance-improved laccase variants. Such advantageous embodiments of laccases according to the invention consequently enable improved washing results on e.g. Soiling containing anthocyanins in a wide temperature range.
- a laccase according to the invention has an enzymatic activity, i.e. it is for the oxidation of e.g. capable of phenol, diphenol and other compounds, especially in a detergent.
- the washing and cleaning agent according to the invention advantageously has an improved cleaning performance, in particular when removing colored stains and soiling.
- the washing and cleaning agent according to the invention is particularly preferably suitable for removing soiling containing anthocyanins.
- a laccase according to the invention is preferably a mature laccase, ie the catalytically active molecule without signal and / or propeptide (s).
- the sequences given also relate to mature (processed) enzymes.
- SEQ ID NO: 1 is the amino acid sequence of the mature protein, while SEQ ID NO: 2 indicates the sequence including the signal peptide.
- "Laccase of the invention" as used herein refers to laccases that are at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81% , 82%, 83%, 84%,
- variants thereof Have sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over their entire length or are variants thereof.
- the variants are characterized in that they can be obtained from a laccase with the specified sequence identity as the starting molecule by one or more conservative amino acid substitution.
- the variants used are characterized in that they can be obtained from a laccase with the specified sequence identity as the starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprise an amino acid sequence which has a length of at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 related amino acids with the parent molecule matches.
- the laccase comprises an amino acid sequence which is at least 95%, 95.5%, 96%, 96.5%, 97%, 97.5% of the amino acid sequence given in SEQ ID NO: 1 over its entire length. , 98%, 98.5%, 98.8%, 99.0%, 99.2%, 99.4%, 99.5%, 99.6% or 99.8%.
- the laccase is a free enzyme. This means that the laccase can act directly with all components of an agent and, if the agent is a liquid agent, that the laccase is in direct contact with the solvent of the agent according to the invention (e.g. water).
- the laccase according to the invention can form an interaction complex with other molecules in an agent or contain an “envelope”.
- a single or several laccase molecules can be separated from the other constituents of an agent by a structure surrounding them.
- a separating structure can result from, but is not limited to, vesicles, such as a micelle or a liposome.
- the surrounding structure can also be a virus particle, a bacterial cell or a eukaryotic cell.
- the laccase according to the invention can be contained in cells from Basidiomyceta which express this laccase or in cell culture supernatants of such cells.
- sequence comparison The identity of nucleic acid or amino acid sequences is determined by a sequence comparison. This sequence comparison is based on the BLAST algorithm established and commonly used in the prior art (cf., for example, Altschul et al. (1990): “Basic local alignment search tool", J. Mol. Biol. 215: 403-410, and Altschul et al. (1997): “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res. 25: 3389-3402) and happens principally in that similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences are assigned to each other. A tabular assignment of the relevant positions is called alignment.
- Sequence comparisons are created using computer programs.
- the Clustal series cf. e.g. Chenna et al. (2003): “Multiple sequence alignment with the Clustal series of programs", Nucleic Acids Res. 31: 3497-3500
- T-Coffee cf. e.g. Notredame et al. (2000): “T-Coffee: A novel method for multiple sequence alignments", J. Mol. Biol. 302: 205-217
- Sequence comparisons are also possible with the computer program Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the specified standard parameters, whose AlignX module for sequence comparisons is based on ClustalW.
- Such a comparison also allows a statement to be made about the similarity of the compared sequences to one another. It is usually expressed in percent identity, i.e. the proportion of identical nucleotides or amino acid residues at the same or in an alignment corresponding positions indicated.
- the broader concept of homology also includes conserved amino acid exchanges in amino acid sequences, that is, amino acids with similar chemical activity, since these usually have similar chemical activities within the protein.
- the similarity of the compared sequences can therefore also be given as percent homology or percent similarity.
- Identity and / or homology information can be made about entire polypeptides or genes or only over individual areas. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences. Such areas often have identical functions.
- nucleic acid or amino acid sequence can be small and contain only a few nucleotides or amino acids. Such small areas often have essential functions for the overall activity of the protein. It can therefore make sense to relate sequence matches only to individual, possibly small, areas. Unless otherwise stated, identity or homology information in the present application relates to the total length of the nucleic acid or amino acid sequence specified in each case.
- the indication that an amino acid position corresponds to a numerically designated position in SEQ ID NO: 1 therefore means that the corresponding position is assigned to the numerically designated position in SEQ ID NO: 1 in an alignment as defined above.
- the laccase is characterized in that its cleaning performance is not significantly reduced compared to that of a laccase which comprises an amino acid sequence which corresponds to the amino acid sequences given in SEQ ID NO: 1, ie at least 70%, 75%, 80%, 85%, 90%, 95% of the reference washing performance.
- the cleaning performance can be determined in a washing system that contains a detergent in a dosage between 4.5 and 7.0 grams per liter of washing liquor as well as the laccase, the laccases to be compared having the same concentration (based on active protein) and the cleaning performance versus Soiling on cotton is determined by measuring the degree of cleaning of the washed textiles. For example, the washing process can take place for 60 minutes at a temperature of 40 ° C.
- the water has a water hardness between 5 ° and 25 °, preferably 10 ° and 20 °, more preferably 13 ° and 17 ° and further preferably 15.5 ° and 16.
- the concentration of laccase in the detergent intended for this washing system is from 0.001 to 1% by weight, preferably from 0.001 to 0.1% by weight, and more preferably from 0.01 to 0.06% by weight, based on active, purified protein.
- a preferred liquid detergent for such a washing system can e.g. be composed as follows (all figures in% by weight): 7% alkylbenzenesulfonic acid, 9% anionic surfactants, 4% Na salts of C12-C18 fatty acids, 7% non-ionic surfactants, 0.7% phosphonates, 3.2 % Citric acid, 3.0% NaOH, 0.04% defoamer, 5.7% 1, 2-propanediol, 0.1% preservatives, 2% ethanol, 0.2% dye transfer inhibitor, remainder demineralized water.
- the dosage of the liquid detergent is preferably between 4.5 and 6.0 grams per liter of wash liquor, for example 4.7, 4.9 or 5.9 grams per liter of wash liquor. Washing is preferably carried out in a pH range between pH 7.5 and pH 10.5, preferably between pH 7.5 and pH 9.
- the cleaning performance is determined at 40 ° C. using a liquid detergent as indicated above, the washing process preferably taking place for 60 minutes.
- the degree of whiteness i.e. the lightening of the soiling, as a measure of the cleaning performance, is determined using optical measuring methods, preferably photometrically.
- a suitable device is, for example, the Minolta CM508d spectrometer.
- the devices used for the measurement are calibrated beforehand with a white standard, preferably a supplied white standard.
- the use of the respective laccase ensures that even if the ratio of active substance to total protein (the values of the specific activity) diverges, the respective enzymatic properties, for example the cleaning performance of certain soiling, are compared. In general, a low specific activity can be compensated for by adding a larger amount of protein.
- the laccase activity is determined in a customary manner, and preferably by an optical measurement method, preferably a photometric method.
- the ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) assay is a common assay for determining the activity of laccases, since ABTS is a natural mediator (cf. e.g.
- the protein concentration can be determined using known methods, e.g. the BCA method (bicinchoninic acid; 2,2'-bichinolyl-4,4'-dicarboxylic acid) or the biuret method (see, for example, Gornall et al. (1948), J. Biol. Chem., 177: 751-766 ) can be determined.
- the determination of the active protein concentration can be carried out by titrating the active centers using a suitable irreversible inhibitor and determining the residual activity (see, for example, Bender et al. (1966), J. Am. Chem. Soc. 88 (24): 5890-5913 ) respectively.
- Laccases according to the invention can have further amino acid changes, in particular amino acid substitutions, insertions or deletions, compared to the laccase described in SEQ ID NO: 1 or SEQ ID NO: 2.
- Such laccases are, for example, by targeted genetic modification, i.e. through mutagenesis processes, further developed and optimized for specific purposes or with regard to special properties (for example with regard to their catalytic activity, stability, etc.).
- nucleic acids according to the invention can be introduced into recombination approaches and thus used to generate completely new laccases or other polypeptides.
- the aim is to introduce targeted mutations such as substitutions, insertions or deletions into the known molecules, for example in order to improve the cleaning performance of enzymes according to the invention.
- the surface charges and / or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed.
- the net charge of the enzymes can be changed in order to influence the substrate binding, especially for use in detergents and cleaning agents.
- the stability of the enzymes can be increased even further by one or more corresponding mutations and their cleaning performance can thereby be improved.
- Advantageous properties of individual mutations, e.g. individual substitutions can complement each other.
- a laccase already optimized with regard to certain properties, e.g. with regard to their activity and / or their tolerance in relation to the substrate spectrum can therefore be further developed within the scope of the invention.
- amino acid exchanges amino acid exchanges
- additional amino acids are named after the sequence position.
- deletions the missing amino acid is replaced by a symbol, for example an asterisk or a dash, or a D is given in front of the corresponding position.
- R45Q describes the substitution of arginine at position 45 by glutamine, N45AQ the insertion of glutamine after the amino acid alanine at position 45 and N45 * or DN45 the deletion of asparagine at position 45.
- This nomenclature is known to the person skilled in the field of enzyme technology.
- Another object of the invention is therefore a laccase which is characterized in that it can be obtained from a laccase as described above as the starting molecule by one or more conservative amino acid substitution.
- conservative amino acid substitution means the substitution of one amino acid residue for another amino acid residue, this exchange not leading to a change in polarity or charge at the position of the amino acid exchanged, e.g. the exchange of a non-polar amino acid residue for another non-polar amino acid residue.
- the laccase can be placed before and e.g. Even after the conservative amino acid substitution, comprise an amino acid sequence which corresponds to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length by at least 70%, 71%, 72%, 73%, 74%, 75%, 76 %, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91 %, 91, 5%, 92%, 92.5%, 93%,
- the laccase is characterized in that it is obtainable from a laccase as the starting molecule as described above by fragmentation, deletion, insertion or substitution mutagenesis and comprises an amino acid sequence which is at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 related amino acids matches the parent molecule.
- the laccase can be placed before and e.g.
- fragmentation, deletion, insertion or substitution mutagenesis comprise an amino acid sequence which is at least 70%, 71%, 72%, 73% of the total length of the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90% , 90.5%, 91%, 91, 5%, 92%,
- the enzymes retain their catalytic activity even after mutagenesis, i.e. their catalytic activity corresponds at least to that of the parent enzyme, i.e. in a preferred embodiment, the catalytic activity is at least 80%, preferably at least 90%, of the activity of the starting enzyme.
- Other substitutions can also have beneficial effects. Both single and multiple contiguous amino acids can be exchanged for other amino acids.
- the further amino acid positions are defined here by an alignment of the amino acid sequence of a laccase according to the invention with the amino acid sequence of the basidiomyceta laccase, in particular Marasmiellus palmivorus, as specified in SEQ ID NO: 1 or SEQ ID NO: 2. Furthermore, the assignment of the positions depends on the mature (mature) protein. This assignment is also to be used in particular if the amino acid sequence of a laccase according to the invention comprises a higher number of amino acid residues than the laccase from Basidiomyceta, in particular Marasmiellus palmivorus, according to SEQ ID NO: 1 or SEQ ID NO: 2. Starting from the positions mentioned in the amino acid sequence of the basidiomyceta laccase, in particular Marasmiellus palmivorus, the change positions in a laccase according to the invention are those which are assigned to these positions in an alignment.
- Comparative experiments can provide further confirmation of the correct assignment of the amino acids to be changed, that is to say in particular their functional correspondence, according to which the two positions assigned to one another on the basis of an alignment are changed in the same way in both compared laccases and it is observed whether in both the enzymatic activity is changed in the same way.
- an amino acid exchange in a specific position of the basidiomyceta laccase, in particular Marasmiellus palmivorus, according to SEQ ID NO: 1 or SEQ ID NO: 2 is accompanied by a change in an enzymatic parameter, for example by an increase in the « M value, and becomes one If a corresponding change in the enzymatic parameter, for example also an increase in the M value, is observed in a laccase variant according to the invention, the amino acid exchange of which has been achieved by the same amino acid introduced, this is to be seen as a confirmation of the correct assignment.
- fragments of laccase as defined herein in particular those according to SEQ ID NO: 1, which are shortened at the N and / or C terminus in such a way that one or more amino acids of laccase, for example 1, 2, 3, 4 , 5, 6, 7, 8, 9 or 10, are no longer included.
- variants can also be used in various embodiments of the invention which have the form shortened by (in each case) 1 to 10 N-terminal and / or C-terminal amino acids starting from the amino acid sequence given in SEQ ID NO: 1 the total length at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85 %, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%,
- laccases are also detected which have an amino acid sequence which, via the laccase, comprises an amino acid sequence which has at least 70%, preferably at least 80%, particularly preferably at least 95% sequence identity with the amino acid sequence given in SEQ ID NO: 1 over its entire length or the variants thereof described here, without the catalytic activity being lost or reduced thereby.
- laccases are preferably those which have N- and / or C-terminal additional amino acids, for example the signal peptide or fragments of the signal peptide, the signal peptide or fragments of the signal peptide being produced in the preparation of the laccase.
- laccases are also recorded which have an amino acid sequence which, compared to a laccase comprising an amino acid sequence, has at least 70%, preferably at least 80%, particularly preferably at least 95% sequence identity with the amino acid sequence given in SEQ ID NO: 2 or the one therein described variants thereof are shortened at the N-terminus such that the signal peptide or one or more amino acids of the signal peptide, for example 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13 , 14, 15, 16, 17, 18, 19, 20, 21, or 22, especially the N-terminal 22 amino acids, are no longer included.
- laccases with the signal peptide or fragments of the signal peptide variants can also be used in various embodiments of the invention which have the form shortened by 1 to 22 N-terminal amino acids based on the amino acid sequence given in SEQ ID NO: 2, over the entire length at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%,
- a method according to the invention comprises a method for producing a laccase, comprising providing a starting laccase which has at least 70%, preferably at least 80%, particularly preferably at least 95% sequence identity to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over their total length, or variants of the starting laccase, the method according to the invention for producing the variants comprising, for example, one or more of the following process steps: a) introducing one or more conservative amino acid substitution into a starting laccase according to SEQ ID NO: 1 or SED ID NO : 2;
- the laccase or the laccase produced by a process according to the invention is still at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92 , 5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5 %, 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99, 1%, 99.2%, 99.3%, 99.4%, 99.5 %, 99.6%, 99.7%, 99.8% or 99.9% identical to the amino acid sequence given in SEQ ID NO: 1 over its entire length.
- Another object of the invention is a previously described laccase which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
- An increase in stability during storage and / or during use, for example in the washing process, means that the enzymatic activity lasts longer and thus the cleaning performance is improved.
- all stabilization options described and / or useful in the prior art come into consideration. Preference is given to those stabilizations which are achieved via mutations in the enzyme itself, since such stabilizations do not require any further steps following the extraction of the enzyme. Examples of suitable sequence changes are mentioned above. Further suitable sequence changes are known from the prior art.
- Stabilization options include:
- Preferred embodiments are those in which the enzyme is stabilized in several ways, since several stabilizing mutations have an additive or synergistic effect.
- Another object of the invention is a laccase as described above, which is characterized in that it has at least one chemical modification.
- a laccase with such a change is called a derivative, i.e. the laccase is derivatized.
- derivatives are understood to mean those proteins whose pure amino acid chain has been chemically modified.
- derivatizations can be carried out, for example, in vivo by the host cell that expresses the protein. Couplings of low molecular weight compounds such as lipids or oligosaccharides are particularly noteworthy in this regard.
- derivatizations can also be carried out in vitro, for example by chemical conversion of a side chain of an amino acid or by covalent binding of another compound to the protein. For example, the coupling of amines to carboxyl groups of an enzyme to change the isoelectric point is possible.
- Such a different compound can also be a further protein which is bound to a protein according to the invention, for example via bifunctional chemical compounds.
- Derivatization is also to be understood to mean covalent binding to a macromolecular carrier or non-covalent inclusion in suitable macromolecular cage structures.
- derivatizations can influence the substrate specificity or the binding strength to the substrate, or can temporarily block the enzymatic activity if the coupled substance is an inhibitor. This can be useful, for example, for the period of storage.
- Such modifications can also affect stability or enzymatic activity. They can also serve to reduce the allergenicity and / or immunogenicity of the protein and thus, for example, to increase its skin tolerance.
- couplings with macromolecular compounds for example polyethylene glycol, can improve the protein with regard to stability and / or skin tolerance.
- Derivatives of a protein according to the invention can also be understood in the broadest sense to mean preparations of these proteins.
- a protein can be combined with various other substances, for example from the culture of the producing microorganisms.
- a protein may also have been specifically mixed with other substances, for example to increase its storage stability. Therefore are according to the invention also all preparations of a protein according to the invention. This is also irrespective of whether it actually exhibits this enzymatic activity in a particular preparation or not. This is because it may be desired that it has little or no activity during storage and that it only develops its enzymatic function at the time of use. This can be controlled, for example, using appropriate accompanying substances. In particular, the joint preparation of laccases with specific inhibitors is possible in this regard.
- laccases according to the invention and those which can be used in the detergents according to the invention are obtainable from plants, fungi and bacteria.
- the laccase comprising SEQ ID NO: 1 or SEQ ID NO: 2 can be obtained from Marasmiellus palmivorus.
- laccases are often very low. It may therefore make sense to increase production by expressing laccase genes in foreign production hosts.
- vectors are generally used which contain a nucleic acid which codes for a laccase according to the invention.
- the invention therefore furthermore relates to a nucleic acid which codes for a laccase according to the invention and a vector comprising such a nucleic acid, in particular a cloning vector or an expression vector.
- the nucleic acid is a nucleic acid according to SEQ ID NO: 3 or SEQ ID NO: 4.
- a particularly preferred vector according to the invention is a vector which comprises a nucleic acid according to SEQ ID NO: 3 or SEQ ID NO: 4.
- RNA molecules can be DNA or RNA molecules. They can be present as a single strand, as a single strand complementary to this single strand or as a double strand. In the case of DNA molecules in particular, the sequences of both complementary strands must be taken into account in all three possible reading frames. It should also be taken into account that different codons, ie base triplets, can code for the same amino acids, so that a certain amino acid sequence can be encoded by several different nucleic acids. Because of this degeneracy of the genetic code, all nucleic acid sequences which can encode one of the laccases described above are included in this subject matter of the invention.
- Bottlenecks in protein biosynthesis can occur if the codons lying on the nucleic acid in the organism are opposed to a comparatively small number of loaded tRNA molecules. Although coding for the same amino acid, this means that a codon in the organism is translated less efficiently than a synonymous codon that codes for the same amino acid. Due to the presence of a higher number of tRNA molecules for the synonymous codon, this can be translated more efficiently in the organism. It is possible for a person skilled in the art to use methods which are generally known today, such as chemical synthesis or the polymerase chain reaction (PCR) in conjunction with standard molecular biological and / or protein-chemical methods, to complete the corresponding nucleic acids using known DNA and / or amino acid sequences To produce genes. Such methods are known, for example, from Sambrook, J., Fritsch, EF and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.
- PCR polymerase chain reaction
- vectors are understood to mean elements consisting of nucleic acids which contain a nucleic acid according to the invention as the characteristic nucleic acid region. They are able to establish this in a species or a cell line as a stable genetic element over several generations or cell divisions.
- Vectors are special plasmids, in particular circular genetic elements, when used in bacteria.
- a nucleic acid according to the invention is cloned into a vector.
- the vectors include, for example, those whose origin is bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements of very different origins. With the other genetic elements present in each case, vectors can establish themselves as stable units in the host cells concerned over several generations. They can be extrachromosomal as separate units or integrated into a chromosome or chromosomal DNA.
- Expression vectors comprise nucleic acid sequences which enable them to replicate in the host cells, preferably microorganisms, particularly preferably bacteria, containing them and to express the nucleic acid contained therein. Expression is influenced in particular by the promoter or promoters which regulate the transcription. In principle, expression can take place through the natural promoter originally located in front of the nucleic acid to be expressed, but also through a promoter of the host cell provided on the expression vector or also through a modified or a completely another promoter of another organism or another host cell. In the present case, at least one promoter is provided for the expression of a nucleic acid according to the invention and used for its expression.
- Expression vectors can also be regulated, for example by changing the cultivation conditions or when a specific cell density of the host cells containing them has been reached or by adding certain substances, in particular activators of gene expression.
- An example of such a substance is the galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon).
- IPTG galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside
- lac operon lac operon
- the invention furthermore relates to a non-human host cell which contains a nucleic acid or a vector according to the invention or which contains a laccase according to the invention, in particular one which secretes the laccase into the medium surrounding the host cell.
- a nucleic acid according to the invention or a vector according to the invention is preferably transformed into a microorganism which then represents a host cell according to the invention.
- individual components, i.e. Nucleic acid parts or fragments of a nucleic acid according to the invention are introduced into a host cell in such a way that the resulting host cell contains a nucleic acid according to the invention or a vector according to the invention.
- This procedure is particularly suitable when the host cell already contains one or more components of a nucleic acid or a vector according to the invention and the further components are then supplemented accordingly.
- Methods for transforming cells are established in the prior art and are well known to the person skilled in the art. In principle, all cells are suitable as host cells, i.e. prokaryotic or eukaryotic cells.
- host cells that can be genetically advantageously handled, for example in relation to the transformation with the nucleic acid or the vector and its stable establishment, for example unicellular fungi or bacteria.
- Preferred host cells are furthermore distinguished by good microbiological and biotechnological manageability. This applies, for example, to easy cultivation, high growth rates, low demands on fermentation media and good production and secretion rates for foreign proteins.
- Preferred host cells according to the invention secrete the (transgenic) expressed protein into the medium surrounding the host cells.
- the laccases can be modified by the cells producing them after their production, for example by attaching sugar molecules, formylations, aminations, etc. Such post-translational modifications can functionally influence the laccase.
- Further preferred embodiments are those host cells whose activity can be regulated on the basis of genetic regulatory elements which are provided, for example, on the vector, but which may also be present in these cells from the outset. For example, through the controlled addition of chemical compounds that act as activators serve, by changing the cultivation conditions or when reaching a certain cell density, these can be stimulated for expression. This enables economical production of the proteins according to the invention.
- An example of such a connection is IPTG as described above.
- Preferred host cells are prokaryotic or bacterial cells.
- Bacteria are characterized by short generation times and low demands on the cultivation conditions. As a result, inexpensive cultivation processes or production processes can be established.
- the specialist in bacteria in fermentation technology has a wealth of experience.
- Gram-negative or gram-positive bacteria can be suitable for a special production for various reasons, which can be determined experimentally in individual cases, such as nutrient sources, product formation rate, time requirement etc.
- Gram-negative bacteria such as Escherichia coli
- a large number of proteins are secreted into the periplasmic space, i.e. into the compartment between the two membranes that enclose the cells.
- Gram-negative bacteria can also be designed in such a way that they not only express the expressed proteins into the periplasmic space, but also into the medium surrounding the bacteria.
- Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of the Actinomycetales, on the other hand, have no outer membrane, so that secreted proteins are immediately released into the medium surrounding the bacteria, usually the nutrient medium, from which the expressed proteins can be purified. They can be isolated directly from the medium or processed further.
- gram-positive bacteria are related or identical to most organisms of origin for technically important enzymes and usually form comparable enzymes themselves, so that they have a similar codon use and their protein synthesis apparatus is naturally designed accordingly.
- Host cells according to the invention can be changed with regard to their requirements for the culture conditions, have different or additional selection markers or can also express other or additional proteins.
- these can also be host cells which transgenically express several proteins or enzymes.
- the present invention is in principle applicable to all microorganisms, in particular to all fermentable microorganisms, particularly preferably to those of the genus Bacillus, and leads to the fact that proteins of the invention can be produced by using such microorganisms. Such microorganisms then represent host cells in the sense of the invention.
- the host cell is characterized in that it is a bacterium, preferably one which is selected from the group of the genera of Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one selected from the group of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus ientus, Bacillusisusususus, Bacillusisususus, Bacillus amylolillus Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus carnosus, Corynebacterium glutamicum, Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor and
- the host cell can also be a eukaryotic cell, which is characterized in that it has a cell nucleus.
- Another object of the invention is therefore a host cell, which is characterized in that it has a cell nucleus.
- eukaryotic cells are able to post-translationally modify the protein formed. Examples include fungi such as Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces. This can be particularly advantageous, for example, if the proteins are to undergo specific modifications in connection with their synthesis which enable such systems.
- modifications that eukaryotic systems carry out in particular in connection with protein synthesis include, for example, the binding of low molecular weight compounds such as membrane anchors or oligosaccharides. Such oligosaccharide modifications may be desirable, for example, to reduce the allergenicity of an expressed protein. Co-expression with the enzymes naturally formed by such cells, such as cellulases, can also be advantageous. Furthermore, for example, thermophilic fungal expression systems can be particularly suitable for the expression of temperature-resistant proteins or variants.
- the host cell is a basidiomycete cell.
- the host cells according to the invention are cultivated and fermented in a conventional manner, for example in discontinuous or continuous systems.
- a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after an experimentally determined period.
- Continuous fermentations are characterized by achieving a steady state in which cells partially die but also regrow over a comparatively long period of time and at the same time the protein formed can be removed from the medium.
- Host cells according to the invention are preferably used to produce laccase according to the invention.
- Another object of the invention is therefore a method for producing a laccase comprising
- This subject of the invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, generally followed by a suitable purification method of the product produced, for example the laccase according to the invention. All fermentation processes which are based on a corresponding process for producing a laccase according to the invention represent embodiments of this subject of the invention.
- Fermentation processes which are characterized in that the fermentation is carried out via a feed strategy, are particularly suitable.
- the media components that are consumed by the ongoing cultivation are fed.
- considerable increases can be achieved both in the cell density and in the cell mass or dry mass and / or in particular in the activity of the laccase of interest.
- the fermentation can also be designed in such a way that undesired metabolic products are filtered out or neutralized by adding buffer or suitable counterions.
- the laccase produced can be harvested from the fermentation medium.
- Such a fermentation process is opposed to isolating the laccase from the host cell, i.e. a product preparation from the cell mass (dry mass) preferred, but requires the provision of suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems so that the host cells secrete the laccase into the fermentation medium.
- isolation of the laccase from the host cell i.e. they are purified from the cell mass, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
- the laccases according to the invention improve the washing performance of liquid detergent formulations in particular and not, as is known from other laccases, the undesired darkening and thus intensification of stains, in particular Stain tea and coffee.
- the invention therefore furthermore relates to an agent, in particular a washing and cleaning agent, which contains a laccase as described herein.
- the laccase has at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99, 1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8% or 99.9% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over their entire length
- washing or cleaning agents both concentrates and agents to be used undiluted, for use on a commercial scale, in the washing machine or for hand washing or cleaning.
- detergents for textiles, carpets, or natural fibers, for which the term detergent is used.
- dishwashing detergents for dishwashers or manual dishwashing detergents or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood or leather, for which the term cleaning agent is used, i.e. in addition to manual and machine Dishwashing detergents, for example, also scouring agents, glass cleaners, toilet scent detergents, etc.
- detergents and cleaning agents in the context of the invention also include washing aids which are added to the actual detergent in the case of manual or machine textile washing in order to achieve a further effect.
- detergents and cleaning agents within the scope of the invention also include textile pre-treatment and post-treatment agents, i.e. agents with which the item of laundry is brought into contact before the actual laundry, for example for dissolving stubborn soiling, and also agents which are contained in one of the actual ones Textile laundry downstream step give the items to be washed further desirable properties such as comfortable grip, freedom from creasing or low static charge. The latter means, among others, the fabric softener counted.
- a detergent may contain conventional ingredients which are compatible with this constituent.
- it can additionally contain one or more color transfer inhibitors, which then preferably contain amounts of 0.1 to 2% by weight, in particular 0.2 to 1% by weight, which in a preferred embodiment are selected from the polymers from vinyl pyrrolidone, vinyl imidazole, vinyl pyridine N-oxide or the copolymers thereof.
- enzymatic systems comprising a peroxidase and hydrogen peroxide or a substance which supplies hydrogen peroxide in water can also be used.
- a mediator compound for the peroxidase for example an acetosyringone, a phenol derivative or a phenotiazine or phenoxazine, is preferred in this case, it also being possible to use the above-mentioned polymeric color transfer inhibitor active ingredients.
- Polyvinylpyrrolidone preferably has an average molar mass in the range from 10,000 to 60,000 g / mol, in particular in the range from 25,000 to 50,000 g / mol.
- copolymers those of vinylpyrrolidone and vinylimidazole in a molar ratio of 5: 1 to 1: 1 with an average molar mass in the range from 5000 to 50,000 g / mol, in particular 10,000 to 20,000 g / mol, are preferred.
- Detergents and cleaning agents according to the invention which can be present as powdery solids, in post-compacted particle form, in granular form, as homogeneous solutions or suspensions, can contain, in addition to a laccase according to the invention, all known ingredients customary in such agents, preferably at least one further ingredient in the Means is available.
- the agents according to the invention can in particular contain surfactants, builders (builders), peroxygen compounds or bleach activators. They can also contain water-miscible organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, graying inhibitors, foam regulators as well as colorants and fragrances and combinations thereof.
- a combination of a laccase according to the invention with one or more further ingredient (s) of the agent is advantageous, since such agent in preferred embodiments according to the invention has improved cleaning performance due to the resulting synergisms.
- Such a synergism can be achieved in particular by combining an amylase according to the invention with a surfactant and / or a builder (builder) and / or a peroxygen compound and / or a bleach activator.
- the detergent according to the invention can contain additional mediators in order to oxidize the dyes to be removed with greater efficiency.
- Mediators suitable according to the invention are, for example, Tempo (2,2,6,6-tetramethyl-1-piperidinyloxy), HBT (1-hydroxybenzotriazole), ABTS (2,2'-azinobis-3-ethylbenzothiazole-6-sulphonate), NHA (N -Hydroxy-acetanilide), 2,5-xylidine, ethanol, copper, 4-methylcatechol, N-hydroxyphthalimide, gallic acid, tannic acid, quercetin, syringic acid, Guaiacol, dimethoxybenzyl alcohol, phenol, violuric acid (isonitrosobarbituric acid), phenol red, bromophenol blue, cellulose, p-coumaric acid, rooibos, o-cresol, dichloroindophenol, hydroxybenzotriazole,
- the agent is characterized in that it
- (a) contains 1 to 85% by weight, preferably 5 to 65% by weight, of surfactants; and or
- (b) contains 0 to 45% by weight, preferably 0.1 to 15% by weight, of builder (builders); and or
- (c) contains 0.0005 to 15% by weight, preferably 0.001 to 5% by weight, of protease; and or
- (d) contains 0.0005 to 15% by weight, preferably 0.001 to 5% by weight, lipase; and or
- (e) contains 0.00005 to 15% by weight, preferably 0.0001 to 5% by weight, mannanase; and or
- (f) contains 0.00005 to 15% by weight, preferably 0.0001 to 5% by weight, cellulase / pectate lyase; and or
- An agent according to the invention advantageously contains the laccase in an amount from 2 pg to 20 mg, preferably from 5 pg to 17.5 mg, particularly preferably from 20 pg to 15 mg and very particularly preferably from 50 pg to 10 mg per gram of the agent.
- the agent according to the invention can advantageously the laccase in an amount of 0.00005 to 15% by weight, based on the active enzyme and the total weight of the agent, preferably from 0.0001 to 5% by weight and particularly preferably from 0.001 to 1 % By weight.
- the concentration of the laccase in the washing and cleaning agent according to the invention can more preferably be from 0.001 to 0.15% by weight, preferably from 0.005 to 0.06% by weight, based on active protein.
- the laccase contained in the agent, and / or further ingredients of the agent can be coated with a substance that is impermeable to the enzyme at room temperature or in the absence of water, which substance becomes permeable to the enzyme under conditions of use of the agent.
- a substance impermeable to the laccase at room temperature or in the absence of water is thus characterized in that the laccase is coated with a substance impermeable to the laccase at room temperature or in the absence of water.
- the washing or cleaning agent itself can also be packaged in a container, preferably an air-permeable container, from which it is released shortly before use or during the washing process.
- the agent is characterized in that it is a) in solid form, in particular as a free-flowing powder with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or
- b) is in pasty or liquid form, and / or c) is in the form of a gel or a sachet (pouch), and / or
- d) is in the form of a one-component system
- inventions of the present invention include all solid, powder, liquid, gel or pasty dosage forms of agents according to the invention, which can optionally also consist of several phases and can be in compressed or uncompressed form.
- the agent can be in the form of a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l or 600 g / l to 850 g / l.
- the solid dosage forms of the agent also include extrudates, granules, tablets or pouches.
- the agent can also be liquid, gel-like or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste.
- the agent can be in the form of a one-component system. Such funds consist of one phase.
- an agent can consist of several phases. Such an agent is therefore divided into several components.
- Washing or cleaning agents according to the invention can only contain a laccase. Alternatively, they can also contain further hydrolytic enzymes or other enzymes in a concentration appropriate for the effectiveness of the agent.
- a further embodiment of the invention thus represent agents which further comprise one or more further enzymes. All enzymes which can develop a catalytic activity in the agent according to the invention, in particular a protease, amylase, lipase, cellulase, cutinase, pullulanase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, ⁇ -glucosidase, can preferably be used as further enzymes.
- Further laccases or multi-copper oxidases in addition to the laccases according to the invention is also possible according to the invention.
- Further enzymes are advantageously contained in the agent each in an amount of 1 ⁇ 10 8 to 5 wt .-% based on active protein.
- Each additional enzyme is increasingly preferred in an amount of 1 ⁇ 10 7 to 3% by weight, from 0.00001 to 1% by weight, from 0.00005 to 0.5% by weight, from 0.0001 to 0.1% by weight and particularly preferably from 0.0001 to 0.05% by weight in agents according to the invention, based on active protein.
- the enzymes particularly preferably show synergistic cleaning performance against certain soiling or stains, ie the enzymes contained in the composition of the agents mutually support one another in their cleaning performance.
- Such a synergism is very particularly preferably present between the laccase according to the invention and a further enzyme of an agent according to the invention, including in particular between the laccase mentioned and an amylase and / or a lipase and / or a protease and / or a mannanase and / or a cellulase and / or a pectinase.
- Synergistic effects can occur not only between different enzymes, but also occur between one or more enzymes and other ingredients of the agent according to the invention.
- the enzymes to be used can also be packaged together with accompanying substances, for example from fermentation.
- the enzymes are preferably used as an enzyme liquid formulation (s).
- the enzymes are not provided in the form of the pure protein, but rather in the form of stabilized, storable and transportable preparations.
- These prefabricated preparations include, for example, the solid preparations obtained by granulation, extrusion or lyophilization or, particularly in the case of liquid or gel form agents, solutions of the enzymes, advantageously as concentrated as possible, low in water and / or with stabilizers or other auxiliaries.
- the enzymes can be encapsulated both for the solid and for the liquid administration form, for example by spray drying or extrusion of the enzyme solution together with a preferably natural polymer or in the form of capsules, for example those in which the enzymes are enclosed as in a solidified gel or in those of the core-shell type in which an enzyme-containing core is coated with a protective layer impermeable to water, air and / or chemicals.
- Additional active ingredients for example stabilizers, emulsifiers, pigments, bleaching agents or dyes, can additionally be applied in superimposed layers.
- Capsules of this type are applied by methods known per se, for example by granular or roll granulation or in fluid-bed processes. Such granules are advantageously low in dust, for example by applying polymeric film formers, and are stable on storage due to the coating.
- water soluble films Such a film enables the enzymes to be released after contact with water.
- water soluble refers to a film structure that is preferably completely water soluble.
- films are also that are substantially water-soluble but have relatively small amounts of a material in the film structure that is not water-soluble; Films with materials that are water-soluble only at relatively high water temperatures or only under restricted pH conditions; and films that include a relatively thin layer of water-insoluble material, all included in the term "water-soluble”.
- Such a film preferably consists of (fully or partially hydrolyzed) polyvinyl alcohol (PVA).
- the film can also contain acid / acrylate copolymers, preferably methacrylic acid / ethyl acrylate copolymer, exclusively or in addition to the PVA, such as that available from Beiland as GBC 2580 and 2600; Styrene-maleic anhydride copolymer (SMA) (available as Scripset (trade name) from Monsanto); Ethylene acrylic acid copolymer (EAA) or metal salt neutralized ethylene Methacrylic acid copolymer (EMAA), known as an ionomer (available from DuPont), in which the acidity of EAA or EMAA is at least about 20 mole percent; Polyether block amide copolymer; Polyhydroxyvaleric acid (available as Biopol (trade name) resins from Imperial Chemical Industries); polyethylene oxide; water soluble polyester or copolyester; Polyethyloxazoline (PEOX 200 from Dow); and water-soluble polyurethane.
- acid / acrylate copolymers preferably me
- the procedure is preferably such that all constituents - possibly one layer each - are combined in one Mixer mixed together and the mixture is pressed by means of conventional tablet presses, for example eccentric presses or rotary presses, with pressing forces in the range from about 50 to 100 kN, preferably at 60 to 70 kN.
- break-resistant tablets which nevertheless dissolve sufficiently quickly under application conditions, are obtained with breaking and bending strengths of normally 100 to 200 N, but preferably over 150 N.
- a tablet produced in this way preferably has a weight of 10 to 50 g, in particular 15 to 40 g on.
- the three-dimensional shape of the tablets is arbitrary and can be round, oval or angular, intermediate forms also being possible. Corners and edges are advantageously rounded.
- Round tablets preferably have a diameter of 30 to 40 mm.
- the size of angular or cuboid tablets which are mainly introduced via the metering device of the washing machine, depends on the geometry and the volume of this metering device.
- Exemplary preferred embodiments have a base area of (20 to 30 mm) ⁇ (34 to 40 mm), in particular 26 ⁇ 36 mm or 24 ⁇ 38 mm.
- Liquid or pasty agents in the form of solutions containing customary solvents are generally prepared by simply mixing the ingredients, which can be added in bulk or as a solution to an automatic mixer.
- Solid and / or liquid detergents and cleaning agents according to the invention can, for example, also be packaged in sachets or (preferably self-dissolving) sachets (pouches), in particular also in multi-chamber pouches.
- the term liquid also includes any solid state dispersions in liquids.
- Liquid agents according to the invention can also be multi-phase, the phases can be arranged, for example, vertically, ie one above the other or horizontally, ie next to one another.
- Another object of the invention is a method for cleaning textiles or hard surfaces, which is characterized in that an agent according to the invention is used in at least one process step or that a laccase according to the invention becomes catalytically active in at least one process step, in particular in such a way that the laccase in an amount of 40 pg to 4 g, preferably from 50 pg to 3 g, particularly preferably from 100 pg to 2 g and very particularly preferably from 200 pg to 1 g.
- the process described above is characterized in that the laccase is used at a temperature of 0 to 100 ° C., preferably 0 to 60 ° C., more preferably 20 to 45 ° C. and most preferably 40 ° C. becomes.
- Processes for cleaning textiles are generally characterized in that various cleaning-active substances are applied to the items to be cleaned and washed off after the exposure time in several process steps, or in that the items to be cleaned are treated in some other way with a detergent or a solution or dilution of this agent.
- the simplest form of the process is realized by bringing textiles in need of cleaning into contact with the aqueous liquor, using a conventional washing machine or doing the washing by hand. According to the invention, it is preferred to carry out the process with intensive aeration of the washing liquor, as is the case when using a conventional household machine washing program. The same applies to processes for cleaning all materials other than textiles, especially hard surfaces.
- washing or cleaning processes can be enriched in at least one of the process steps by the use of a washing or cleaning agent according to the invention or a laccase according to the invention and then represent embodiments of the present invention.
- All the facts, objects and embodiments described for the inventive laccases and agents containing them are also applicable to this subject of the invention. Therefore, reference is expressly made at this point to the disclosure at the appropriate point, with the note that this disclosure also applies to the above method according to the invention.
- laccases according to the invention naturally already have a hydrolytic activity and also develop this in media which otherwise have no cleaning power, such as, for example, in mere buffer, a single and / or the only step of such a method can consist, if desired, of an inventive cleaning component as the only active cleaning component Laccase is brought into contact with the soiling, preferably in a buffer solution or in water.
- a single and / or the only step of such a method can consist, if desired, of an inventive cleaning component as the only active cleaning component Laccase is brought into contact with the soiling, preferably in a buffer solution or in water.
- Alternative embodiments of this subject matter of the invention also represent methods for treating textile raw materials or for textile care, in which a laccase according to the invention becomes active in at least one method step.
- processes for textile raw materials, fibers or textiles with natural components are preferred, and very particularly for those with wool or silk.
- the present invention relates to the use of a laccase according to the invention or a laccase obtainable by a method according to the invention in a washing or cleaning agent for removing starchy soiling.
- Another object of the invention is the use of a laccase according to the invention to improve the washing performance of a washing and cleaning agent, in particular when removing colored stains and soiling, particularly preferably when removing soiling containing anthocyanins.
- the present invention relates to the use of a laccase according to the invention or a laccase obtainable by a method according to the invention or a laccase as used in the agents of the invention described in a washing or cleaning agent for removing anthocyanin-containing soiling. All facts, objects and embodiments that are described for laccase according to the invention and agents containing it can also be applied to this object of the invention. Examples:
- All basidiomycetes were grown in a standard liquid nutrient (SNL) medium.
- a preculture was first cultivated in SNL medium for one week at 24 ° C and 150 rpm.
- a standardized inoculum was then transferred to the main culture (SNL). The cultivation was carried out at 24 ° C. and 150 rpm for four days in a reactor system.
- the wild-type Mpa laccase was separated by means of AEX centrifuge column chromatography. 19 ml of culture supernatant was added to the Pierce® strand anion exchange spin column (Maxi, equilibrated with 10 ml of 50 mM sodium acetate buffer, pH 5). The columns were then washed twice with 10 ml of 50 mM sodium acetate buffer (pH 5). The laccase was gradually eluted with 10 ml of 2, 4, 6, 8 and 100% 50 mM sodium acetate buffer (pH 5) with 2 M NaCl. The resulting fractions were analyzed for their laccase activity and their bleaching effect on colored textiles.
- the activity of the laccase was determined using an ABTS assay in the microtiter plate.
- the total volume is 300 pl. 245 ml of 50 mM Na acetate buffer (pH 4.5) are mixed with 30 ml of a 5 mM ABTS solution and 10 ml of a 2 mM H 2 O 2 solution.
- ABTS 0.0368 cm 2 * pmo
- the activity in mitioI-released ABTS radicals per minute and ml can then be calculated using the molar extinction coefficient for ABTS:
- e ABTS corresponds to the extinction coefficient of ABTS (0.0368 cm 2 * pmol 1 , at 405-420 nm),
- the activity of the laccase against ABTS is obtained in U / ml.
- One unit is defined as 1 pmol substrate oxidized per minute under defined conditions.
- a mini-wash test was carried out with the purified wild-type supernatant from Marasmiellus palmivorus, in which the laccase with the amino acid sequence SEQ ID NO: 1 or SEQ ID NO: 2 is present.
- Laccase concentration 25 mU / ml
- Sample 1 only detergent as a benchmark
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention is in the field of enzyme technology. The invention relates to laccases that are in particular suitable for use in detergents and cleaning agents, all sufficiently similar laccases having a correspondingly similar sequence according to SEQ ID NO:1, and nucleic acids coding for said laccases. The invention further relates to the production of said laccases, to a method for using said laccases, to the use of said laccases as such, and to agents containing said laccases, in particular detergents and cleaning agents.
Description
Laccasehaltiges Waschmittel mit verbesserter Reinigungsleistung Laccase detergent with improved cleaning performance
Die Erfindung liegt auf dem Gebiet der Enzymtechnologie. Die Erfindung betrifft Laccasen, die insbesondere im Hinblick auf den Einsatz in Wasch- und Reinigungsmitteln verwendet werden können, alle hinreichend ähnlichen Laccasen mit einer entsprechend ähnlichen Sequenz zu SEQ ID NO: 1 und für sie codierende Nukleinsäuren. Die Erfindung betrifft ferner deren Herstellung sowie Verfahren zur Verwendung dieser Laccasen, deren Verwendung als solche sowie diese enthaltende Mittel, insbesondere Wasch- und Reinigungsmittel. The invention is in the field of enzyme technology. The invention relates to laccases, which can be used in particular with a view to their use in detergents and cleaning agents, all sufficiently similar laccases with a sequence similar to SEQ ID NO: 1 and nucleic acids coding for them. The invention further relates to their production and methods for using these laccases, their use as such and agents containing them, in particular detergents and cleaning agents.
Laccasen (EC 1.10.3.2) sind kupferhaltige, "blaue" Enzyme, die in vielen Pflanzen, Pilzen und Mikroorganismen Vorkommen. Laccasen zählen zu den Oxidoreduktasen. Das katalytisch aktive Zentrum enthält vier Kupferionen, die nach ihren spektroskopischen Eigenschaften unterschieden werden können. Das "blaue" Typ 1-Kupfer ist an der Substratoxidation beteiligt, ein Typ 2- und zwei Typ 3-Kupferionen bilden einen trinuklearen Cluster, der Sauerstoff bindet und zu Wasser reduziert. Laccasen werden auch als p-Diphenol-Oxidasen bezeichnet. Zusätzlich zu Diphenolen oxidieren Laccasen viele andere Substrate wie methoxysubstituierte Phenole und Diamine. In Bezug auf ihre Substrate sind Laccasen erstaunlich unspezifisch. Wegen ihrer breiten Substratspezifität und ihrer Fähigkeit, phenolische Verbindungen zu oxidieren, haben Laccasen großes Interesse bei industriellen Anwendungen geweckt. Vielversprechende Gebiete zur Anwendung von Laccasen schließen zum Beispiel die Delignifizierung und das Kleben von Faserplatten der Holzindustrie, das Färben von Stoffen und das Entgiften von Färbeabwässern in der Textilindustrie, sowie die Verwendung in Biosensoren ein. Laccases (EC 1.10.3.2) are copper-containing, "blue" enzymes that are found in many plants, fungi and microorganisms. Laccases are among the oxidoreductases. The catalytically active center contains four copper ions, which can be differentiated according to their spectroscopic properties. The "blue" type 1 copper is involved in the substrate oxidation, one type 2 and two type 3 copper ions form a trinuclear cluster that binds oxygen and reduces it to water. Laccases are also known as p-diphenol oxidases. In addition to diphenols, laccases oxidize many other substrates such as methoxy substituted phenols and diamines. With regard to their substrates, laccases are surprisingly unspecific. Because of their broad substrate specificity and ability to oxidize phenolic compounds, laccases have aroused great interest in industrial applications. Promising areas for the use of laccases include, for example, the delignification and gluing of fiberboard in the wood industry, the dyeing of substances and the detoxification of dyeing waste in the textile industry, and the use in biosensors.
Mit Hilfe von Mediatoren, d.h. zwischengeschalteten Molekülen, können Laccasen auch Substrate oxidieren, die sie sonst nicht in der Lage wären zu oxidieren. Die Mediatoren sind typischerweise "Small Molecule Compounds", die durch Laccasen oxidiert werden. Der oxidierte Mediator oxidiert dann wiederum das tatsächliche Substrat. With the help of mediators, i.e. interposed molecules, laccases can also oxidize substrates that they would otherwise not be able to oxidize. The mediators are typically "small molecule compounds" that are oxidized by laccases. The oxidized mediator then in turn oxidizes the actual substrate.
Die erste Laccase wurde 1883 im japanischen Lackbaum ( Rhus vernicifera) gefunden. Laccasen finden sich in vielen Pflanzen wie Pfirsich, Tomate, Mango und Kartoffel; Laccasen sind auch aus einigen Insekten bekannt. Die am häufigsten eingesetzten Laccasen stammen jedoch aus Pilzen, beispielsweise aus den Arten Agaricus, Aspergillus, Cerrena, Curvularia, Fusarium, Lentinius, Monocillium, Myceliophtora, Neurospora, Penicillium, Phanerochaete, Phlebia, Pleurotus, Podospora, Schizophyllum, Sporotrichum, Stagonospora und Trametes. In der Natur besteht die Funktion der Laccasen u.a. in der Mitwirkung an der Dekompostierung von Lignocellulose, der Biosynthese von Zellwänden, dem Braunwerden von Früchten und Gemüsen, sowie der Vorbeugung gegen mikrobische Angriffe auf Pflanzen.
Es ist oft schwierig, farbige Flecken/Verschmutzungen effektiv aus verschmutzter Wäsche oder von einem verschmutzten Gegenstand zu entfernen. Stark farbige Flecken und Verschmutzungen, d.h. von Obst und/oder Gemüse stammende Flecken, sind beim Entfernen eine besondere Herausforderung. Diese Flecken und Anschmutzungen enthalten Farbkörper auf der Basis von Carotinoidverbindungen, wie a-, b- und g-Carotin und Lycopin, von Porphyrinen, wie Chlorophyll, und von Flavonoidpigmenten und Farbstoffbestandteilen. Diese letztere Gruppe von Farbstoffbestandteilen auf der Basis von natürlichem Flavonoid umfasst die stark farbigen Anthocyanin-Farbstoffe und -Pigmente auf der Basis von Pelargonidin, Cyanidin, Delphidin und deren Methylestern und die Anthoxanthine. Diese Verbindungen sind der Ursprung der meisten orangefarbenen, roten, violetten und blauen Farben in Früchten und sind in allen Beeren, Kirschen, roten und schwarzen Johannisbeeren, Grapefruits, Maracuja, Orangen, Zitronen, Äpfeln, Birnen, Granatapfel, Rotkohl, roten Beten und auch in Blumen reichlich vorhanden. Derivate von Cyanidin sind in bis zu 80 % der pigmentierten Blätter, in bis zu 70 % der Früchte und in bis zu 50 % der Blumen vorhanden. Zu speziellen Beispielen solcher Verschmutzungen gehören Anschmutzungen aus Tee, Kaffee, Rotwein, Gewürzen wie Curry und Paprika, Orange, Tomate, Banane, Tee, Mango, Brokkoli, Möhre, rote Bete, Spinat und Gras. Kugelschreibertinte ist auch als sehr schwer zu entfernende farbige Flecken bekannt. Diese stark farbigen Flavonoid- und Carotinoid-Farbstoffe sind oft polycyclische und heterocyclische Verbindungen mit Systemen einer konjugierten Doppelbindung. Diese chemische Struktur ist oft für die deutliche Farbe der Verbindungen verantwortlich. The first laccase was found in the Japanese lacquer tree (Rhus vernicifera) in 1883. Laccases can be found in many plants such as peach, tomato, mango and potato; Laccases are also known from some insects. The most commonly used laccases, however, come from mushrooms, for example from the species Agaricus, Aspergillus, Cerrena, Curvularia, Fusarium, Lentinius, Monocillium, Myceliophtora, Neurospora, Penicillium, Phanerochaete, Phlebia, Pleurotus, Podospora, Schizophyllum, Stagonosporyllum, Sporotosporus. In nature, the function of laccases is, among other things, to participate in the decomposting of lignocellulose, the biosynthesis of cell walls, the browning of fruits and vegetables, and the prevention of microbial attacks on plants. It is often difficult to effectively remove colored stains / stains from soiled laundry or from a soiled object. Strongly colored stains and soiling, ie stains from fruit and / or vegetables, are a particular challenge when removing them. These stains and soiling contain color bodies based on carotenoid compounds, such as a-, b- and g-carotene and lycopene, on porphyrins, such as chlorophyll, and on flavonoid pigments and dye components. This latter group of dye components based on natural flavonoid comprises the strongly colored anthocyanin dyes and pigments based on pelargonidine, cyanidine, delphidine and their methyl esters and the anthoxanthines. These compounds are the origin of most orange, red, purple and blue colors in fruits and are found in all berries, cherries, red and black currants, grapefruits, passion fruit, oranges, lemons, apples, pears, pomegranates, red cabbage, beetroot and also abundant in flowers. Derivatives of cyanidine are present in up to 80% of the pigmented leaves, in up to 70% of the fruits and in up to 50% of the flowers. Specific examples of such soiling include soiling from tea, coffee, red wine, spices such as curry and paprika, orange, tomato, banana, tea, mango, broccoli, carrot, beetroot, spinach and grass. Ballpoint pen ink is also known as very difficult to remove colored stains. These strongly colored flavonoid and carotenoid dyes are often polycyclic and heterocyclic compounds with conjugated double bond systems. This chemical structure is often responsible for the clear color of the compounds.
Die genannten Schwierigkeiten bei der Entfernung farbiger Flecken und Anschmutzungen sind besonders gravierend bei der Formulierung flüssiger Wasch- und Reinigungsmittel, da diese üblicherweise keine Bleichmittel enthalten. Es besteht daher Bedarf flüssige Wasch- und Reinigungsmittel, insbesondere solche ohne Bleichmittel, dahingehend weiterzuentwickeln, dass sie im Hinblick auf die Entfernung farbiger Flecken und Anschmutzungen, insbesondere anthocyanhaltiger Anschmutzungen, verbessert sind. The difficulties mentioned in the removal of colored stains and soiling are particularly serious when formulating liquid detergents and cleaning agents, since these usually do not contain any bleaching agents. There is therefore a need to further develop liquid detergents and cleaning agents, in particular those without bleach, in such a way that they are improved with regard to the removal of colored stains and soiling, in particular soiling containing anthocyanins.
Überraschenderweise wurde gefunden, dass eine bislang unbekannte Laccase aus Marasmiellus palmivorus (Mpa), oder hierzu hinreichend ähnliche Laccasen (bezogen auf die Sequenzidentität), besonders für den Einsatz in flüssigen Wasch- oder Reinigungsmitteln geeignet ist, da sie ein breites Spektrum an farbige Flecken und Anschmutzungen, insbesondere anthocyanhaltige Anschmutzungen, unter Standard-Waschbedingungen entfernt. Surprisingly, it has been found that a hitherto unknown laccase from Marasmiellus palmivorus (Mpa), or sufficiently similar laccases (based on the sequence identity), is particularly suitable for use in liquid detergents or cleaning agents, since it contains a wide range of colored stains and Soiling, in particular anthocyanin-containing soiling, is removed under standard washing conditions.
Gegenstand der Erfindung ist daher eine Laccase, umfassend eine Aminosäuresequenz, die mindestens 70 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist, oder Varianten davon.
Die erfindungsgemäßen Varianten sind dadurch gekennzeichnet, dass sie aus einer Laccase, die eine Aminosäuresequenz mit mindestens 70 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist, als Ausgangsmolekül durch ein- oder mehrfache konservative Aminosäuresubstitution erhältlich sind. Alternativ oder ergänzend sind die erfindungsgemäßen Varianten dadurch gekennzeichnet, dass sie aus einer Laccase, die eine Aminosäuresequenz mit mindestens 70 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist, als Ausgangsmolekül durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese erhältlich sind und eine Aminosäuresequenz umfasst, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 445, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit dem Ausgangsmolekül übereinstimmt. The invention therefore relates to a laccase comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, or variants thereof. The variants according to the invention are characterized in that they consist of a laccase which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, as the starting molecule by one or more conservative ones Amino acid substitution are available. Alternatively or additionally, the variants according to the invention are characterized in that they start from a laccase which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, by fragmentation, Deletion, insertion or substitution mutagenesis are available and comprise an amino acid sequence which has a length of at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 445, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 connected amino acids matches the starting molecule.
Ein weiterer Gegenstand der Erfindung ist ein Verfahren zur Herstellung einer Laccase, umfassend das Bereitstellen einer Ausgangslaccase, die mindestens 70 % Sequenzidentität zu der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist oder Varianten der Ausgangslaccase, wobei die Varianten wie vorstehend definiert sind. Another object of the invention is a method for producing a laccase, comprising providing a starting laccase which has at least 70% sequence identity to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length or variants of the starting laccase, wherein the variants are as defined above.
Eine Laccase im Sinne der vorliegenden Patentanmeldung umfasst daher sowohl die Laccase als solche als auch eine mit einem erfindungsgemäßen Verfahren hergestellte Laccase. Alle Ausführungen zur Laccase beziehen sich daher sowohl auf die Laccase als Stoff wie auch auf die entsprechenden Verfahren, insbesondere Herstellungsverfahren der Laccase. Eine zur Aminosäuresequenz gemäß SEQ ID NO:1 oder SEQ ID NO:2 korrespondierende Nukleotidsequenz ist in SEQ ID NO:3 bzw. SEQ ID NO:4 angegeben. A laccase in the sense of the present patent application therefore includes both the laccase as such and a laccase produced by a method according to the invention. All statements on laccase therefore relate both to laccase as a substance and to the corresponding processes, in particular laccase production processes. A nucleotide sequence corresponding to the amino acid sequence according to SEQ ID NO: 1 or SEQ ID NO: 2 is given in SEQ ID NO: 3 or SEQ ID NO: 4.
Als weitere Erfindungsgegenstände sind mit den erfindungsgemäßen Laccasen bzw. den Herstellungsverfahren für erfindungsgemäße Laccasen für diese Laccasen codierende Nukleinsäuren, erfindungsgemäße Laccasen oder Nukleinsäuren enthaltende nicht-menschliche Wirtszellen verbunden. Further objects of the invention are associated with the laccases according to the invention or the production processes for laccases according to the invention for nucleic acids coding for these laccases, non-human host cells according to the invention or nucleic acids containing nucleic acids.
Die Erfindung betrifft ferner Laccasen umfassende Mittel, insbesondere Wasch- und Reinigungsmittel, Wasch- und Reinigungsverfahren, und über die hierin beschriebenen Laccasen definierte Verwendungen, wobei die hierbei eingesetzten Laccasen mindestens 70 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweisen oder Varianten davon sind. Die hier eingesetzten Varianten sind dadurch gekennzeichnet, dass sie aus einer Laccase, die eine Aminosäuresequenz mit mindestens 70 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist, als Ausgangsmolekül durch ein- oder mehrfache konservative Aminosäuresubstitution erhältlich sind. Alternativ oder ergänzend sind die
eingesetzten Varianten dadurch gekennzeichnet, dass sie aus einer Laccase, die eine Aminosäuresequenz mit mindestens 70 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist, als Ausgangsmolekül durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese erhältlich sind und eine Aminosäuresequenz umfasst, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit dem Ausgangsmolekül übereinstimmt. The invention further relates to agents comprising laccases, in particular detergents and cleaning agents, washing and cleaning processes, and uses defined by the laccases described herein, the laccases used here having at least 70% sequence identity with the one in SEQ ID NO: 1 or SEQ ID NO: 2 indicated amino acid sequence over their total length or are variants thereof. The variants used here are characterized in that they consist of a laccase, which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, as a starting molecule by one or more conservative amino acid substitution are available. They are alternative or supplementary Variants used, characterized in that it consists of a laccase which has an amino acid sequence with at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length, as the starting molecule by fragmentation, deletion, insertion or substitution mutagenesis are available and comprise an amino acid sequence that is at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487 in length , 488, 489, 490, 491, 492, 493, 494 or 495 connected amino acids matches the starting molecule.
Die vorliegende Erfindung basiert auf der überraschenden Erkenntnis der Erfinder, dass eine erfindungsgemäße Laccase aus Basidiomyceta, insbesondere Marasmiellus palmivorus, die eine zu der in SEQ ID NO:1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz zu mindestens 70 % identische Aminosäuresequenz umfasst, die Entfernung von farbigen Flecken und Anschmutzungen, insbesondere anthocyanhaltige Anschmutzungen, unter Standard-Waschbedingungen bewirkt. Das ist insbesondere insoweit überraschend, als dass bisher für keine der Laccasen aus Basidiomyceta, insbesondere Marasmiellus palmivorus, die Verwendung in Wasch- oder Reinigungsmitteln beschrieben wurde. The present invention is based on the surprising finding of the inventors that a basidiomyceta laccase according to the invention, in particular Marasmiellus palmivorus, which comprises an amino acid sequence which is at least 70% identical to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2, the removal of colored stains and soiling, in particular soiling containing anthocyanins, under standard washing conditions. This is particularly surprising insofar as the use in detergents or cleaning agents has not been described for any of the basidiomyceta laccases, in particular Marasmiellus palmivorus.
Die erfindungsgemäßen Laccasen verfügen über eine hohe Stabilität in Wasch- oder Reinigungsmitteln, beispielsweise gegenüber Tensiden und/oder Bleichmitteln und/oder gegenüber Temperatureinflüssen und/oder gegenüber sauren oder alkalischen Bedingungen und/oder gegenüber pH-Wert-Änderungen und/oder gegenüber denaturierenden oder oxidierenden Agentien und/oder gegenüber proteolytischem Abbau und/oder gegenüber einer Veränderung der Redox- Verhältnisse. Mit besonders bevorzugten Ausführungsformen der Erfindung werden folglich leistungsverbesserte Laccase-Varianten bereitgestellt. Solche vorteilhaften Ausführungsformen erfindungsgemäßer Laccasen ermöglichen folglich verbesserte Waschergebnisse an z.B. anthocyanhaltigen Anschmutzungen in einem weiten Temperaturbereich. The laccases according to the invention have high stability in detergents or cleaning agents, for example with respect to surfactants and / or bleaching agents and / or with respect to temperature influences and / or with respect to acidic or alkaline conditions and / or with respect to pH changes and / or with respect to denaturing or oxidizing agents Agents and / or against proteolytic degradation and / or against a change in the redox ratios. Consequently, particularly preferred embodiments of the invention provide performance-improved laccase variants. Such advantageous embodiments of laccases according to the invention consequently enable improved washing results on e.g. Soiling containing anthocyanins in a wide temperature range.
Eine erfindungsgemäße Laccase weist eine enzymatische Aktivität auf, d.h. sie ist zur Oxidation von z.B. phenol-, diphenolhaltigen und anderen Verbindungen befähigt, insbesondere in einem Wasch- und Reinigungsmittel. Vorteilhafterweise weist das erfindungsgemäße Wasch- und Reinigungsmittel eine verbesserte Reinigungsleistung, insbesondere bei der Entfernung farbiger Flecken und Anschmutzungen auf. Besonders bevorzugt eignet sich das erfindungsgemäße Wasch- und Reinigungsmittel zur Entfernung anthocyanhaltiger Anschmutzungen. A laccase according to the invention has an enzymatic activity, i.e. it is for the oxidation of e.g. capable of phenol, diphenol and other compounds, especially in a detergent. The washing and cleaning agent according to the invention advantageously has an improved cleaning performance, in particular when removing colored stains and soiling. The washing and cleaning agent according to the invention is particularly preferably suitable for removing soiling containing anthocyanins.
Ferner handelt es sich bei einer erfindungsgemäßen Laccase vorzugsweise um eine reife (mature) Laccase, d.h. um das katalytisch aktive Molekül ohne Signal- und/oder Propeptid(e). Soweit nicht anders angegeben, beziehen sich auch die angegebenen Sequenzen auf jeweils reife (prozessierte) Enzyme. Wie hierin verwendet, ist SEQ ID NO: 1 die Aminosäuresequenz des reifen Proteins, während SEQ ID NO:2 die Sequenz inklusive Signalpeptid angibt.
"Erfindungsgemäße Laccase", wie hierin verwendet, bezieht sich auf Laccasen die mindestens 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %,Furthermore, a laccase according to the invention is preferably a mature laccase, ie the catalytically active molecule without signal and / or propeptide (s). Unless otherwise stated, the sequences given also relate to mature (processed) enzymes. As used herein, SEQ ID NO: 1 is the amino acid sequence of the mature protein, while SEQ ID NO: 2 indicates the sequence including the signal peptide. "Laccase of the invention" as used herein refers to laccases that are at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81% , 82%, 83%, 84%,
85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %, 92,5 %, 93 %, 93,5 %, 94 %,85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%,
94,5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,6 %, 98,7 %, 98,8 %, 98,9 %,94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, 98.6%, 98.7%, 98.8 %, 98.9%,
99 %, 99,1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder 99,9 %99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8% or 99.9%
Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweisen oder Varianten davon sind. Die Varianten sind dadurch gekennzeichnet, dass sie aus einer Laccase mit der angegebenen Sequenzidentität als Ausgangsmolekül durch ein- oder mehrfache konservative Aminosäuresubstitution erhältlich sind. Alternativ oder ergänzend sind die eingesetzten Varianten dadurch gekennzeichnet, dass sie aus einer Laccase mit der angegebenen Sequenzidentität als Ausgangsmolekül durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese erhältlich sind und eine Aminosäuresequenz umfasst, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit dem Ausgangsmolekül übereinstimmt. Have sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over their entire length or are variants thereof. The variants are characterized in that they can be obtained from a laccase with the specified sequence identity as the starting molecule by one or more conservative amino acid substitution. Alternatively or additionally, the variants used are characterized in that they can be obtained from a laccase with the specified sequence identity as the starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprise an amino acid sequence which has a length of at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 related amino acids with the parent molecule matches.
In verschiedenen Ausführungsformen der Erfindung umfasst die Laccase eine Aminosäuresequenz, die zu der in SEQ ID NO: 1 angegebenen Aminosäuresequenz über deren Gesamtlänge zu mindestens 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,8 %, 99,0 %, 99,2 %, 99,4 %, 99,5 %, 99,6 % oder 99,8 % identisch ist. In various embodiments of the invention, the laccase comprises an amino acid sequence which is at least 95%, 95.5%, 96%, 96.5%, 97%, 97.5% of the amino acid sequence given in SEQ ID NO: 1 over its entire length. , 98%, 98.5%, 98.8%, 99.0%, 99.2%, 99.4%, 99.5%, 99.6% or 99.8%.
In weiteren verschiedenen Ausführungsformen der Erfindung ist die Laccase ein frei vorliegendes Enzym. Dies bedeutet, dass die Laccase mit allen Komponenten eines Mittels direkt agieren kann und, falls es sich bei dem Mittel um ein Flüssigmittel handelt, dass die Laccase direkt mit dem Lösungsmittel des erfindungsgemäßen Mittels (z.B. Wasser) in Kontakt steht. In anderen Ausführungsformen kann die erfindungsgemäße Laccase in einem Mittel einen Interaktionskomplex mit anderen Molekülen bilden oder eine "Umhüllung" enthalten. Hierbei kann ein einzelnes oder mehrere Laccase-Moleküle durch eine sie umgebende Struktur von den anderen Bestandteilen eines Mittels getrennt sein. Eine solche trennende Struktur kann entstehen durch, ist allerdings nicht beschränkt auf, Vesikel, wie etwa eine Micelle oder ein Liposom. Die umgebende Struktur kann aber auch ein Viruspartikel, eine bakterielle Zelle oder eine eukaryotische Zelle sein. In verschiedenen Ausführungsformen kann die erfindungsgemäße Laccase in Zellen von Basidiomyceta, die diese Laccase exprimieren, oder in Zellkulturüberständen solcher Zellen enthalten sein. In other various embodiments of the invention, the laccase is a free enzyme. This means that the laccase can act directly with all components of an agent and, if the agent is a liquid agent, that the laccase is in direct contact with the solvent of the agent according to the invention (e.g. water). In other embodiments, the laccase according to the invention can form an interaction complex with other molecules in an agent or contain an “envelope”. Here, a single or several laccase molecules can be separated from the other constituents of an agent by a structure surrounding them. Such a separating structure can result from, but is not limited to, vesicles, such as a micelle or a liposome. The surrounding structure can also be a virus particle, a bacterial cell or a eukaryotic cell. In various embodiments, the laccase according to the invention can be contained in cells from Basidiomyceta which express this laccase or in cell culture supernatants of such cells.
Die Bestimmung der Identität von Nukleinsäure- oder Aminosäuresequenzen erfolgt durch einen Sequenzvergleich. Dieser Sequenzvergleich basiert auf dem im Stand der Technik etablierten und üblicherweise genutzten BLAST-Algorithmus (vgl. z.B. Altschul et al. (1990): "Basic local alignment search tool", J. Mol. Biol. 215:403-410, und Altschul et al. (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res. 25:3389-3402) und
geschieht prinzipiell dadurch, dass ähnliche Abfolgen von Nukleotiden oder Aminosäuren in den Nukleinsäure- oder Aminosäuresequenzen einander zugeordnet werden. Eine tabellarische Zuordnung der betreffenden Positionen wird als Alignment bezeichnet. Ein weiterer im Stand der Technik verfügbarer Algorithmus ist der FASTA-Algorithmus. Sequenzvergleiche (Alignments), insbesondere multiple Sequenzvergleiche, werden mit Computerprogrammen erstellt. Häufig genutzt werden beispielsweise die Clustal-Serie (vgl. z.B. Chenna et al. (2003): "Multiple sequence alignment with the Clustal series of programs", Nucleic Acids Res. 31 :3497-3500), T-Coffee (vgl. z.B. Notredame et al. (2000): "T-Coffee: A novel method for multiple sequence alignments", J. Mol. Biol. 302:205-217) oder Programme, die auf diesen Programmen bzw. Algorithmen basieren. Ferner möglich sind Sequenzvergleiche (Alignments) mit dem Computer-Programm Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, Kalifornien, USA) mit den vorgegebenen Standard parametern, dessen AlignX-Modul für die Sequenzvergleiche auf ClustalW basiert. The identity of nucleic acid or amino acid sequences is determined by a sequence comparison. This sequence comparison is based on the BLAST algorithm established and commonly used in the prior art (cf., for example, Altschul et al. (1990): "Basic local alignment search tool", J. Mol. Biol. 215: 403-410, and Altschul et al. (1997): "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res. 25: 3389-3402) and happens principally in that similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences are assigned to each other. A tabular assignment of the relevant positions is called alignment. Another algorithm available in the prior art is the FASTA algorithm. Sequence comparisons (alignments), in particular multiple sequence comparisons, are created using computer programs. For example, the Clustal series (cf. e.g. Chenna et al. (2003): "Multiple sequence alignment with the Clustal series of programs", Nucleic Acids Res. 31: 3497-3500), T-Coffee (cf. e.g. Notredame et al. (2000): "T-Coffee: A novel method for multiple sequence alignments", J. Mol. Biol. 302: 205-217) or programs based on these programs or algorithms. Sequence comparisons (alignments) are also possible with the computer program Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the specified standard parameters, whose AlignX module for sequence comparisons is based on ClustalW.
Solch ein Vergleich erlaubt auch eine Aussage über die Ähnlichkeit der verglichenen Sequenzen zueinander. Sie wird üblicherweise in Prozent-Identität, d.h. dem Anteil der identischen Nukleotide oder Ami nosäure reste an denselben oder in einem Alignment einander entsprechenden Positionen angegeben. Der weiter gefasste Begriff der Homologie bezieht bei Aminosäuresequenzen konservierte Aminosäureaustausche in die Betrachtung mit ein, also Aminosäuren mit ähnlicher chemischer Aktivität, da diese innerhalb des Proteins meist ähnliche chemische Aktivitäten ausüben. Daher kann die Ähnlichkeit der verglichenen Sequenzen auch Prozent-Homologie oder Prozent- Ähnlichkeit angegeben sein. Identitäts- und/oder Homologieangaben können über ganze Polypeptide oder Gene oder nur über einzelne Bereiche getroffen werden. Homologe oder identische Bereiche von verschiedenen Nukleinsäure- oder Aminosäuresequenzen sind daher durch Übereinstimmungen in den Sequenzen definiert. Solche Bereiche weisen oftmals identische Funktionen auf. Sie können klein sein und nur wenige Nukleotide oder Aminosäuren umfassen. Oftmals üben solche kleinen Bereiche für die Gesamtaktivität des Proteins essentielle Funktionen aus. Es kann daher sinnvoll sein, Sequenzübereinstimmungen nur auf einzelne, gegebenenfalls kleine Bereiche zu beziehen. Soweit nicht anders angegeben beziehen sich Identitäts- oder Homologieangaben in der vorliegenden Anmeldung aber auf die Gesamtlänge der jeweils angegebenen Nukleinsäure- oder Aminosäuresäuresequenz. Such a comparison also allows a statement to be made about the similarity of the compared sequences to one another. It is usually expressed in percent identity, i.e. the proportion of identical nucleotides or amino acid residues at the same or in an alignment corresponding positions indicated. The broader concept of homology also includes conserved amino acid exchanges in amino acid sequences, that is, amino acids with similar chemical activity, since these usually have similar chemical activities within the protein. The similarity of the compared sequences can therefore also be given as percent homology or percent similarity. Identity and / or homology information can be made about entire polypeptides or genes or only over individual areas. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences. Such areas often have identical functions. They can be small and contain only a few nucleotides or amino acids. Such small areas often have essential functions for the overall activity of the protein. It can therefore make sense to relate sequence matches only to individual, possibly small, areas. Unless otherwise stated, identity or homology information in the present application relates to the total length of the nucleic acid or amino acid sequence specified in each case.
Im Zusammenhang mit der vorliegenden Erfindung bedeutet die Angabe, dass eine Aminosäureposition einer numerisch bezeichneten Position in SEQ ID NO: 1 entspricht daher, dass die entsprechende Position der numerisch bezeichneten Position in SEQ ID NO:1 in einem wie oben definierten Alignment zugeordnet ist. In connection with the present invention, the indication that an amino acid position corresponds to a numerically designated position in SEQ ID NO: 1 therefore means that the corresponding position is assigned to the numerically designated position in SEQ ID NO: 1 in an alignment as defined above.
In einer weiteren Ausführungsform der Erfindung ist die Laccase dadurch gekennzeichnet, dass ihre Reinigungsleistung gegenüber derjenigen einer Laccase, die eine Aminosäuresequenz umfasst, die der in SEQ ID NO: 1 angegebenen Aminosäuresequenzen entspricht, nicht signifikant verringert ist,
d.h. mindestens 70 %, 75 %, 80 %, 85 %, 90 %, 95 % der Referenzwaschleistung besitzt. Die Reinigungsleistung kann in einem Waschsystem bestimmt werden, das ein Waschmittel in einer Dosierung zwischen 4,5 und 7,0 Gramm pro Liter Waschflotte sowie die Laccase enthält, wobei die zu vergleichenden Laccasen konzentrationsgleich (bezogen auf aktives Protein) eingesetzt sind und die Reinigungsleistung gegenüber einer Anschmutzung auf Baumwolle bestimmt wird durch Messung des Reinigungsgrades der gewaschenen Textilien. Beispielsweise kann der Waschvorgang für 60 Minuten bei einer Temperatur von 40 °C erfolgen und das Wasser eine Wasserhärte zwischen 5° und 25°, bevorzugt 10° und 20°, bevorzugter 13° und 17° und ferner bevorzugt 15,5° und 16,5° (deutsche Härte) aufweisen. Die Konzentration der Laccase in dem für dieses Waschsystem bestimmten Waschmittel beträgt von 0,001 bis 1 Gew.-%, vorzugsweise von 0,001 bis 0,1 Gew. %, und noch bevorzugter von 0,01 bis 0,06 Gew.-%, bezogen auf aktives, gereinigtes Protein. In a further embodiment of the invention, the laccase is characterized in that its cleaning performance is not significantly reduced compared to that of a laccase which comprises an amino acid sequence which corresponds to the amino acid sequences given in SEQ ID NO: 1, ie at least 70%, 75%, 80%, 85%, 90%, 95% of the reference washing performance. The cleaning performance can be determined in a washing system that contains a detergent in a dosage between 4.5 and 7.0 grams per liter of washing liquor as well as the laccase, the laccases to be compared having the same concentration (based on active protein) and the cleaning performance versus Soiling on cotton is determined by measuring the degree of cleaning of the washed textiles. For example, the washing process can take place for 60 minutes at a temperature of 40 ° C. and the water has a water hardness between 5 ° and 25 °, preferably 10 ° and 20 °, more preferably 13 ° and 17 ° and further preferably 15.5 ° and 16. Have 5 ° (German hardness). The concentration of laccase in the detergent intended for this washing system is from 0.001 to 1% by weight, preferably from 0.001 to 0.1% by weight, and more preferably from 0.01 to 0.06% by weight, based on active, purified protein.
Ein bevorzugtes flüssiges Waschmittel für ein solches Waschsystem kann z.B. wie folgt zusammengesetzt sein (alle Angaben in Gew.-%): 7 % Alkylbenzolsulfonsäure, 9 % anionische Tenside, 4 % Na-Salze von C12-C18 Fettsäuren, 7 % nicht-ionische Tenside, 0,7 % Phosphonate, 3,2 % Zitronensäure, 3,0 % NaOH, 0,04 % Entschäumer, 5,7 % 1 ,2-Propandiol, 0,1 % Konservierungsstoffe, 2 % Ethanol, 0,2 % Farbstoff-Transfer-Inhibitor, Rest demineralisiertes Wasser. Bevorzugt beträgt die Dosierung des flüssigen Waschmittels zwischen 4,5 und 6,0 Gramm pro Liter Waschflotte, beispielsweise 4,7, 4,9 oder 5,9 Gramm pro Liter Waschflotte. Bevorzugt wird gewaschen in einem pH-Wertebereich zwischen pH 7,5 und pH 10,5, bevorzugt zwischen pH 7,5 und pH 9. A preferred liquid detergent for such a washing system can e.g. be composed as follows (all figures in% by weight): 7% alkylbenzenesulfonic acid, 9% anionic surfactants, 4% Na salts of C12-C18 fatty acids, 7% non-ionic surfactants, 0.7% phosphonates, 3.2 % Citric acid, 3.0% NaOH, 0.04% defoamer, 5.7% 1, 2-propanediol, 0.1% preservatives, 2% ethanol, 0.2% dye transfer inhibitor, remainder demineralized water. The dosage of the liquid detergent is preferably between 4.5 and 6.0 grams per liter of wash liquor, for example 4.7, 4.9 or 5.9 grams per liter of wash liquor. Washing is preferably carried out in a pH range between pH 7.5 and pH 10.5, preferably between pH 7.5 and pH 9.
Im Rahmen der Erfindung erfolgt die Bestimmung die Reinigungsleistung bei 40 °C unter Verwendung eines flüssigen Waschmittels wie vorstehend angegeben, wobei der Waschvorgang vorzugsweise für 60 Minuten erfolgt. In the context of the invention, the cleaning performance is determined at 40 ° C. using a liquid detergent as indicated above, the washing process preferably taking place for 60 minutes.
Der Weißheitsgrad, d.h. die Aufhellung der Anschmutzungen, als Maß für die Reinigungsleistung wird mit optischen Messverfahren bestimmt, bevorzugt photometrisch. Ein hierfür geeignetes Gerät ist beispielsweise das Spektrometer Minolta CM508d. Üblicherweise werden die für die Messung eingesetzten Geräte zuvor mit einem Weißstandard, bevorzugt einem mitgelieferten Weißstandard, kalibriert. The degree of whiteness, i.e. the lightening of the soiling, as a measure of the cleaning performance, is determined using optical measuring methods, preferably photometrically. A suitable device is, for example, the Minolta CM508d spectrometer. Usually, the devices used for the measurement are calibrated beforehand with a white standard, preferably a supplied white standard.
Durch den aktivitätsgleichen Einsatz der jeweiligen Laccase wird sichergestellt, dass auch bei einem etwaigen Auseinanderklaffen des Verhältnisses von Aktivsubstanz zu Gesamtprotein (die Werte der spezifischen Aktivität) die jeweiligen enzymatischen Eigenschaften, also beispielsweise die Reinigungsleistung an bestimmten Anschmutzungen, verglichen werden. Generell gilt, dass eine niedrige spezifische Aktivität durch Zugabe einer größeren Proteinmenge ausgeglichen werden kann.
Die Laccase-Aktivität wird in fachüblicher Weise bestimmt, und zwar vorzugsweise durch ein optisches Messverfahren, bevorzugt ein photometrisches Verfahren. Der ABTS-(2,2'-azino-bis (3- ethylbenzothiazoline-6-sulfonic acid)-Assay ist ein gängiger Assay zur Aktivitätsbestimmung von Laccasen, da ABTS einen natürlichen Mediator darstellt (vgl. z.B. Bourbonnais and Paice (1990) FEBS Lett. 267(1 ):99-102, Canas et al. (2010)“Laccases and their natural mediators”, Biotechnol. Advances 28:694-705, Frasconi et al. (2009)“Kinetic and biochemical properties of high and low redox potential laccases from fungal and plant origin” Biochemica et Biophysica Acta 1804:899-908). The use of the respective laccase, which has the same activity, ensures that even if the ratio of active substance to total protein (the values of the specific activity) diverges, the respective enzymatic properties, for example the cleaning performance of certain soiling, are compared. In general, a low specific activity can be compensated for by adding a larger amount of protein. The laccase activity is determined in a customary manner, and preferably by an optical measurement method, preferably a photometric method. The ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) assay is a common assay for determining the activity of laccases, since ABTS is a natural mediator (cf. e.g. Bourbonnais and Paice (1990) FEBS Lett. 267 (1): 99-102, Canas et al. (2010) “Laccases and their natural mediators”, Biotechnol. Advances 28: 694-705, Frasconi et al. (2009) “Kinetic and biochemical properties of high and low redox potential laccases from fungal and plant origin ”Biochemica et Biophysica Acta 1804: 899-908).
Die Proteinkonzentration kann mit Hilfe bekannter Methoden, z.B. dem BCA-Verfahren (Bicinchoninsäure; 2,2‘-Bichinolyl-4,4‘-dicarbonsäure) oder dem Biuret-Verfahren (vgl. z.B. Gornall et al. (1948), J. Biol. Chem., 177:751-766) bestimmt werden. Die Bestimmung der Aktivproteinkonzentration kann diesbezüglich über eine Titration der aktiven Zentren unter Verwendung eines geeigneten irreversiblen Inhibitors und Bestimmung der Restaktivität (vgl. z.B. Bender et al. (1966), J. Am. Chem. Soc. 88(24):5890-5913) erfolgen. The protein concentration can be determined using known methods, e.g. the BCA method (bicinchoninic acid; 2,2'-bichinolyl-4,4'-dicarboxylic acid) or the biuret method (see, for example, Gornall et al. (1948), J. Biol. Chem., 177: 751-766 ) can be determined. In this regard, the determination of the active protein concentration can be carried out by titrating the active centers using a suitable irreversible inhibitor and determining the residual activity (see, for example, Bender et al. (1966), J. Am. Chem. Soc. 88 (24): 5890-5913 ) respectively.
Erfindungsgemäße Laccasen können im Vergleich zu der in SEQ ID NO: 1 oder SEQ ID NO:2 beschriebenen Laccase weitere Aminosäureveränderungen, insbesondere Aminosäure- Substitutionen, -Insertionen oder -Deletionen, aufweisen. Solche Laccasen sind beispielsweise durch gezielte genetische Veränderung, d.h. durch Mutageneseverfahren, weiterentwickelt und für bestimmte Einsatzzwecke oder hinsichtlich spezieller Eigenschaften (beispielsweise hinsichtlich ihrer katalytischen Aktivität, Stabilität, usw.) optimiert. Ferner können erfindungsgemäße Nukleinsäuren in Rekombinationsansätze eingebracht und damit zur Erzeugung völlig neuartiger Laccasen oder anderer Polypeptide genutzt werden. Laccases according to the invention can have further amino acid changes, in particular amino acid substitutions, insertions or deletions, compared to the laccase described in SEQ ID NO: 1 or SEQ ID NO: 2. Such laccases are, for example, by targeted genetic modification, i.e. through mutagenesis processes, further developed and optimized for specific purposes or with regard to special properties (for example with regard to their catalytic activity, stability, etc.). Furthermore, nucleic acids according to the invention can be introduced into recombination approaches and thus used to generate completely new laccases or other polypeptides.
Das Ziel ist es, in die bekannten Moleküle gezielte Mutationen wie Substitutionen, Insertionen oder Deletionen einzuführen, um beispielsweise die Reinigungsleistung von erfindungsgemäßen Enzymen zu verbessern. Hierzu können insbesondere die Oberflächenladungen und/oder der isoelektrische Punkt der Moleküle und dadurch ihre Wechselwirkungen mit dem Substrat verändert werden. So kann beispielsweise die Nettoladung der Enzyme verändert werden, um darüber die Substratbindung insbesondere für den Einsatz in Wasch- und Reinigungsmitteln zu beeinflussen. Alternativ oder ergänzend kann durch eine oder mehrere entsprechende Mutationen die Stabilität der Enzyme noch weiter erhöht und dadurch ihre Reinigungsleistung verbessert werden. Vorteilhafte Eigenschaften einzelner Mutationen, z.B. einzelner Substitutionen, können sich ergänzen. Eine hinsichtlich bestimmter Eigenschaften bereits optimierte Laccase, z.B. hinsichtlich ihrer Aktivität und/oder ihrer Toleranz in Bezug auf das Substratspektrum, kann daher im Rahmen der Erfindung zusätzlich weiterentwickelt sein. The aim is to introduce targeted mutations such as substitutions, insertions or deletions into the known molecules, for example in order to improve the cleaning performance of enzymes according to the invention. For this purpose, in particular the surface charges and / or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed. For example, the net charge of the enzymes can be changed in order to influence the substrate binding, especially for use in detergents and cleaning agents. Alternatively or additionally, the stability of the enzymes can be increased even further by one or more corresponding mutations and their cleaning performance can thereby be improved. Advantageous properties of individual mutations, e.g. individual substitutions can complement each other. A laccase already optimized with regard to certain properties, e.g. with regard to their activity and / or their tolerance in relation to the substrate spectrum, can therefore be further developed within the scope of the invention.
Für die Beschreibung von Substitutionen, die genau eine Aminosäureposition betreffen (Aminosäureaustausche), wird folgende Konvention angewendet: zunächst wird die natürlicherweise
vorhandene Aminosäure in Form des international gebräuchlichen Einbuchstaben-Codes bezeichnet, dann folgt die zugehörige Sequenzposition und schließlich die eingefügte Aminosäure. Mehrere Austausche innerhalb derselben Polypeptidkette werden durch Schrägstriche voneinander getrennt. Bei Insertionen sind nach der Sequenzposition zusätzliche Aminosäuren benannt. Bei Deletionen ist die fehlende Aminosäure durch ein Symbol, beispielsweise einen Stern oder einen Strich, ersetzt oder vor der entsprechenden Position ein D angegeben. Beispielsweise beschreibt R45Q die Substitution von Arginin an Position 45 durch Glutamin, N45AQ die Insertion von Glutamin nach der Aminosäure Alanin an Position 45 und N45* oder DN45 die Deletion von Asparagin an Position 45. Diese Nomenklatur ist dem Fachmann auf dem Gebiet der Enzymtechnologie bekannt. The following convention is used to describe substitutions that relate to exactly one amino acid position (amino acid exchanges): First, it is natural existing amino acid in the form of the internationally used one-letter code, followed by the associated sequence position and finally the inserted amino acid. Multiple exchanges within the same polypeptide chain are separated from one another by slashes. In the case of insertions, additional amino acids are named after the sequence position. In the case of deletions, the missing amino acid is replaced by a symbol, for example an asterisk or a dash, or a D is given in front of the corresponding position. For example, R45Q describes the substitution of arginine at position 45 by glutamine, N45AQ the insertion of glutamine after the amino acid alanine at position 45 and N45 * or DN45 the deletion of asparagine at position 45. This nomenclature is known to the person skilled in the field of enzyme technology.
Ein weiterer Gegenstand der Erfindung ist daher eine Laccase, die dadurch gekennzeichnet ist, dass sie aus einer Laccase wie vorstehend beschrieben als Ausgangsmolekül durch ein- oder mehrfache konservative Aminosäuresubstitution erhältlich ist. Der Begriff "konservative Aminosäuresubstitution" bedeutet den Austausch (Substitution) eines Aminosäurerestes gegen einen anderen Aminosäurerest, wobei dieser Austausch nicht zu einer Änderung der Polarität oder Ladung an der Position der ausgetauschten Aminosäure führt, z.B. der Austausch eines unpolaren Aminosäurerestes gegen einen anderen unpolaren Aminosäurerest. Konservative Aminosäuresubstitutionen im Rahmen der Erfindung umfassen beispielsweise: G=A=S, l=V=L=M, D=E, N=Q, K=R, Y=F, S=T, G=A=I=V=L=M=Y=F=W=P=S=T. Dabei kann die Laccase vor und z.B. auch nach der konservativen Aminosäuresubstitution eine Aminosäuresequenz umfassen, die zu der in SEQ ID NO:1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge zu mindestens 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %, 92,5 %, 93 %,Another object of the invention is therefore a laccase which is characterized in that it can be obtained from a laccase as described above as the starting molecule by one or more conservative amino acid substitution. The term "conservative amino acid substitution" means the substitution of one amino acid residue for another amino acid residue, this exchange not leading to a change in polarity or charge at the position of the amino acid exchanged, e.g. the exchange of a non-polar amino acid residue for another non-polar amino acid residue. Conservative amino acid substitutions within the scope of the invention include, for example: G = A = S, I = V = L = M, D = E, N = Q, K = R, Y = F, S = T, G = A = I = V = L = M = Y = F = W = P = S = T. The laccase can be placed before and e.g. Even after the conservative amino acid substitution, comprise an amino acid sequence which corresponds to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length by at least 70%, 71%, 72%, 73%, 74%, 75%, 76 %, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91 %, 91, 5%, 92%, 92.5%, 93%,
93.5 %, 94 %, 94,5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,6 %, 98,7 %,93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, 98.6%, 98, 7%,
98.8 %, 98,9 %, 99,0 %, 99, 1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder98.8%, 98.9%, 99.0%, 99, 1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99, 8% or
99.9 % identisch ist. 99.9% is identical.
Alternativ oder ergänzend ist die Laccase dadurch gekennzeichnet, dass sie aus einer Laccase wie vorstehend beschrieben als Ausgangsmolekül durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese erhältlich ist und eine Aminosäuresequenz umfasst, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit dem Ausgangsmolekül übereinstimmt. Dabei kann die Laccase vor und z.B. auch nach der Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese eine Aminosäuresequenz umfassen, die zu der in SEQ ID NO:1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge zu mindestens 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %,Alternatively or additionally, the laccase is characterized in that it is obtainable from a laccase as the starting molecule as described above by fragmentation, deletion, insertion or substitution mutagenesis and comprises an amino acid sequence which is at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 related amino acids matches the parent molecule. The laccase can be placed before and e.g. also after the fragmentation, deletion, insertion or substitution mutagenesis comprise an amino acid sequence which is at least 70%, 71%, 72%, 73% of the total length of the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90% , 90.5%, 91%, 91, 5%, 92%,
92.5 %, 93 %, 93,5 %, 94 %, 94,5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %,
98,6 %, 98,7 %, 98,8 %, 98,9 %, 99,0 %, 99,1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder 99,9 % identisch ist. 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5% . 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8% or 99.9% is identical.
So ist es beispielsweise möglich, an den Termini oder in den Loops des Enzyms einzelne Aminosäuren zu deletieren, ohne dass dadurch die katalytische Aktivität verloren oder vermindert wird. Ferner kann durch derartige Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese beispielsweise auch die Allergenizität betreffender Enzyme gesenkt und somit insgesamt ihre Einsetzbarkeit verbessert werden. Vorteilhafterweise behalten die Enzyme auch nach der Mutagenese ihre katalytische Aktivität, d.h. ihre katalytische Aktivität entspricht mindestens derjenigen des Ausgangsenzyms, d.h. in einer bevorzugten Ausführungsform beträgt die katalytische Aktivität mindestens 80 %, vorzugsweise mindestens 90 % der Aktivität des Ausgangsenzyms. Auch weitere Substitutionen können vorteilhafte Wirkungen zeigen. Sowohl einzelne wie auch mehrere zusammenhängende Aminosäuren können gegen andere Aminosäuren ausgetauscht werden. For example, it is possible to delete individual amino acids at the termini or in the loops of the enzyme without losing or reducing the catalytic activity. Furthermore, such fragmentation, deletion, insertion or substitution mutagenesis can, for example, also reduce the allergenicity of enzymes and thus overall improve their usability. Advantageously, the enzymes retain their catalytic activity even after mutagenesis, i.e. their catalytic activity corresponds at least to that of the parent enzyme, i.e. in a preferred embodiment, the catalytic activity is at least 80%, preferably at least 90%, of the activity of the starting enzyme. Other substitutions can also have beneficial effects. Both single and multiple contiguous amino acids can be exchanged for other amino acids.
Die weiteren Aminosäurepositionen werden hierbei durch ein Alignment der Aminosäuresequenz einer erfindungsgemäßen Laccase mit der Aminosäuresequenz der Laccase aus Basidiomyceta, insbesondere Marasmiellus palmivorus, wie sie in SEQ ID NO: 1 oder SEQ ID NO:2 angegeben ist, definiert. Weiterhin richtet sich die Zuordnung der Positionen nach dem reifen (maturen) Protein. Diese Zuordnung ist insbesondere auch anzuwenden, wenn die Aminosäuresequenz einer erfindungsgemäßen Laccase eine höhere Zahl von Aminosäureresten umfasst als die Laccase aus Basidiomyceta, insbesondere Marasmiellus palmivorus, gemäß SEQ ID NO: 1 oder SEQ ID NO:2. Ausgehend von den genannten Positionen in der Aminosäuresequenz der Laccase aus Basidiomyceta, insbesondere Marasmiellus palmivorus, sind die Veränderungspositionen in einer erfindungsgemäßen Laccase diejenigen, die eben diesen Positionen in einem Alignment zugeordnet sind. The further amino acid positions are defined here by an alignment of the amino acid sequence of a laccase according to the invention with the amino acid sequence of the basidiomyceta laccase, in particular Marasmiellus palmivorus, as specified in SEQ ID NO: 1 or SEQ ID NO: 2. Furthermore, the assignment of the positions depends on the mature (mature) protein. This assignment is also to be used in particular if the amino acid sequence of a laccase according to the invention comprises a higher number of amino acid residues than the laccase from Basidiomyceta, in particular Marasmiellus palmivorus, according to SEQ ID NO: 1 or SEQ ID NO: 2. Starting from the positions mentioned in the amino acid sequence of the basidiomyceta laccase, in particular Marasmiellus palmivorus, the change positions in a laccase according to the invention are those which are assigned to these positions in an alignment.
Eine weitere Bestätigung der korrekten Zuordnung der zu verändernden Aminosäuren, d.h. insbesondere deren funktionelle Entsprechung, können Vergleichsversuche liefern, wonach die beiden auf der Basis eines Alignments einander zugeordneten Positionen in beiden miteinander verglichenen Laccasen auf die gleiche Weise verändert werden und beobachtet wird, ob bei beiden die enzymatische Aktivität auf gleiche Weise verändert wird. Geht beispielsweise ein Aminosäureaustausch in einer bestimmten Position der Laccase aus Basidiomyceta, insbesondere Marasmiellus palmivorus, gemäß SEQ ID NO: 1 oder SEQ ID NO:2 mit einer Veränderung eines enzymatischen Parameters einher, beispielsweise mit der Erhöhung des «M-Wertes, und wird eine entsprechende Veränderung des enzymatischen Parameters, beispielsweise also ebenfalls eine Erhöhung des «M-Wertes, in einer erfindungsgemäßen Laccase-Variante beobachtet, deren Aminosäureaustausch durch dieselbe eingeführte Aminosäure erreicht wurde, so ist hierin eine Bestätigung der korrekten Zuordnung zu sehen.
Insbesondere werden erfindungsgemäß auch Fragmente der Laccase wie hierin definiert, insbesondere solche gemäß SEQ ID NO: 1 , die am N- und/oder C-Terminus derart verkürzt sind, dass ein oder mehrere Aminosäuren der Laccase, beispielsweise 1 , 2, 3, 4, 5, 6, 7, 8, 9 oder 10, nicht länger enthalten sind, erfasst. Auch von diesen verkürzten Fragmenten können in verschiedenen Ausführungsformen der Erfindung Varianten verwendet werden, die zu der ausgehend von der in SEQ ID NO:1 angegebenen Aminosäuresequenz um (jeweils) 1 bis 10 N- terminale und/oder C-terminale Aminosäuren verkürzten Form, über die Gesamtlänge zu mindestens 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %, 92,5 %, 93 %, 93,5 %, 94 %,Comparative experiments can provide further confirmation of the correct assignment of the amino acids to be changed, that is to say in particular their functional correspondence, according to which the two positions assigned to one another on the basis of an alignment are changed in the same way in both compared laccases and it is observed whether in both the enzymatic activity is changed in the same way. If, for example, an amino acid exchange in a specific position of the basidiomyceta laccase, in particular Marasmiellus palmivorus, according to SEQ ID NO: 1 or SEQ ID NO: 2 is accompanied by a change in an enzymatic parameter, for example by an increase in the « M value, and becomes one If a corresponding change in the enzymatic parameter, for example also an increase in the M value, is observed in a laccase variant according to the invention, the amino acid exchange of which has been achieved by the same amino acid introduced, this is to be seen as a confirmation of the correct assignment. In particular, fragments of laccase as defined herein, in particular those according to SEQ ID NO: 1, which are shortened at the N and / or C terminus in such a way that one or more amino acids of laccase, for example 1, 2, 3, 4 , 5, 6, 7, 8, 9 or 10, are no longer included. Of these shortened fragments, variants can also be used in various embodiments of the invention which have the form shortened by (in each case) 1 to 10 N-terminal and / or C-terminal amino acids starting from the amino acid sequence given in SEQ ID NO: 1 the total length at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85 %, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%,
94.5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,6 %, 98,7 %, 98,8 %, 98,9 %, 99,0 %, 99,1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder 99,9 % identisch sind. Beispielsweise werden erfindungsgemäß auch Laccasen erfasst, die eine Aminosäuresequenz aufweisen, die über die Laccase umfassend eine Aminosäuresequenz, die mindestens 70 %, vorzugsweise mindestens 80 %, besonders bevorzugt mindestens 95 % Sequenzidentität mit der in SEQ ID NO: 1 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist bzw. den hierin beschriebenen Varianten davon, hinausgeht, ohne dass dadurch die katalytische Aktivität verloren oder vermindert wird. Vorzugsweise sind derartige Laccasen solche, die N- und/oder C-terminal zusätzliche Aminosäuren, beispielsweise das Signal-Peptid oder Fragmente des Signal-Peptids aufweisen, wobei das Signal-Peptid oder die Fragmente des Signal-Peptids bei der Herstellung der Laccase entstehen. 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8% or 99.9% are identical. For example, according to the invention, laccases are also detected which have an amino acid sequence which, via the laccase, comprises an amino acid sequence which has at least 70%, preferably at least 80%, particularly preferably at least 95% sequence identity with the amino acid sequence given in SEQ ID NO: 1 over its entire length or the variants thereof described here, without the catalytic activity being lost or reduced thereby. Such laccases are preferably those which have N- and / or C-terminal additional amino acids, for example the signal peptide or fragments of the signal peptide, the signal peptide or fragments of the signal peptide being produced in the preparation of the laccase.
Erfindungsgemäß werden auch Laccasen erfasst, die eine Aminosäuresequenz aufweisen, die gegenüber einer Laccase umfassend eine Aminosäuresequenz, die mindestens 70 %, vorzugsweise mindestens 80 %, besonders bevorzugt mindestens 95 % Sequenzidentität mit der in SEQ ID NO:2 angegebene Aminosäuresequenz aufweist bzw. den hierin beschriebenen Varianten davon, am N- Terminus derart verkürzt sind, dass das Signalpeptid oder ein oder mehrere Aminosäuren des Signalpeptids, beispielsweise 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , oder 22, insbesondere die N-terminalen 22 Aminosäuren, nicht länger enthalten sind. Auch von diesen Laccasen mit dem Signal-Peptid oder Fragmenten des Signal-Peptids können in verschiedenen Ausführungsformen der Erfindung Varianten verwendet werden, die zu der ausgehend von der in SEQ ID NO:2 angegebenen Aminosäuresequenz um 1 bis 22 N-terminale Aminosäuren verkürzten Form, über die Gesamtlänge zu mindestens 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %, 92,5 %, 93 %, 93,5 %, 94 %, 94,5 %, 95 %, 95,5 %, 96 %,According to the invention, laccases are also recorded which have an amino acid sequence which, compared to a laccase comprising an amino acid sequence, has at least 70%, preferably at least 80%, particularly preferably at least 95% sequence identity with the amino acid sequence given in SEQ ID NO: 2 or the one therein described variants thereof are shortened at the N-terminus such that the signal peptide or one or more amino acids of the signal peptide, for example 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13 , 14, 15, 16, 17, 18, 19, 20, 21, or 22, especially the N-terminal 22 amino acids, are no longer included. Of these laccases with the signal peptide or fragments of the signal peptide, variants can also be used in various embodiments of the invention which have the form shortened by 1 to 22 N-terminal amino acids based on the amino acid sequence given in SEQ ID NO: 2, over the entire length at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%,
96.5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,6 %, 98,7 %, 98,8 %, 98,9 %, 99,0 %, 99, 1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder 99,9 % identisch sind. 96.5%, 97%, 97.5%, 98%, 98.5%, 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99, 1%, 99 , 2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8% or 99.9% are identical.
Alle genannten Sachverhalte sind auch auf die erfindungsgemäßen Verfahren zur Herstellung einer Laccase anwendbar.
Demnach umfasst ein erfindungsgemäßes Verfahren ein Verfahren zur Herstellung einer Laccase, umfassend das Bereitstellen einer Ausgangslaccase, die mindestens 70 %, vorzugsweise mindestens 80 %, besonders bevorzugt mindestens 95 % Sequenzidentität zu der in SEQ ID NO:1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist, oder Varianten der Ausgangslaccase, wobei das erfindungsgemäße Verfahren zum Herstellen der Varianten beispielsweise einen oder mehrere der folgenden Verfahrensschritte umfasst: a) Einbringen einer ein- oder mehrfachen konservativen Aminosäuresubstitution in eine Ausgangslaccase gemäß SEQ ID NO: 1 oder SED ID NO:2; All of the facts mentioned can also be applied to the processes according to the invention for producing a laccase. Accordingly, a method according to the invention comprises a method for producing a laccase, comprising providing a starting laccase which has at least 70%, preferably at least 80%, particularly preferably at least 95% sequence identity to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over their total length, or variants of the starting laccase, the method according to the invention for producing the variants comprising, for example, one or more of the following process steps: a) introducing one or more conservative amino acid substitution into a starting laccase according to SEQ ID NO: 1 or SED ID NO : 2;
b) Veränderung der in SEQ ID NO: 1 oder SED ID NO:2 angegebenen Aminosäuresequenz durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese derart, dass die Laccase eine Aminosäuresequenz umfasst, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit dem Ausgangsmolekül übereinstimmt. b) modification of the amino acid sequence given in SEQ ID NO: 1 or SED ID NO: 2 by fragmentation, deletion, insertion or substitution mutagenesis such that the laccase comprises an amino acid sequence which is at least 345, 350, 360, 370 in length , 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 related amino acids matches the starting molecule ,
Sämtliche Ausführungsformen gelten auch für die erfindungsgemäßen Verfahren. All embodiments also apply to the method according to the invention.
In weiteren Ausgestaltungen der Erfindung ist die Laccase bzw. die mit einem erfindungsgemäßen Verfahren hergestellte Laccase noch mindestens zu 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %, 84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %, 92,5 %, 93 %, 93,5 %, 94 %, 94,5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,6 %, 98,7 %, 98,8 %, 98,9 %, 99,0 %, 99, 1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder 99,9 % identisch zu der in SEQ ID NO: 1 angegebenen Aminosäuresequenz über deren Gesamtlänge. In further refinements of the invention, the laccase or the laccase produced by a process according to the invention is still at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92 , 5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5 %, 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99, 1%, 99.2%, 99.3%, 99.4%, 99.5 %, 99.6%, 99.7%, 99.8% or 99.9% identical to the amino acid sequence given in SEQ ID NO: 1 over its entire length.
Ein weiterer Gegenstand der Erfindung ist eine zuvor beschriebene Laccase, die zusätzlich stabilisiert ist, insbesondere durch eine oder mehrere Mutationen, beispielsweise Substitutionen, oder durch Kopplung an ein Polymer. Eine Erhöhung der Stabilität bei der Lagerung und/oder während des Einsatzes, beispielsweise beim Waschprozess, führt dazu, dass die enzymatische Aktivität länger anhält und damit die Reinigungsleistung verbessert wird. Grundsätzlich kommen alle im Stand der Technik beschriebenen und/oder zweckmäßigen Stabilisierungsmöglichkeiten in Betracht. Bevorzugt sind solche Stabilisierungen, die über Mutationen des Enzyms selbst erreicht werden, da solche Stabilisierungen im Anschluss an die Gewinnung des Enzyms keine weiteren Arbeitsschritte erfordern. Beispiele für hierfür geeignete Sequenzveränderungen sind vorstehend genannt. Weitere geeignete Sequenzveränderungen sind aus dem Stand der Technik bekannt. Another object of the invention is a previously described laccase which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer. An increase in stability during storage and / or during use, for example in the washing process, means that the enzymatic activity lasts longer and thus the cleaning performance is improved. Basically, all stabilization options described and / or useful in the prior art come into consideration. Preference is given to those stabilizations which are achieved via mutations in the enzyme itself, since such stabilizations do not require any further steps following the extraction of the enzyme. Examples of suitable sequence changes are mentioned above. Further suitable sequence changes are known from the prior art.
Möglichkeiten der Stabilisierung sind beispielsweise: Stabilization options include:
Schutz gegen den Einfluss von denaturierenden Agentien wie Tensiden durch Mutationen, die eine Veränderung der Aminosäuresequenz auf oder an der Oberfläche des Proteins bewirken;
Austausch von Aminosäuren, die nahe dem N-Terminus liegen, gegen solche, die vermutlich über nicht-kovalente Wechselwirkungen mit dem Rest des Moleküls in Kontakt treten und somit einen Beitrag zur Aufrechterhaltung der globulären Struktur leisten. Protection against the influence of denaturing agents such as surfactants by mutations that change the amino acid sequence on or on the surface of the protein; Exchange of amino acids that are close to the N-terminus for those that presumably come into contact with the rest of the molecule via non-covalent interactions and thus contribute to the maintenance of the globular structure.
Bevorzugte Ausführungsformen sind solche, bei denen das Enzym auf mehrere Arten stabilisiert wird, da mehrere stabilisierende Mutationen additiv oder synergistisch wirken. Preferred embodiments are those in which the enzyme is stabilized in several ways, since several stabilizing mutations have an additive or synergistic effect.
Ein weiterer Gegenstand der Erfindung ist eine Laccase wie vorstehend beschrieben, die dadurch gekennzeichnet ist, dass sie mindestens eine chemische Modifikation aufweist. Eine Laccase mit einer solchen Veränderung wird als Derivat bezeichnet, d.h. die Laccase ist derivatisiert. Another object of the invention is a laccase as described above, which is characterized in that it has at least one chemical modification. A laccase with such a change is called a derivative, i.e. the laccase is derivatized.
Unter Derivaten werden im Sinne der vorliegenden Anmeldung demnach solche Proteine verstanden, deren reine Aminosäurekette chemisch modifiziert worden ist. Solche Derivatisierungen können beispielsweise in vivo durch die Wirtszelle erfolgen, die das Protein exprimiert. Diesbezüglich sind Kopplungen niedrigmolekularer Verbindungen wie von Lipiden oder Oligosacchariden besonders hervorzuheben. Derivatisierungen können aber auch in vitro durchgeführt werden, etwa durch die chemische Umwandlung einer Seitenkette einer Aminosäure oder durch kovalente Bindung einer anderen Verbindung an das Protein. Beispielsweise ist die Kopplung von Aminen an Carboxylgruppen eines Enzyms zur Veränderung des isoelektrischen Punkts möglich. Eine solche andere Verbindung kann auch ein weiteres Protein sein, das beispielsweise über bifunktionelle chemische Verbindungen an ein erfindungsgemäßes Protein gebunden wird. Ebenso ist unter Derivatisierung die kovalente Bindung an einen makromolekularen Träger zu verstehen, oder auch ein nichtkovalenter Einschluss in geeignete makromolekulare Käfigstrukturen. Derivatisierungen können beispielsweise die Substratspezifität oder die Bindungsstärke an das Substrat beeinflussen oder eine vorübergehende Blockierung der enzymatischen Aktivität herbeiführen, wenn es sich bei der angekoppelten Substanz um einen Inhibitor handelt. Dies kann beispielsweise für den Zeitraum der Lagerung sinnvoll sein. Derartige Modifikationen können ferner die Stabilität oder die enzymatische Aktivität beeinflussen. Sie können ferner auch dazu dienen, die Allergenizität und/oder Immunogenizität des Proteins herabzusetzen und damit beispielsweise dessen Hautverträglichkeit zu erhöhen. Beispielsweise können Kopplungen mit makromolekularen Verbindungen, beispielsweise Polyethylenglykol, das Protein hinsichtlich der Stabilität und/oder Hautverträglichkeit verbessern. In the context of the present application, derivatives are understood to mean those proteins whose pure amino acid chain has been chemically modified. Such derivatizations can be carried out, for example, in vivo by the host cell that expresses the protein. Couplings of low molecular weight compounds such as lipids or oligosaccharides are particularly noteworthy in this regard. However, derivatizations can also be carried out in vitro, for example by chemical conversion of a side chain of an amino acid or by covalent binding of another compound to the protein. For example, the coupling of amines to carboxyl groups of an enzyme to change the isoelectric point is possible. Such a different compound can also be a further protein which is bound to a protein according to the invention, for example via bifunctional chemical compounds. Derivatization is also to be understood to mean covalent binding to a macromolecular carrier or non-covalent inclusion in suitable macromolecular cage structures. For example, derivatizations can influence the substrate specificity or the binding strength to the substrate, or can temporarily block the enzymatic activity if the coupled substance is an inhibitor. This can be useful, for example, for the period of storage. Such modifications can also affect stability or enzymatic activity. They can also serve to reduce the allergenicity and / or immunogenicity of the protein and thus, for example, to increase its skin tolerance. For example, couplings with macromolecular compounds, for example polyethylene glycol, can improve the protein with regard to stability and / or skin tolerance.
Unter Derivaten eines erfindungsgemäßen Proteins können im weitesten Sinne auch Präparationen dieser Proteine verstanden werden. Je nach Gewinnung, Aufarbeitung oder Präparation kann ein Protein mit diversen anderen Stoffen kombiniert sein, beispielsweise aus der Kultur der produzierenden Mikroorganismen. Ein Protein kann auch, beispielsweise zur Erhöhung seiner Lagerstabilität, mit anderen Stoffen gezielt versetzt worden sein. Erfindungsgemäß sind deshalb
auch alle Präparationen eines erfindungsgemäßen Proteins. Das ist auch unabhängig davon, ob es in einer bestimmten Präparation tatsächlich diese enzymatische Aktivität entfaltet oder nicht. Denn es kann gewünscht sein, dass es bei der Lagerung keine oder nur geringe Aktivität besitzt, und erst zum Zeitpunkt der Verwendung seine enzymatische Funktion entfaltet. Dies kann beispielsweise über entsprechende Begleitstoffe gesteuert werden. Insbesondere die gemeinsame Präparation von Laccasen mit spezifischen Inhibitoren ist diesbezüglich möglich. Derivatives of a protein according to the invention can also be understood in the broadest sense to mean preparations of these proteins. Depending on the extraction, processing or preparation, a protein can be combined with various other substances, for example from the culture of the producing microorganisms. A protein may also have been specifically mixed with other substances, for example to increase its storage stability. Therefore are according to the invention also all preparations of a protein according to the invention. This is also irrespective of whether it actually exhibits this enzymatic activity in a particular preparation or not. This is because it may be desired that it has little or no activity during storage and that it only develops its enzymatic function at the time of use. This can be controlled, for example, using appropriate accompanying substances. In particular, the joint preparation of laccases with specific inhibitors is possible in this regard.
Betreffend alle vorstehend beschriebenen Laccasen bzw. Laccase-Varianten und/oder Derivate sind im Rahmen der vorliegenden Erfindung diejenigen besonders bevorzugt, deren katalytische Aktivität und/oder deren Substrattoleranz derjenigen der Laccase gemäß SEQ ID NO:1 entspricht, wobei die katalytische Aktivität und die Substrattoleranz wie hierin beschrieben bestimmt werden. With regard to all the laccases or laccase variants and / or derivatives described above, those whose catalytic activity and / or their substrate tolerance corresponds to that of the laccase according to SEQ ID NO: 1 are particularly preferred in the context of the present invention, the catalytic activity and the substrate tolerance as determined herein.
Die erfindungsgemäßen und die in den erfindungsgemäßen Waschmitteln einsetzbaren Laccasen sind aus Pflanzen, Pilzen und Bakterien erhältlich. Die die SEQ ID NO:1 oder SEQ ID NO:2 umfassende Laccase kann aus Marasmiellus palmivorus gewonnen werden. The laccases according to the invention and those which can be used in the detergents according to the invention are obtainable from plants, fungi and bacteria. The laccase comprising SEQ ID NO: 1 or SEQ ID NO: 2 can be obtained from Marasmiellus palmivorus.
Die natürlichen Produktionsmengen der Laccasen sind allerdings oft sehr niedrig. Es kann daher sinnvoll sein, die Produktion zu erhöhen, indem man Laccase-Gene in fremden Produktionswirten exprimiert. Zu diesem Zweck verwendet man in der Regel Vektoren, die eine Nukleinsäure enthalten, die für eine erfindungsgemäße Laccase codiert. However, the natural production quantities of laccases are often very low. It may therefore make sense to increase production by expressing laccase genes in foreign production hosts. For this purpose, vectors are generally used which contain a nucleic acid which codes for a laccase according to the invention.
Ein weiterer Gegenstand der Erfindung ist daher eine Nukleinsäure, die für eine erfindungsgemäße Laccase codiert, sowie ein Vektor enthaltend eine solche Nukleinsäure, insbesondere ein Klonierungsvektor oder ein Expressionsvektor. In bevorzugten Ausführungsformen ist die Nukleinsäure eine Nukleinsäure gemäß SEQ ID NO:3 oder SEQ ID NO:4. Dementsprechend ist ein besonders bevorzugter erfindungsgemäßer Vektor ein Vektor, der eine Nukleinsäure gemäß SEQ ID NO:3 oder SEQ ID NO:4 umfasst. The invention therefore furthermore relates to a nucleic acid which codes for a laccase according to the invention and a vector comprising such a nucleic acid, in particular a cloning vector or an expression vector. In preferred embodiments, the nucleic acid is a nucleic acid according to SEQ ID NO: 3 or SEQ ID NO: 4. Accordingly, a particularly preferred vector according to the invention is a vector which comprises a nucleic acid according to SEQ ID NO: 3 or SEQ ID NO: 4.
Hierbei kann es sich um DNA- oder RNA-Moleküle handeln. Sie können als Einzelstrang, als ein zu diesem Einzelstrang komplementärer Einzelstrang oder als Doppelstrang vorliegen. Insbesondere bei DNA-Molekülen sind die Sequenzen beider komplementärer Stränge in jeweils allen drei möglichen Leserastern zu berücksichtigen. Ferner ist zu berücksichtigen, dass verschiedene Codons, also Basentriplets, für die gleichen Aminosäuren codieren können, so dass eine bestimmte Aminosäuresequenz von mehreren unterschiedlichen Nukleinsäuren codiert werden kann. Auf Grund dieser Degeneriertheit des genetischen Codes sind sämtliche Nukleinsäuresequenzen in diesem Erfindungsgegenstand eingeschlossen, die eine der vorstehend beschriebenen Laccasen codieren können. Der Fachmann ist in der Lage, diese Nukleinsäuresequenzen zweifelsfrei zu bestimmen, da trotz der Degeneriertheit des genetischen Codes einzelnen Codons definierte Aminosäuren zuzuordnen sind. Daher kann der Fachmann ausgehend von einer
Aminosäuresequenz für diese Aminosäuresequenz codierende Nukleinsäuren problemlos ermitteln. Weiterhin können bei erfindungsgemäßen Nukleinsäuren ein oder mehrere Codons durch synonyme Codons ersetzt sein. Dieser Aspekt bezieht sich insbesondere auf die heterologe Expression der erfindungsgemäßen Enzyme. So besitzt jeder Organismus, beispielsweise eine Wirtszelle eines Produktionsstammes, eine bestimmte Codon-Verwendung. Unter Codon-Verwendung wird die Übersetzung des genetischen Codes in Aminosäuren durch den jeweiligen Organismus verstanden. Es kann zu Engpässen in der Proteinbiosynthese kommen, wenn die auf der Nukleinsäure liegenden Codons in dem Organismus einer vergleichsweise geringen Zahl von beladenen tRNA-Molekülen gegenüberstehen. Obwohl für die gleiche Aminosäure codierend führt das dazu, dass in dem Organismus ein Codon weniger effizient translatiert wird als ein synonymes Codon, das für dieselbe Aminosäure codiert. Auf Grund des Vorliegens einer höheren Anzahl von tRNA-Molekülen für das synonyme Codon kann dieses in dem Organismus effizienter translatiert werden. Einem Fachmann ist es über heutzutage allgemein bekannte Methoden, wie beispielsweise die chemische Synthese oder die Polymerase-Kettenreaktion (PCR) in Verbindung mit molekularbiologischen und/oder proteinchemischen Stand ardmethoden möglich, anhand bekannter DNA- und/oder Aminosäuresequenzen die entsprechenden Nukleinsäuren bis hin zu vollständigen Genen herzustellen. Derartige Methoden sind beispielsweise aus Sambrook, J., Fritsch, E.F. and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3. Edition Cold Spring Laboratory Press, bekannt. These can be DNA or RNA molecules. They can be present as a single strand, as a single strand complementary to this single strand or as a double strand. In the case of DNA molecules in particular, the sequences of both complementary strands must be taken into account in all three possible reading frames. It should also be taken into account that different codons, ie base triplets, can code for the same amino acids, so that a certain amino acid sequence can be encoded by several different nucleic acids. Because of this degeneracy of the genetic code, all nucleic acid sequences which can encode one of the laccases described above are included in this subject matter of the invention. The person skilled in the art is able to determine these nucleic acid sequences without any doubt since, despite the degeneracy of the genetic code, individual codons can be assigned to defined codons. Therefore, the expert can start from a Determine the amino acid sequence for this amino acid sequence coding nucleic acids without problems. Furthermore, one or more codons can be replaced by synonymous codons in the nucleic acids according to the invention. This aspect relates in particular to the heterologous expression of the enzymes according to the invention. Every organism, for example a host cell of a production strain, has a certain codon usage. Codon use means the translation of the genetic code into amino acids by the respective organism. Bottlenecks in protein biosynthesis can occur if the codons lying on the nucleic acid in the organism are opposed to a comparatively small number of loaded tRNA molecules. Although coding for the same amino acid, this means that a codon in the organism is translated less efficiently than a synonymous codon that codes for the same amino acid. Due to the presence of a higher number of tRNA molecules for the synonymous codon, this can be translated more efficiently in the organism. It is possible for a person skilled in the art to use methods which are generally known today, such as chemical synthesis or the polymerase chain reaction (PCR) in conjunction with standard molecular biological and / or protein-chemical methods, to complete the corresponding nucleic acids using known DNA and / or amino acid sequences To produce genes. Such methods are known, for example, from Sambrook, J., Fritsch, EF and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.
Unter Vektoren werden im Sinne der vorliegenden Erfindung aus Nukleinsäuren bestehende Elemente verstanden, die als kennzeichnenden Nukleinsäurebereich eine erfindungsgemäße Nukleinsäure enthalten. Sie vermögen diese in einer Spezies oder einer Zelllinie über mehrere Generationen oder Zellteilungen hinweg als stabiles genetisches Element zu etablieren. Vektoren sind insbesondere bei der Verwendung in Bakterien spezielle Plasmide, also zirkulare genetische Elemente. Im Rahmen der vorliegenden Erfindung wird eine erfindungsgemäße Nukleinsäure in einen Vektor kloniert. Zu den Vektoren zählen beispielsweise solche, deren Ursprung bakterielle Plasmide, Viren oder Bakteriophagen sind, oder überwiegend synthetische Vektoren oder Plasmide mit Elementen verschiedenster Herkunft. Mit den weiteren jeweils vorhandenen genetischen Elementen vermögen Vektoren sich in den betreffenden Wirtszellen über mehrere Generationen hinweg als stabile Einheiten zu etablieren. Sie können extrachromosomal als eigene Einheiten vorliegen oder in ein Chromosom oder chromosomale DNA integrieren. For the purposes of the present invention, vectors are understood to mean elements consisting of nucleic acids which contain a nucleic acid according to the invention as the characteristic nucleic acid region. They are able to establish this in a species or a cell line as a stable genetic element over several generations or cell divisions. Vectors are special plasmids, in particular circular genetic elements, when used in bacteria. In the context of the present invention, a nucleic acid according to the invention is cloned into a vector. The vectors include, for example, those whose origin is bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements of very different origins. With the other genetic elements present in each case, vectors can establish themselves as stable units in the host cells concerned over several generations. They can be extrachromosomal as separate units or integrated into a chromosome or chromosomal DNA.
Expressionsvektoren umfassen Nukleinsäuresequenzen, die sie dazu befähigen, in den sie enthaltenden Wirtszellen, vorzugsweise Mikroorganismen, besonders bevorzugt Bakterien, zu replizieren und dort eine enthaltene Nukleinsäure zur Expression zu bringen. Die Expression wird insbesondere von dem oder den Promotoren beeinflusst, welche die Transkription regulieren. Prinzipiell kann die Expression durch den natürlichen, ursprünglich vor der zu exprimierenden Nukleinsäure lokalisierten Promotor erfolgen, aber auch durch einen auf dem Expressionsvektor bereitgestellten Promotor der Wirtszelle oder auch durch einen modifizierten oder einen völlig
anderen Promotor eines anderen Organismus oder einer anderen Wirtszelle. Im vorliegenden Fall wird zumindest ein Promotor für die Expression einer erfindungsgemäßen Nukleinsäure zur Verfügung gestellt und für deren Expression genutzt. Expressionsvektoren können ferner regulierbar sein, beispielsweise durch Änderung der Kultivierungsbedingungen oder bei Erreichen einer bestimmten Zelldichte der sie enthaltenen Wirtszellen oder durch Zugabe von bestimmten Substanzen, insbesondere Aktivatoren der Genexpression. Ein Beispiel für eine solche Substanz ist das Galactose-Derivat Isopropyl-ß-D-thiogalactopyranosid (IPTG), welches als Aktivator des bakteriellen Lactose-Operons (lac-Operons) verwendet wird. Im Gegensatz zu Expressionsvektoren wird die enthaltene Nukleinsäure in Klonierungsvektoren nicht exprimiert. Expression vectors comprise nucleic acid sequences which enable them to replicate in the host cells, preferably microorganisms, particularly preferably bacteria, containing them and to express the nucleic acid contained therein. Expression is influenced in particular by the promoter or promoters which regulate the transcription. In principle, expression can take place through the natural promoter originally located in front of the nucleic acid to be expressed, but also through a promoter of the host cell provided on the expression vector or also through a modified or a completely another promoter of another organism or another host cell. In the present case, at least one promoter is provided for the expression of a nucleic acid according to the invention and used for its expression. Expression vectors can also be regulated, for example by changing the cultivation conditions or when a specific cell density of the host cells containing them has been reached or by adding certain substances, in particular activators of gene expression. An example of such a substance is the galactose derivative isopropyl-β-D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon). In contrast to expression vectors, the nucleic acid contained in cloning vectors is not expressed.
Ein weiterer Gegenstand der Erfindung ist eine nicht-menschliche Wirtszelle, die eine erfindungsgemäße Nukleinsäure oder einen erfindungsgemäßen Vektor beinhaltet, oder die eine erfindungsgemäße Laccase beinhaltet, insbesondere eine, die die Laccase in das die Wirtszelle umgebende Medium sezerniert. Bevorzugt wird eine erfindungsgemäße Nukleinsäure oder ein erfindungsgemäßer Vektor in einen Mikroorganismus transformiert, der dann eine erfindungsgemäße Wirtszelle darstellt. Alternativ können auch einzelne Komponenten, d.h. Nukleinsäure-Teile oder -Fragmente einer erfindungsgemäßen Nukleinsäure derart in eine Wirtszelle eingebracht werden, dass die dann resultierende Wirtszelle eine erfindungsgemäße Nukleinsäure oder einen erfindungsgemäßen Vektor enthält. Dieses Vorgehen eignet sich besonders dann, wenn die Wirtszelle bereits einen oder mehrere Bestandteile einer erfindungsgemäßen Nukleinsäure oder eines erfindungsgemäßen Vektors enthält und die weiteren Bestandteile dann entsprechend ergänzt werden. Verfahren zur Transformation von Zellen sind im Stand der Technik etabliert und dem Fachmann hinlänglich bekannt. Als Wirtszellen eignen sich prinzipiell alle Zellen, d.h. prokaryotische oder eukaryotische Zellen. Bevorzugt sind solche Wirtszellen, die sich genetisch vorteilhaft handhaben lassen, was beispielsweise die Transformation mit der Nukleinsäure oder dem Vektor und dessen stabile Etablierung angeht, beispielsweise einzellige Pilze oder Bakterien. Ferner zeichnen sich bevorzugte Wirtszellen durch eine gute mikrobiologische und biotechnologische Handhabbarkeit aus. Das betrifft beispielsweise leichte Kultivierbarkeit, hohe Wachstumsraten, geringe Anforderungen an Fermentationsmedien und gute Produktions- und Sekretionsraten für Fremdproteine. Bevorzugte erfindungsgemäße Wirtszellen sezernieren das (transgen) exprimierte Protein in das die Wirtszellen umgebende Medium. Ferner können die Laccasen von den sie produzierenden Zellen nach deren Herstellung modifiziert werden, beispielsweise durch Anknüpfung von Zuckermolekülen, Formylierungen, Aminierungen, usw. Solche posttranslationale Modifikationen können die Laccase funktionell beeinflussen. The invention furthermore relates to a non-human host cell which contains a nucleic acid or a vector according to the invention or which contains a laccase according to the invention, in particular one which secretes the laccase into the medium surrounding the host cell. A nucleic acid according to the invention or a vector according to the invention is preferably transformed into a microorganism which then represents a host cell according to the invention. Alternatively, individual components, i.e. Nucleic acid parts or fragments of a nucleic acid according to the invention are introduced into a host cell in such a way that the resulting host cell contains a nucleic acid according to the invention or a vector according to the invention. This procedure is particularly suitable when the host cell already contains one or more components of a nucleic acid or a vector according to the invention and the further components are then supplemented accordingly. Methods for transforming cells are established in the prior art and are well known to the person skilled in the art. In principle, all cells are suitable as host cells, i.e. prokaryotic or eukaryotic cells. Preferred are host cells that can be genetically advantageously handled, for example in relation to the transformation with the nucleic acid or the vector and its stable establishment, for example unicellular fungi or bacteria. Preferred host cells are furthermore distinguished by good microbiological and biotechnological manageability. This applies, for example, to easy cultivation, high growth rates, low demands on fermentation media and good production and secretion rates for foreign proteins. Preferred host cells according to the invention secrete the (transgenic) expressed protein into the medium surrounding the host cells. Furthermore, the laccases can be modified by the cells producing them after their production, for example by attaching sugar molecules, formylations, aminations, etc. Such post-translational modifications can functionally influence the laccase.
Weitere bevorzugte Ausführungsformen stellen solche Wirtszellen dar, die aufgrund genetischer Regulationselemente, die beispielsweise auf dem Vektor zur Verfügung gestellt werden, aber auch von vornherein in diesen Zellen vorhanden sein können, in ihrer Aktivität regulierbar sind. Beispielsweise durch kontrollierte Zugabe von chemischen Verbindungen, die als Aktivatoren
dienen, durch Änderung der Kultivierungsbedingungen oder bei Erreichen einer bestimmten Zelldichte können diese zur Expression angeregt werden. Dies ermöglicht eine wirtschaftliche Produktion der erfindungsgemäßen Proteine. Ein Beispiel für eine solche Verbindung ist IPTG wie vorstehend beschrieben. Further preferred embodiments are those host cells whose activity can be regulated on the basis of genetic regulatory elements which are provided, for example, on the vector, but which may also be present in these cells from the outset. For example, through the controlled addition of chemical compounds that act as activators serve, by changing the cultivation conditions or when reaching a certain cell density, these can be stimulated for expression. This enables economical production of the proteins according to the invention. An example of such a connection is IPTG as described above.
Bevorzugte Wirtszellen sind prokaryotische oder bakterielle Zellen. Bakterien zeichnen sich durch kurze Generationszeiten und geringe Ansprüche an die Kultivierungsbedingungen aus. Dadurch können kostengünstige Kultivierungsverfahren oder Herstellungsverfahren etabliert werden. Zudem verfügt der Fachmann bei Bakterien in der Fermentationstechnik über einen reichhaltigen Erfahrungsschatz. Für eine spezielle Produktion können aus verschiedensten, im Einzelfall experimentell zu ermittelnden Gründen wie Nährstoffquellen, Produktbildungsrate, Zeitbedarf usw., gramnegative oder grampositive Bakterien geeignet sein. Preferred host cells are prokaryotic or bacterial cells. Bacteria are characterized by short generation times and low demands on the cultivation conditions. As a result, inexpensive cultivation processes or production processes can be established. In addition, the specialist in bacteria in fermentation technology has a wealth of experience. Gram-negative or gram-positive bacteria can be suitable for a special production for various reasons, which can be determined experimentally in individual cases, such as nutrient sources, product formation rate, time requirement etc.
Bei gramnegativen Bakterien wie beispielsweise Escherichia coli wird eine Vielzahl von Proteinen in den periplasmatischen Raum sezerniert, also in das Kompartiment zwischen den beiden die Zellen einschließenden Membranen. Dies kann für spezielle Anwendungen vorteilhaft sein. Ferner können auch gramnegative Bakterien so ausgestaltet werden, dass sie die exprimierten Proteine nicht nur in den periplasmatischen Raum, sondern in das das Bakterium umgebende Medium ausschleusen. Grampositive Bakterien wie beispielsweise Bacilli oder Actinomyceten oder andere Vertreter der Actinomycetales besitzen demgegenüber keine äußere Membran, so dass sezernierte Proteine sogleich in das die Bakterien umgebende Medium, in der Regel das Nährmedium, abgegeben werden, aus welchem sich die exprimierten Proteine aufreinigen lassen. Sie können aus dem Medium direkt isoliert oder weiter prozessiert werden. Zudem sind grampositive Bakterien mit den meisten Herkunftsorganismen für technisch wichtige Enzyme verwandt oder identisch und bilden meist selbst vergleichbare Enzyme, so dass sie über eine ähnliche Codon-Verwendung verfügen und ihr Protein-Syntheseapparat naturgemäß entsprechend ausgerichtet ist. In Gram-negative bacteria such as Escherichia coli, a large number of proteins are secreted into the periplasmic space, i.e. into the compartment between the two membranes that enclose the cells. This can be advantageous for special applications. Furthermore, gram-negative bacteria can also be designed in such a way that they not only express the expressed proteins into the periplasmic space, but also into the medium surrounding the bacteria. Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of the Actinomycetales, on the other hand, have no outer membrane, so that secreted proteins are immediately released into the medium surrounding the bacteria, usually the nutrient medium, from which the expressed proteins can be purified. They can be isolated directly from the medium or processed further. In addition, gram-positive bacteria are related or identical to most organisms of origin for technically important enzymes and usually form comparable enzymes themselves, so that they have a similar codon use and their protein synthesis apparatus is naturally designed accordingly.
Erfindungsgemäße Wirtszellen können hinsichtlich ihrer Anforderungen an die Kulturbedingungen verändert sein, andere oder zusätzliche Selektionsmarker aufweisen oder noch andere oder zusätzliche Proteine exprimieren. Es kann sich insbesondere auch um solche Wirtszellen handeln, die mehrere Proteine oder Enzyme transgen exprimieren. Host cells according to the invention can be changed with regard to their requirements for the culture conditions, have different or additional selection markers or can also express other or additional proteins. In particular, these can also be host cells which transgenically express several proteins or enzymes.
Die vorliegende Erfindung ist prinzipiell auf alle Mikroorganismen, insbesondere auf alle fermentierbaren Mikroorganismen, besonders bevorzugt auf solche der Gattung Bacillus, anwendbar und führt dazu, dass sich durch den Einsatz solcher Mikroorganismen erfindungsgemäße Proteine hersteilen lassen. Solche Mikroorganismen stellen dann Wirtszellen im Sinne der Erfindung dar. The present invention is in principle applicable to all microorganisms, in particular to all fermentable microorganisms, particularly preferably to those of the genus Bacillus, and leads to the fact that proteins of the invention can be produced by using such microorganisms. Such microorganisms then represent host cells in the sense of the invention.
In einer weiteren Ausführungsform der Erfindung ist die Wirtszelle dadurch gekennzeichnet, dass sie ein Bakterium ist, bevorzugt eines, das ausgewählt ist aus der Gruppe der Gattungen von
Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas und Pseudomonas, weiter bevorzugt eines, das ausgewählt ist aus der Gruppe von Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus ientus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus carnosus, Corynebacterium glutamicum, Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor und Stenotrophomonas maltophilia. In a further embodiment of the invention, the host cell is characterized in that it is a bacterium, preferably one which is selected from the group of the genera of Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one selected from the group of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus ientus, Bacillusisusususus, Bacillusisususus, Bacillus amylolillus Bacillus globigii, Bacillus gibsonii, Bacillus clausii, Bacillus halodurans, Bacillus pumilus, Staphylococcus carnosus, Corynebacterium glutamicum, Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor and Stenotrophomonas maltophilia.
Die Wirtszelle kann aber auch eine eukaryotische Zelle sein, die dadurch gekennzeichnet ist, dass sie einen Zellkern besitzt. Einen weiteren Gegenstand der Erfindung stellt daher eine Wirtszelle dar, die dadurch gekennzeichnet ist, dass sie einen Zellkern besitzt. Im Gegensatz zu prokaryotischen Zellen sind eukaryotische Zellen in der Lage, das gebildete Protein posttranslational zu modifizieren. Beispiele dafür sind Pilze wie Actinomyceten oder Hefen wie Saccharomyces oder Kluyveromyces. Dies kann beispielsweise dann besonders vorteilhaft sein, wenn die Proteine im Zusammenhang mit ihrer Synthese spezifische Modifikationen erfahren sollen, die derartige Systeme ermöglichen. Zu den Modifikationen, die eukaryotische Systeme besonders im Zusammenhang mit der Proteinsynthese durchführen, gehören beispielsweise die Bindung niedermolekularer Verbindungen wie Membrananker oder Oligosaccharide. Derartige Oligosaccharid-Modifikationen können beispielsweise zur Senkung der Allergenizität eines exprimierten Proteins wünschenswert sein. Auch eine Co-Expression mit den natürlicherweise von derartigen Zellen gebildeten Enzymen, wie beispielsweise Cellulasen, kann vorteilhaft sein. Ferner können sich beispielsweise thermophile pilzliche Expressionssysteme besonders zur Expression temperaturbeständiger Proteine oder Varianten eignen. In bevorzugten Ausführungsformen der Erfindung ist die Wirtszelle eine Basidiomyceten- Ze Ile. The host cell can also be a eukaryotic cell, which is characterized in that it has a cell nucleus. Another object of the invention is therefore a host cell, which is characterized in that it has a cell nucleus. In contrast to prokaryotic cells, eukaryotic cells are able to post-translationally modify the protein formed. Examples include fungi such as Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces. This can be particularly advantageous, for example, if the proteins are to undergo specific modifications in connection with their synthesis which enable such systems. The modifications that eukaryotic systems carry out in particular in connection with protein synthesis include, for example, the binding of low molecular weight compounds such as membrane anchors or oligosaccharides. Such oligosaccharide modifications may be desirable, for example, to reduce the allergenicity of an expressed protein. Co-expression with the enzymes naturally formed by such cells, such as cellulases, can also be advantageous. Furthermore, for example, thermophilic fungal expression systems can be particularly suitable for the expression of temperature-resistant proteins or variants. In preferred embodiments of the invention, the host cell is a basidiomycete cell.
Die erfindungsgemäßen Wirtszellen werden in üblicher Weise kultiviert und fermentiert, beispielsweise in diskontinuierlichen oder kontinuierlichen Systemen. Im ersten Fall wird ein geeignetes Nährmedium mit den Wirtszellen beimpft und das Produkt nach einem experimentell zu ermittelnden Zeitraum aus dem Medium geerntet. Kontinuierliche Fermentationen zeichnen sich durch Erreichen eines Fließgleichgewichts aus, in dem über einen vergleichsweise langen Zeitraum Zellen teilweise absterben aber auch nachwachsen und gleichzeitig aus dem Medium das gebildete Protein entnommen werden kann. The host cells according to the invention are cultivated and fermented in a conventional manner, for example in discontinuous or continuous systems. In the first case, a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after an experimentally determined period. Continuous fermentations are characterized by achieving a steady state in which cells partially die but also regrow over a comparatively long period of time and at the same time the protein formed can be removed from the medium.
Erfindungsgemäße Wirtszellen werden bevorzugt verwendet, um erfindungsgemäße Laccase herzustellen. Ein weiterer Gegenstand der Erfindung ist daher ein Verfahren zur Herstellung einer Laccase umfassend Host cells according to the invention are preferably used to produce laccase according to the invention. Another object of the invention is therefore a method for producing a laccase comprising
a) Kultivieren einer erfindungsgemäßen Wirtszelle, und a) cultivating a host cell according to the invention, and
b) Isolieren der Laccase aus dem Kulturmedium oder aus der Wirtszelle.
Dieser Erfindungsgegenstand umfasst bevorzugt Fermentationsverfahren. Fermentationsverfahren sind an sich aus dem Stand der Technik bekannt und stellen den eigentlichen großtechnischen Produktionsschritt dar, in der Regel gefolgt von einer geeigneten Aufreinigungsmethode des hergestellten Produktes, beispielsweise der erfindungsgemäßen Laccase. Alle Fermentationsverfahren, die auf einem entsprechenden Verfahren zur Herstellung einer erfindungsgemäßen Laccase beruhen, stellen Ausführungsformen dieses Erfindungsgegenstandes dar. b) isolating the laccase from the culture medium or from the host cell. This subject of the invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, generally followed by a suitable purification method of the product produced, for example the laccase according to the invention. All fermentation processes which are based on a corresponding process for producing a laccase according to the invention represent embodiments of this subject of the invention.
Fermentationsverfahren, die dadurch gekennzeichnet sind, dass die Fermentation über eine Zulaufstrategie durchgeführt wird, kommen insbesondere in Betracht. Hierbei werden die Medienbestandteile, die durch die fortlaufende Kultivierung verbraucht werden, zugefüttert. Hierdurch können beträchtliche Steigerungen sowohl in der Zelldichte als auch in der Zellmasse bzw. Trockenmasse und/oder insbesondere in der Aktivität der interessierenden Laccase erreicht werden. Ferner kann die Fermentation auch so gestaltet werden, dass unerwünschte Stoffwechselprodukte herausgefiltert oder durch Zugabe von Puffer oder jeweils passende Gegenionen neutralisiert werden. Fermentation processes, which are characterized in that the fermentation is carried out via a feed strategy, are particularly suitable. Here, the media components that are consumed by the ongoing cultivation are fed. As a result, considerable increases can be achieved both in the cell density and in the cell mass or dry mass and / or in particular in the activity of the laccase of interest. Furthermore, the fermentation can also be designed in such a way that undesired metabolic products are filtered out or neutralized by adding buffer or suitable counterions.
Die hergestellte Laccase kann aus dem Fermentationsmedium geerntet werden. Ein solches Fermentationsverfahren ist gegenüber einer Isolation der Laccase aus der Wirtszelle, d.h. einer Produktaufbereitung aus der Zellmasse (Trockenmasse) bevorzugt, erfordert jedoch die Zurverfügungstellung von geeigneten Wirtszellen oder von einem oder mehreren geeigneten Sekretionsmarkern oder -mechanismen und/oder Transportsystemen, damit die Wirtszellen die Laccase in das Fermentationsmedium sezernieren. Ohne Sekretion kann alternativ die Isolation der Laccase aus der Wirtszelle, d.h. eine Aufreinigung derselben aus der Zellmasse, erfolgen, beispielsweise durch Fällung mit Ammoniumsulfat oder Ethanol, oder durch chromatographische Reinigung. The laccase produced can be harvested from the fermentation medium. Such a fermentation process is opposed to isolating the laccase from the host cell, i.e. a product preparation from the cell mass (dry mass) preferred, but requires the provision of suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems so that the host cells secrete the laccase into the fermentation medium. Alternatively, without secretion, isolation of the laccase from the host cell, i.e. they are purified from the cell mass, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
Alle vorstehend ausgeführten Sachverhalte können zu Verfahren kombiniert werden, um erfindungsgemäße Laccasen herzustellen. All of the facts set out above can be combined to form processes for producing laccases according to the invention.
Überraschenderweise wurde gefunden, dass die erfindungsgemäßen Laccasen, insbesondere die die SEQ ID NO: 1 oder SEQ ID NO:2 umfassende Laccase die Waschleistung insbesondere flüssiger Waschmittelformulierungen verbessern und nicht, wie von anderen Laccasen bekannt, die unerwünschte Verdunklung und damit Intensivierung von Flecken, insbesondere Tee- und Kaffeeflecken bewirken. Surprisingly, it was found that the laccases according to the invention, in particular the laccase comprising SEQ ID NO: 1 or SEQ ID NO: 2, improve the washing performance of liquid detergent formulations in particular and not, as is known from other laccases, the undesired darkening and thus intensification of stains, in particular Stain tea and coffee.
Ein weiterer Gegenstand der Erfindung ist daher ein Mittel, insbesondere ein Wasch- und Reinigungsmittel, das eine wie hierin beschriebene Laccase enthält. Die Laccase weist dabei mindestens 70 %, 71 %, 72 %, 73 %, 74 %, 75 %, 76 %, 77 %, 78 %, 79 %, 80 %, 81 %, 82 %, 83 %,
84 %, 85 %, 86 %, 87 %, 88 %, 89 %, 90 %, 90,5 %, 91 %, 91 ,5 %, 92 %, 92,5 %, 93 %, 93,5 %, 94 %, 94,5 %, 95 %, 95,5 %, 96 %, 96,5 %, 97 %, 97,5 %, 98 %, 98,5 %, 98,6 %, 98,7 %, 98,8 %, 98,9 %, 99,0 %, 99, 1 %, 99,2 %, 99,3 %, 99,4 %, 99,5 %, 99,6 %, 99,7 %, 99,8 % oder 99,9 % Sequenzidentität mit der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge auf oder ist eine wie oben beschriebene Variante davon, die ausgehend von einer vorstehend beschriebenen Laccase als Ausgangsmolekül erhältlich ist und vor und vorzugsweise auch nach der Variation die angegebenen Sequenzidentität mit SEQ ID NO:1 oder SEQ ID NO:2 aufweist. The invention therefore furthermore relates to an agent, in particular a washing and cleaning agent, which contains a laccase as described herein. The laccase has at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5%, 98.6%, 98.7%, 98.8%, 98.9%, 99.0%, 99, 1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8% or 99.9% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over their entire length or is a variant thereof as described above, which is obtainable as a starting molecule from a laccase described above and before and preferably also after the variation has the specified sequence identity with SEQ ID NO: 1 or SEQ ID NO: 2.
Zu diesem Erfindungsgegenstand zählen alle denkbaren Wasch- oder Reinigungsmittelarten, sowohl Konzentrate als auch unverdünnt anzuwendende Mittel, zum Einsatz im kommerziellen Maßstab, in der Waschmaschine oder bei der Handwäsche bzw. -reinigung. Dazu gehören beispielsweise Waschmittel für Textilien, Teppiche, oder Naturfasern, für die die Bezeichnung Waschmittel verwendet wird. Dazu gehören beispielsweise auch Geschirrspülmittel für Geschirrspülmaschinen oder manuelle Geschirrspülmittel oder Reiniger für harte Oberflächen wie Metall, Glas, Porzellan, Keramik, Kacheln, Stein, lackierte Oberflächen, Kunststoffe, Holz oder Leder, für die die Bezeichnung Reinigungsmittel verwendet wird, also neben manuellen und maschinellen Geschirrspülmitteln beispielsweise auch Scheuermittel, Glasreiniger, WC-Duftspüler, usw. Zu den Wasch- und Reinigungsmitteln im Rahmen der Erfindung zählen ferner Waschhilfsmittel, die bei der manuellen oder maschinellen Textilwäsche zum eigentlichen Waschmittel hinzudosiert werden, um eine weitere Wirkung zu erzielen. Ferner zählen zu Wasch- und Reinigungsmitteln im Rahmen der Erfindung auch Textilvor- und Nachbehandlungsmittel, also solche Mittel, mit denen das Wäschestück vor der eigentlichen Wäsche in Kontakt gebracht wird, beispielsweise zum Anlösen hartnäckiger Verschmutzungen, und auch solche Mittel, die in einem der eigentlichen Textilwäsche nachgeschalteten Schritt dem Waschgut weitere wünschenswerte Eigenschaften wie angenehmen Griff, Knitterfreiheit oder geringe statische Aufladung verleihen. Zu letztgenannten Mittel werden u.a. die Weichspüler gerechnet. This subject of the invention includes all conceivable types of washing or cleaning agents, both concentrates and agents to be used undiluted, for use on a commercial scale, in the washing machine or for hand washing or cleaning. These include, for example, detergents for textiles, carpets, or natural fibers, for which the term detergent is used. This also includes, for example, dishwashing detergents for dishwashers or manual dishwashing detergents or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood or leather, for which the term cleaning agent is used, i.e. in addition to manual and machine Dishwashing detergents, for example, also scouring agents, glass cleaners, toilet scent detergents, etc. The detergents and cleaning agents in the context of the invention also include washing aids which are added to the actual detergent in the case of manual or machine textile washing in order to achieve a further effect. Furthermore, detergents and cleaning agents within the scope of the invention also include textile pre-treatment and post-treatment agents, i.e. agents with which the item of laundry is brought into contact before the actual laundry, for example for dissolving stubborn soiling, and also agents which are contained in one of the actual ones Textile laundry downstream step give the items to be washed further desirable properties such as comfortable grip, freedom from creasing or low static charge. The latter means, among others, the fabric softener counted.
Ein Waschmittel kann neben den genannten, zur Entfernung farbiger Flecken und Anschmutzungen geeigneten Laccasen, übliche mit diesem Bestandteil verträgliche Inhaltsstoffe enthalten. So kann es beispielsweise zusätzlich noch einen oder mehrere Farbübertragungsinhibitoren, diese dann vorzugsweise in Mengen von 0,1 bis 2 Gew.-%, insbesondere 0,2 bis 1 Gew.-%, enthalten, die in einer bevorzugten Ausgestaltung ausgewählt werden aus den Polymeren aus Vinylpyrrolidon, Vinylimidazol, Vinylpyridin-N-Oxid oder den Copolymeren aus diesen. Brauchbar sind sowohl Polyvinylpyrrolidone mit Molgewichten von 15.000 bis 50.000 g/mol wie auch Polyvinylpyrrolidone mit höheren Molgewichten von beispielsweise bis zu über 1.000.000 g/mol, insbesondere von 1 .500.000 bis 4.000.000 g/mol, N-Vinylimidazol/N-Vinylpyrrolidon-Copolymere, Polyvinyloxazolidone, Copolymere auf Basis von Vinylmonomeren und Carbonsäureamiden, pyrrolidongruppenhaltige Polyester und Polyamide, gepfropfte Polyamidoamine und
Polyethylenimine, Polyamin-N-Oxid-Polymere und Polyvinylalkohole. Eingesetzt werden können aber auch enzymatische Systeme, umfassend eine Peroxidase und Wasserstoffperoxid bzw. eine in Wasser Wasserstoffperoxid-Iiefernde Substanz. Der Zusatz einer Mediatorverbindung für die Peroxidase, zum Beispiel eines Acetosyringons, eines Phenolderivats oder eines Phenotiazins oder Phenoxazins, ist in diesem Fall bevorzugt, wobei auch zusätzlich obengenannte polymere Farbübertragungsinhibitorwirkstoffe eingesetzt werden können. Polyvinylpyrrolidon weist vorzugsweise eine durchschnittliche Molmasse im Bereich von 10000 bis 60000 g/mol, insbesondere im Bereich von 25000 bis 50000 g/mol auf. Unter den Copolymeren sind solche aus Vinylpyrrolidon und Vinylimidazol im Molverhältnis 5:1 bis 1 : 1 mit einer durchschnittlichen Molmasse im Bereich von 5000 bis 50000 g/mol, insbesondere 10000 bis 20000 g/mol bevorzugt. In addition to the laccases mentioned, which are suitable for removing colored stains and soiling, a detergent may contain conventional ingredients which are compatible with this constituent. For example, it can additionally contain one or more color transfer inhibitors, which then preferably contain amounts of 0.1 to 2% by weight, in particular 0.2 to 1% by weight, which in a preferred embodiment are selected from the polymers from vinyl pyrrolidone, vinyl imidazole, vinyl pyridine N-oxide or the copolymers thereof. Both polyvinylpyrrolidones with molecular weights of 15,000 to 50,000 g / mol and polyvinylpyrrolidones with higher molecular weights of, for example, up to over 1,000,000 g / mol, in particular from 1,500,000 to 4,000,000 g / mol, N-vinylimidazole / N- Vinylpyrrolidone copolymers, polyvinyloxazolidones, copolymers based on vinyl monomers and carboxamides, pyrrolidone group-containing polyesters and polyamides, grafted polyamidoamines and Polyethyleneimines, polyamine N-oxide polymers and polyvinyl alcohols. However, enzymatic systems comprising a peroxidase and hydrogen peroxide or a substance which supplies hydrogen peroxide in water can also be used. The addition of a mediator compound for the peroxidase, for example an acetosyringone, a phenol derivative or a phenotiazine or phenoxazine, is preferred in this case, it also being possible to use the above-mentioned polymeric color transfer inhibitor active ingredients. Polyvinylpyrrolidone preferably has an average molar mass in the range from 10,000 to 60,000 g / mol, in particular in the range from 25,000 to 50,000 g / mol. Among the copolymers, those of vinylpyrrolidone and vinylimidazole in a molar ratio of 5: 1 to 1: 1 with an average molar mass in the range from 5000 to 50,000 g / mol, in particular 10,000 to 20,000 g / mol, are preferred.
Erfindungsgemäße Wasch- und Reinigungsmittel, die als pulverförmige Feststoffe, in nachverdichteter Teilchenform, in granulärer Form, als homogene Lösungen oder Suspensionen vorliegen können, können neben einer erfindungsgemäßen Laccase alle bekannten und in derartigen Mitteln üblichen Inhaltsstoffe enthalten, wobei bevorzugt mindestens ein weiterer Inhaltsstoff in dem Mittel vorhanden ist. Die erfindungsgemäßen Mittel können insbesondere Tenside, Builder (Gerüststoffe), Persauerstoffverbindungen oder Bleichaktivatoren enthalten. Ferner können sie wassermischbare organische Lösungsmittel, weitere Enzyme, Sequestrierungsmittel, Elektrolyte, pH-Regulatoren und/oder weitere Hilfsstoffe wie optische Aufheller, Vergrauungsinhibitoren, Schaumregulatoren sowie Färb- und Duftstoffe sowie Kombinationen hiervon enthalten. Detergents and cleaning agents according to the invention, which can be present as powdery solids, in post-compacted particle form, in granular form, as homogeneous solutions or suspensions, can contain, in addition to a laccase according to the invention, all known ingredients customary in such agents, preferably at least one further ingredient in the Means is available. The agents according to the invention can in particular contain surfactants, builders (builders), peroxygen compounds or bleach activators. They can also contain water-miscible organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, graying inhibitors, foam regulators as well as colorants and fragrances and combinations thereof.
Insbesondere eine Kombination einer erfindungsgemäßen Laccase mit einem oder mehreren weiteren Inhaltsstoff(en) des Mittels ist vorteilhaft, da ein solches Mittel in bevorzugten erfindungsgemäßen Ausgestaltungen eine verbesserte Reinigungsleistung durch sich ergebende Synergismen aufweist. Insbesondere durch die Kombination einer erfindungsgemäßen Amylase mit einem Tensid und/oder einem Builder (Gerüststoff) und/oder einer Persauerstoffverbindung und/oder einem Bleichaktivator kann ein solcher Synergismus erreicht werden. In particular, a combination of a laccase according to the invention with one or more further ingredient (s) of the agent is advantageous, since such agent in preferred embodiments according to the invention has improved cleaning performance due to the resulting synergisms. Such a synergism can be achieved in particular by combining an amylase according to the invention with a surfactant and / or a builder (builder) and / or a peroxygen compound and / or a bleach activator.
Vorteilhafte Inhaltsstoffe erfindungsgemäßer Mittel sind offenbart in der internationalen Patentanmeldung WO 2009/121725, dort beginnend auf Seite 5, vorletzter Absatz, und endend auf Seite 13 nach dem zweiten Absatz. Auf diese Offenbarung wird ausdrücklich Bezug genommen und der dortige Offenbarungsgehalt in die vorliegende Patentanmeldung einbezogen. Advantageous ingredients of agents according to the invention are disclosed in international patent application WO 2009/121725, beginning there on page 5, penultimate paragraph, and ending on page 13 after the second paragraph. Reference is expressly made to this disclosure and the content of the disclosure therein is included in the present patent application.
Das erfindungsgemäße Waschmittel kann zusätzliche Mediatoren enthalten, um die zu entfernenden Farbstoffe mit höherer Effizienz zu oxidieren. Erfindungsgemäß geeignete Mediatoren sind beispielsweise Tempo (2,2,6,6-Tetramethyl-1-Piperidinyloxy), HBT (1-Hydroxybenzotriazol), ABTS (2,2'-Azinobis-3-Ethylbenzthiazol-6-Sulphonat), NHA (N-Hydroxy-Acetanilid), 2,5-Xylidin, Ethanol, Kupfer, 4-Methylcatechol, N-Hydroxyphthalimid, Gallussäure, Gerbsäure, Quercetin, Syringasäure,
Guaiacol, Dimethoxybenzylalkohol, Phenol, Violursäure (Isonitrosobarbitursäure), Phenolrot, Bromphenolblau, Cellulose, p-Kumarinsäure, Rooibos, o-Kresol, Dichloroindophenol, Hydroxybenzotriazol, Cycloheximid oder Vanillin. The detergent according to the invention can contain additional mediators in order to oxidize the dyes to be removed with greater efficiency. Mediators suitable according to the invention are, for example, Tempo (2,2,6,6-tetramethyl-1-piperidinyloxy), HBT (1-hydroxybenzotriazole), ABTS (2,2'-azinobis-3-ethylbenzothiazole-6-sulphonate), NHA (N -Hydroxy-acetanilide), 2,5-xylidine, ethanol, copper, 4-methylcatechol, N-hydroxyphthalimide, gallic acid, tannic acid, quercetin, syringic acid, Guaiacol, dimethoxybenzyl alcohol, phenol, violuric acid (isonitrosobarbituric acid), phenol red, bromophenol blue, cellulose, p-coumaric acid, rooibos, o-cresol, dichloroindophenol, hydroxybenzotriazole, cycloheximide or vanillin.
In weiteren Ausführungsformen der Erfindung ist das Mittel dadurch gekennzeichnet, dass esIn further embodiments of the invention, the agent is characterized in that it
(a) 1 bis 85 Gew.-%, vorzugsweise 5 bis 65 Gew.-%, Tenside enthält; und/oder (a) contains 1 to 85% by weight, preferably 5 to 65% by weight, of surfactants; and or
(b) 0 bis 45 Gew.-%, vorzugsweise 0,1 bis 15 Gew.-%, Builder (Gerüststoffe) enthält; und/oder (b) contains 0 to 45% by weight, preferably 0.1 to 15% by weight, of builder (builders); and or
(c) 0,0005 bis 15 Gew.-%, vorzugsweise 0,001 bis 5 Gew.-%, Protease enthält; und/oder (c) contains 0.0005 to 15% by weight, preferably 0.001 to 5% by weight, of protease; and or
(d) 0,0005 bis 15 Gew.-%, vorzugsweise 0,001 bis 5 Gew.-%, Lipase enthält; und/oder (d) contains 0.0005 to 15% by weight, preferably 0.001 to 5% by weight, lipase; and or
(e) 0,00005 bis 15 Gew.-%, vorzugsweise 0,0001 bis 5 Gew.-%, Mannanase enthält; und/oder (e) contains 0.00005 to 15% by weight, preferably 0.0001 to 5% by weight, mannanase; and or
(f) 0,00005 bis 15 Gew.-%, vorzugsweise 0,0001 bis 5 Gew.-%, Cellulase/Pektatlyase enthält; und/oder (f) contains 0.00005 to 15% by weight, preferably 0.0001 to 5% by weight, cellulase / pectate lyase; and or
(g) 0,00005 bis 15 g/Waschladung, vorzugsweise 0,0001 bis 5 g/Waschladung, Xanthanlyase enthält; und/oder (g) 0.00005 to 15 g / washload, preferably 0.0001 to 5 g / washload, contains xanthan lyase; and or
(h) 0,00005 bis 15 g/Waschladung, vorzugsweise 0,00005 bis 15 g/Waschladung, Endoglucanase, die fähig ist Xanthan zu verdauen, enthält. (h) 0.00005 to 15 g / washload, preferably 0.00005 to 15 g / washload, containing endoglucanase capable of digesting xanthan gum.
Ein erfindungsgemäßes Mittel enthält die Laccase vorteilhafterweise in einer Menge von 2 pg bis 20 mg, vorzugsweise von 5 pg bis 17,5 mg, besonders bevorzugt von 20 pg bis 15 mg und ganz besonders bevorzugt von 50 pg bis 10 mg pro Gramm des Mittels. Darüber hinaus kann das erfindungsgemäße Mittel die Laccase vorteilhafterweise in einer Menge von 0,00005 bis 15 Gew. % bezogen auf das aktive Enzym und das Gesamtgewicht des Mittels, vorzugsweise von 0,0001 bis 5 Gew.-% und besonders bevorzugt von 0,001 bis 1 Gew.-% enthalten. Weiter bevorzugt kann die Konzentration der Laccase im erfindungsgemäßen Wasch- und Reinigungsmittel von 0,001 bis 0, 15 Gew.-%, vorzugsweise von 0,005 bis 0,06 Gew.-%, bezogen auf aktives Protein betragen. An agent according to the invention advantageously contains the laccase in an amount from 2 pg to 20 mg, preferably from 5 pg to 17.5 mg, particularly preferably from 20 pg to 15 mg and very particularly preferably from 50 pg to 10 mg per gram of the agent. In addition, the agent according to the invention can advantageously the laccase in an amount of 0.00005 to 15% by weight, based on the active enzyme and the total weight of the agent, preferably from 0.0001 to 5% by weight and particularly preferably from 0.001 to 1 % By weight. The concentration of the laccase in the washing and cleaning agent according to the invention can more preferably be from 0.001 to 0.15% by weight, preferably from 0.005 to 0.06% by weight, based on active protein.
Ferner kann die in dem Mittel enthaltene Laccase, und/oder weitere Inhaltsstoffe des Mittels, mit einer bei Raumtemperatur oder bei Abwesenheit von Wasser für das Enzym undurchlässigen Substanz umhüllt sein, welche unter Anwendungsbedingungen des Mittels durchlässig für das Enzym wird. Eine solche Ausführungsform der Erfindung ist somit dadurch gekennzeichnet, dass die Laccase mit einer bei Raumtemperatur oder bei Abwesenheit von Wasser für die Laccase undurchlässigen Substanz umhüllt ist. Weiterhin kann auch das Wasch- oder Reinigungsmittel selbst in einem Behältnis, vorzugsweise einem luftdurchlässigen Behältnis, verpackt sein, aus dem es kurz vor Gebrauch oder während des Waschvorgangs freigesetzt wird. Furthermore, the laccase contained in the agent, and / or further ingredients of the agent, can be coated with a substance that is impermeable to the enzyme at room temperature or in the absence of water, which substance becomes permeable to the enzyme under conditions of use of the agent. Such an embodiment of the invention is thus characterized in that the laccase is coated with a substance impermeable to the laccase at room temperature or in the absence of water. Furthermore, the washing or cleaning agent itself can also be packaged in a container, preferably an air-permeable container, from which it is released shortly before use or during the washing process.
In weiteren Ausführungsformen der Erfindung ist das Mittel dadurch gekennzeichnet, dass es a) in fester Form vorliegt, insbesondere als rieselfähiges Pulver mit einem Schüttgewicht von 300 g/l bis 1200 g/l, insbesondere 500 g/l bis 900 g/l, oder In further embodiments of the invention, the agent is characterized in that it is a) in solid form, in particular as a free-flowing powder with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or
b) in pastöser oder in flüssiger Form vorliegt, und/oder
c) in gelförmiger oder dosierbeutelförmiger (Pouches) Form vorliegt, und/oder b) is in pasty or liquid form, and / or c) is in the form of a gel or a sachet (pouch), and / or
d) als Einkomponentensystem vorliegt, oder d) is in the form of a one-component system, or
e) in mehrere Komponenten aufgeteilt ist. e) is divided into several components.
Diese Ausführungsformen der vorliegenden Erfindung umfassen alle festen, pulverförmigen, flüssigen, gelförmigen oder pastösen Darreichungsformen erfindungsgemäßer Mittel, die gegebenenfalls auch aus mehreren Phasen bestehen können sowie in komprimierter oder nicht komprimierter Form vorliegen können. Das Mittel kann als rieselfähiges Pulver vorliegen, insbesondere mit einem Schüttgewicht von 300 g/l bis 1200 g/l, insbesondere 500 g/l bis 900 g/l oder 600 g/l bis 850 g/l. Zu den festen Darreichungsformen des Mittels zählen ferner Extrudate, Granulate, Tabletten oder Pouches. Alternativ kann das Mittel auch flüssig, gelförmig oder pastös sein, beispielsweise in Form eines nicht-wässrigen Flüssigwaschmittels oder einer nicht-wässrigen Paste oder in Form eines wässrigen Flüssigwaschmittels oder einer wasserhaltigen Paste. Weiterhin kann das Mittel als Einkomponentensystem vorliegen. Solche Mittel bestehen aus einer Phase. Alternativ kann ein Mittel auch aus mehreren Phasen bestehen. Ein solches Mittel ist demnach in mehrere Komponenten aufgeteilt. These embodiments of the present invention include all solid, powder, liquid, gel or pasty dosage forms of agents according to the invention, which can optionally also consist of several phases and can be in compressed or uncompressed form. The agent can be in the form of a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l or 600 g / l to 850 g / l. The solid dosage forms of the agent also include extrudates, granules, tablets or pouches. Alternatively, the agent can also be liquid, gel-like or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste. Furthermore, the agent can be in the form of a one-component system. Such funds consist of one phase. Alternatively, an agent can consist of several phases. Such an agent is therefore divided into several components.
Erfindungsgemäße Wasch- oder Reinigungsmittel können ausschließlich eine Laccase enthalten. Alternativ können sie auch weitere hydrolytische Enzyme oder andere Enzyme in einer für die Wirksamkeit des Mittels zweckmäßigen Konzentration enthalten. Eine weitere Ausführungsform der Erfindung stellen somit Mittel dar, die ferner eines oder mehrere weitere Enzyme umfassen. Als weitere Enzyme bevorzugt einsetzbar sind alle Enzyme, die in dem erfindungsgemäßen Mittel eine katalytische Aktivität entfalten können, insbesondere eine Protease, Amylase, Lipase, Cellulase, Cutinase, Pullulanase, Hemicellulase, Mannanase, Tannase, Xylanase, Xanthanase, Xyloglucanase, ß-Glucosidase, Pektinase, Carrageenase, Perhydrolase, Oxidase, Oxidoreduktase, Peroxidase oder andere. Auch der Einsatz einer oder mehrerer weiterer Laccasen bzw. Multi-Kupfer- Oxidasen zusätzlich zu den erfindungsgemäßen Laccasen ist erfindungsgemäß möglich. Weitere Enzyme sind in dem Mittel vorteilhafterweise jeweils in einer Menge von 1 x 10 8 bis 5 Gew.-% bezogen auf aktives Protein enthalten. Zunehmend bevorzugt ist jedes weitere Enzym in einer Menge von 1 x 10 7 bis 3 Gew.-%, von 0,00001 bis 1 Gew.-%, von 0,00005 bis 0,5 Gew.-%, von 0,0001 bis 0, 1 Gew.-% und besonders bevorzugt von 0,0001 bis 0,05 Gew.-% in erfindungsgemäßen Mitteln enthalten, bezogen auf aktives Protein. Besonders bevorzugt zeigen die Enzyme synergistische Reinigungsleistungen gegenüber bestimmten Anschmutzungen oder Flecken, d.h. die in der Mittelzusammensetzung enthaltenen Enzyme unterstützen sich in ihrer Reinigungsleistung gegenseitig. Ganz besonders bevorzugt liegt ein solcher Synergismus vor zwischen der erfindungsgemäß enthaltenen Laccase und einem weiteren Enzym eines erfindungsgemäßen Mittels, darunter insbesondere zwischen der genannten Laccase und einer Amylase und/oder einer Lipase und/oder einer Protease und/oder einer Mannanase und/oder einer Cellulase und/oder einer Pektinase. Synergistische Effekte können nicht nur zwischen verschiedenen Enzymen, sondern
auch zwischen einem oder mehreren Enzymen und weiteren Inhaltsstoffen des erfindungsgemäßen Mittels auftreten. Washing or cleaning agents according to the invention can only contain a laccase. Alternatively, they can also contain further hydrolytic enzymes or other enzymes in a concentration appropriate for the effectiveness of the agent. A further embodiment of the invention thus represent agents which further comprise one or more further enzymes. All enzymes which can develop a catalytic activity in the agent according to the invention, in particular a protease, amylase, lipase, cellulase, cutinase, pullulanase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, β-glucosidase, can preferably be used as further enzymes. Pectinase, carrageenase, perhydrolase, oxidase, oxidoreductase, peroxidase or others. The use of one or more further laccases or multi-copper oxidases in addition to the laccases according to the invention is also possible according to the invention. Further enzymes are advantageously contained in the agent each in an amount of 1 × 10 8 to 5 wt .-% based on active protein. Each additional enzyme is increasingly preferred in an amount of 1 × 10 7 to 3% by weight, from 0.00001 to 1% by weight, from 0.00005 to 0.5% by weight, from 0.0001 to 0.1% by weight and particularly preferably from 0.0001 to 0.05% by weight in agents according to the invention, based on active protein. The enzymes particularly preferably show synergistic cleaning performance against certain soiling or stains, ie the enzymes contained in the composition of the agents mutually support one another in their cleaning performance. Such a synergism is very particularly preferably present between the laccase according to the invention and a further enzyme of an agent according to the invention, including in particular between the laccase mentioned and an amylase and / or a lipase and / or a protease and / or a mannanase and / or a cellulase and / or a pectinase. Synergistic effects can occur not only between different enzymes, but also occur between one or more enzymes and other ingredients of the agent according to the invention.
In den hierin beschriebenen Reinigungsmitteln können die einzusetzenden Enzyme ferner zusammen mit Begleitstoffen, etwa aus der Fermentation, konfektioniert sein. In flüssigen Formulierungen werden die Enzyme bevorzugt als Enzymflüssigformulierung(en) eingesetzt. In the cleaning agents described herein, the enzymes to be used can also be packaged together with accompanying substances, for example from fermentation. In liquid formulations, the enzymes are preferably used as an enzyme liquid formulation (s).
Die Enzyme werden in der Regel nicht in Form des reinen Proteins, sondern vielmehr in Form stabilisierter, lager- und transportfähiger Zubereitungen bereitgestellt. Zu diesen vorkonfektionierten Zubereitungen zählen beispielsweise die durch Granulation, Extrusion oder Lyophilisierung erhaltenen festen Präparationen oder, insbesondere bei flüssigen oder gelförmigen Mitteln, Lösungen der Enzyme, vorteilhafterweise möglichst konzentriert, wasserarm und/oder mit Stabilisatoren oder weiteren Hilfsmitteln versetzt. As a rule, the enzymes are not provided in the form of the pure protein, but rather in the form of stabilized, storable and transportable preparations. These prefabricated preparations include, for example, the solid preparations obtained by granulation, extrusion or lyophilization or, particularly in the case of liquid or gel form agents, solutions of the enzymes, advantageously as concentrated as possible, low in water and / or with stabilizers or other auxiliaries.
Alternativ können die Enzyme sowohl für die feste als auch für die flüssige Darreichungsform verkapselt werden, beispielsweise durch Sprühtrocknung oder Extrusion der Enzymlösung zusammen mit einem vorzugsweise natürlichen Polymer oder in Form von Kapseln, beispielsweise solchen, bei denen die Enzyme wie in einem erstarrten Gel eingeschlossen sind oder in solchen vom Kern-Schale-Typ, bei dem ein enzymhaltiger Kern mit einer Wasser-, Luft- und/oder Chemikalienundurchlässigen Schutzschicht überzogen ist. In aufgelagerten Schichten können zusätzlich weitere Wirkstoffe, beispielsweise Stabilisatoren, Emulgatoren, Pigmente, Bleich- oder Farbstoffe aufgebracht werden. Derartige Kapseln werden nach an sich bekannten Methoden, beispielsweise durch Schüttei- oder Rollgranulation oder in Fluid-bed-Prozessen aufgebracht. Vorteilhafterweise sind derartige Granulate, beispielsweise durch Aufbringen polymerer Filmbildner, staubarm und aufgrund der Beschichtung lagerstabil. Alternatively, the enzymes can be encapsulated both for the solid and for the liquid administration form, for example by spray drying or extrusion of the enzyme solution together with a preferably natural polymer or in the form of capsules, for example those in which the enzymes are enclosed as in a solidified gel or in those of the core-shell type in which an enzyme-containing core is coated with a protective layer impermeable to water, air and / or chemicals. Additional active ingredients, for example stabilizers, emulsifiers, pigments, bleaching agents or dyes, can additionally be applied in superimposed layers. Capsules of this type are applied by methods known per se, for example by granular or roll granulation or in fluid-bed processes. Such granules are advantageously low in dust, for example by applying polymeric film formers, and are stable on storage due to the coating.
Die Enzyme können auch in wasserlösliche Filme eingebracht werden. Ein derartiger Film ermöglicht die Freisetzung der Enzyme nach Kontakt mit Wasser. Wie hier verwendet, bezieht sich "wasserlöslich" auf eine Filmstruktur, die vorzugsweise vollständig wasserlöslich ist. Jedoch sind auch Filme, die im Wesentlichen wasserlöslich sind, aber relativ kleine Mengen eines Materials in der Filmstruktur aufweisen, welches nicht wasserlöslich ist; Folien mit Materialien, die nur bei relativ hohen Wassertemperaturen oder nur unter eingeschränkten pH-Bedingungen wasserlöslich sind; und Folien, die eine relativ dünne Schicht aus wasserunlöslichem Material einschließen, alle in der Bezeichnung "wasserlöslich" eingeschlossen. Bevorzugt besteht ein solcher Film aus (vollständig oder teilweise hydrolysiertem) Polyvinylalkohol (PVA). Der Film kann aber auch ausschließlich oder zusätzlich zum PVA enthalten Säure/Acrylat-Copolymere, vorzugsweise Methacrylsäure/Ethylacrylat-Copolymer, wie das von Beiland als GBC 2580 und 2600 erhältliche; Styrol-Maleinsäureanhydrid-Copolymer (SMA) (verfügbar als Scripset (Handelsname) von Monsanto); Ethylen-Acrylsäure-Copolymer (EAA) oder durch Metallsalz neutralisiertes Ethylen-
Methacrylsäure-Copolymer (EMAA), bekannt als lonomer (verfügbar von DuPont), bei welchem der Säuregehalt von EAA oder EMAA mindestens etwa 20 Mol-% beträgt; Polyether-Blockamid- Copolymer; Polyhydroxyvalerinsäure (verfügbar als Biopol (Handelsname)-Harze von Imperial Chemical Industries); Polyethylenoxid; wasserlöslichen Polyester oder Copolyester; Polyethyloxazolin (PEOX 200 von Dow); und wasserlösliches Polyurethan ein. The enzymes can also be introduced into water-soluble films. Such a film enables the enzymes to be released after contact with water. As used herein, "water soluble" refers to a film structure that is preferably completely water soluble. However, films are also that are substantially water-soluble but have relatively small amounts of a material in the film structure that is not water-soluble; Films with materials that are water-soluble only at relatively high water temperatures or only under restricted pH conditions; and films that include a relatively thin layer of water-insoluble material, all included in the term "water-soluble". Such a film preferably consists of (fully or partially hydrolyzed) polyvinyl alcohol (PVA). However, the film can also contain acid / acrylate copolymers, preferably methacrylic acid / ethyl acrylate copolymer, exclusively or in addition to the PVA, such as that available from Beiland as GBC 2580 and 2600; Styrene-maleic anhydride copolymer (SMA) (available as Scripset (trade name) from Monsanto); Ethylene acrylic acid copolymer (EAA) or metal salt neutralized ethylene Methacrylic acid copolymer (EMAA), known as an ionomer (available from DuPont), in which the acidity of EAA or EMAA is at least about 20 mole percent; Polyether block amide copolymer; Polyhydroxyvaleric acid (available as Biopol (trade name) resins from Imperial Chemical Industries); polyethylene oxide; water soluble polyester or copolyester; Polyethyloxazoline (PEOX 200 from Dow); and water-soluble polyurethane.
Weiterhin ist es möglich, zwei oder mehrere Enzyme zusammen zu konfektionieren, so dass ein einzelnes Granulat mehrere Enzymaktivitäten aufweist. Furthermore, it is possible to assemble two or more enzymes together, so that a single granulate has several enzyme activities.
Die Herstellung fester Wasch- und Reinigungsmittel bietet keine Schwierigkeiten und kann auf bekannte Weise, z.B. durch Sprühtrocknen oder Granulation, erfolgen, wobei Enzyme und eventuelle weitere thermisch empfindliche Inhaltsstoffe wie z.B. Bleichmittel ggf. später separat zugesetzt werden. Zur Herstellung von Mitteln mit erhöhtem Schüttgewicht, insbesondere im Bereich von 650 bis 950 g/l, ist ein einen Extrusionsschritt aufweisendes Verfahren bevorzugt. The manufacture of solid detergents and cleaning agents presents no difficulties and can be carried out in a known manner, e.g. by spray drying or granulation, with enzymes and any other thermally sensitive ingredients such as Bleach may be added separately later if necessary. A method having an extrusion step is preferred for producing agents with increased bulk density, in particular in the range from 650 to 950 g / l.
Zur Herstellung von Mitteln in Tablettenform, die einphasig oder mehrphasig, einfarbig oder mehrfarbig und insbesondere aus einer Schicht oder aus mehreren, insbesondere aus zwei Schichten bestehen können, geht man vorzugsweise derart vor, dass man alle Bestandteile - ggf. je einer Schicht - in einem Mischer miteinander vermischt und das Gemisch mittels herkömmlicher Tablettenpressen, beispielsweise Exzenterpressen oder Rundläuferpressen, mit Presskräften im Bereich von etwa 50 bis 100 kN, vorzugsweise bei 60 bis 70 kN verpresst. Insbesondere bei mehrschichtigen Tabletten kann es von Vorteil sein, wenn mindestens eine Schicht vorverpresst wird. Dies wird vorzugsweise bei Presskräften zwischen 5 und 20 kN, insbesondere bei 10 bis 15 kN durchgeführt. Man erhält so problemlos bruchfeste und dennoch unter Anwendungsbedingungen ausreichend schnell lösliche Tabletten mit Bruch- und Biegefestigkeiten von normalerweise 100 bis 200 N, bevorzugt jedoch über 150 N. Vorzugsweise weist eine derart hergestellte Tablette ein Gewicht von 10 bis 50 g, insbesondere von 15 bis 40 g auf. Die Raumform der Tabletten ist beliebig und kann rund, oval oder eckig sein, wobei auch Zwischenformen möglich sind. Ecken und Kanten sind vorteilhafterweise abgerundet. Runde Tabletten weisen vorzugsweise einen Durchmesser von 30 bis 40 mm auf. Insbesondere die Größe von eckig oder quaderförmig gestalteten Tabletten, welche überwiegend über die Dosiervorrichtung der Waschmaschine eingebracht werden, ist abhängig von der Geometrie und dem Volumen dieser Dosiervorrichtung. Beispielhaft bevorzugte Ausführungsformen weisen eine Grundfläche von (20 bis 30 mm) x (34 bis 40 mm), insbesondere von 26 x 36 mm oder von 24 x 38 mm auf. For the preparation of tablets, which can be single-phase or multi-phase, single-color or multi-color and in particular consist of one or more layers, in particular two layers, the procedure is preferably such that all constituents - possibly one layer each - are combined in one Mixer mixed together and the mixture is pressed by means of conventional tablet presses, for example eccentric presses or rotary presses, with pressing forces in the range from about 50 to 100 kN, preferably at 60 to 70 kN. In the case of multi-layer tablets in particular, it can be advantageous if at least one layer is pre-compressed. This is preferably carried out at press forces between 5 and 20 kN, in particular at 10 to 15 kN. In this way, break-resistant tablets, which nevertheless dissolve sufficiently quickly under application conditions, are obtained with breaking and bending strengths of normally 100 to 200 N, but preferably over 150 N. A tablet produced in this way preferably has a weight of 10 to 50 g, in particular 15 to 40 g on. The three-dimensional shape of the tablets is arbitrary and can be round, oval or angular, intermediate forms also being possible. Corners and edges are advantageously rounded. Round tablets preferably have a diameter of 30 to 40 mm. In particular, the size of angular or cuboid tablets, which are mainly introduced via the metering device of the washing machine, depends on the geometry and the volume of this metering device. Exemplary preferred embodiments have a base area of (20 to 30 mm) × (34 to 40 mm), in particular 26 × 36 mm or 24 × 38 mm.
Flüssige bzw. pastöse Mittel in Form von übliche Lösungsmittel enthaltenden Lösungen werden in der Regel durch einfaches Mischen der Inhaltsstoffe, die in Substanz oder als Lösung in einen automatischen Mischer gegeben werden können, hergestellt.
Erfindungsgemäße feste und/oder flüssige Wasch- und Reinigungsmittel können z.B. auch in Portions-Säckchen oder (vorzugsweise selbstauflösenden) Portionsbeuteln (pouches) abgepackt sein, insbesondere auch in Mehrkammerpouches. Unter den Begriff der Flüssigkeit fallen im Sinne der Erfindung auch jegliche Festkörperdispersionen in Flüssigkeiten. Erfindungsgemäße flüssige Mittel können auch mehrphasig sein, die Phasen können z.B. vertikal, also übereinander oder horizontal, also nebeneinander angeordnet sein. Liquid or pasty agents in the form of solutions containing customary solvents are generally prepared by simply mixing the ingredients, which can be added in bulk or as a solution to an automatic mixer. Solid and / or liquid detergents and cleaning agents according to the invention can, for example, also be packaged in sachets or (preferably self-dissolving) sachets (pouches), in particular also in multi-chamber pouches. For the purposes of the invention, the term liquid also includes any solid state dispersions in liquids. Liquid agents according to the invention can also be multi-phase, the phases can be arranged, for example, vertically, ie one above the other or horizontally, ie next to one another.
Ein weiterer Erfindungsgegenstand ist ein Verfahren zur Reinigung von Textilien oder harten Oberflächen, das dadurch gekennzeichnet ist, dass in mindestens einem Verfahrensschritt ein erfindungsgemäßes Mittel angewendet wird, oder dass in mindestens einem Verfahrensschritt eine erfindungsgemäße Laccase katalytisch aktiv wird, insbesondere derart, dass die Laccase in einer Menge von 40 pg bis 4 g, vorzugsweise von 50 pg bis 3 g, besonders bevorzugt von 100 pg bis 2 g und ganz besonders bevorzugt von 200 pg bis 1 g eingesetzt wird. Another object of the invention is a method for cleaning textiles or hard surfaces, which is characterized in that an agent according to the invention is used in at least one process step or that a laccase according to the invention becomes catalytically active in at least one process step, in particular in such a way that the laccase in an amount of 40 pg to 4 g, preferably from 50 pg to 3 g, particularly preferably from 100 pg to 2 g and very particularly preferably from 200 pg to 1 g.
In verschieden Ausführungsformen zeichnet sich das oben beschriebene Verfahren dadurch aus, dass die Laccase bei einer Temperatur von 0 bis 100 °C, bevorzugt von 0 bis 60 °C, weiter bevorzugt von 20 bis 45 °C und am meisten bevorzugt bei 40 °C eingesetzt wird. In various embodiments, the process described above is characterized in that the laccase is used at a temperature of 0 to 100 ° C., preferably 0 to 60 ° C., more preferably 20 to 45 ° C. and most preferably 40 ° C. becomes.
Hierunter fallen sowohl manuelle als auch maschinelle Verfahren, wobei maschinelle Verfahren bevorzugt sind. Verfahren zur Reinigung von Textilien zeichnen sich im Allgemeinen dadurch aus, dass in mehreren Verfahrensschritten verschiedene reinigungsaktive Substanzen auf das Reinigungsgut aufgebracht und nach der Einwirkzeit abgewaschen werden, oder dass das Reinigungsgut in sonstiger Weise mit einem Waschmittel oder einer Lösung oder Verdünnung dieses Mittels behandelt wird. Das Verfahren wird in seiner einfachsten Form dadurch realisiert, dass man reinigungsbedürftige Textilien mit der wässrigen Flotte in Kontakt bringt, wobei man eine übliche Waschmaschine einsetzen oder die Wäsche mit der Hand durchführen kann. Es ist erfindungsgemäß bevorzugt, das Verfahren unter intensiver Belüftung der Waschflotte durchzuführen, wie dies bei Verwendung eines üblichen Haushaltsmaschinen-Waschprogramms der Fall ist. Entsprechendes gilt für Verfahren zur Reinigung von allen anderen Materialien als Textilien, insbesondere von harten Oberflächen. Alle denkbaren Wasch- oder Reinigungsverfahren können in wenigstens einem der Verfahrensschritte um die Anwendung eines erfindungsgemäßen Waschoder Reinigungsmittels oder einer erfindungsgemäßen Laccase bereichert werden und stellen dann Ausführungsformen der vorliegenden Erfindung dar. Alle Sachverhalte, Gegenstände und Ausführungsformen, die für erfindungsgemäße Laccasen und sie enthaltende Mittel beschrieben sind, sind auch auf diesen Erfindungsgegenstand anwendbar. Daher wird an dieser Stelle ausdrücklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch für die vorstehenden erfindungsgemäßen Verfahren gilt.
Da erfindungsgemäße Laccasen natürlicherweise bereits eine hydrolytische Aktivität besitzen und diese auch in Medien entfalten, die sonst keine Reinigungskraft besitzen wie beispielsweise in bloßem Puffer, kann ein einzelner und/oder der einzige Schritt eines solchen Verfahrens darin bestehen, dass gewünschtenfalls als einzige reinigungsaktive Komponente eine erfindungsgemäße Laccase mit der Anschmutzung in Kontakt gebracht wird, bevorzugt in einer Pufferlösung oder in Wasser. Dies stellt eine weitere Ausführungsform dieses Erfindungsgegenstandes dar. This includes both manual and machine processes, with machine processes being preferred. Processes for cleaning textiles are generally characterized in that various cleaning-active substances are applied to the items to be cleaned and washed off after the exposure time in several process steps, or in that the items to be cleaned are treated in some other way with a detergent or a solution or dilution of this agent. The simplest form of the process is realized by bringing textiles in need of cleaning into contact with the aqueous liquor, using a conventional washing machine or doing the washing by hand. According to the invention, it is preferred to carry out the process with intensive aeration of the washing liquor, as is the case when using a conventional household machine washing program. The same applies to processes for cleaning all materials other than textiles, especially hard surfaces. All conceivable washing or cleaning processes can be enriched in at least one of the process steps by the use of a washing or cleaning agent according to the invention or a laccase according to the invention and then represent embodiments of the present invention. All the facts, objects and embodiments described for the inventive laccases and agents containing them are also applicable to this subject of the invention. Therefore, reference is expressly made at this point to the disclosure at the appropriate point, with the note that this disclosure also applies to the above method according to the invention. Since laccases according to the invention naturally already have a hydrolytic activity and also develop this in media which otherwise have no cleaning power, such as, for example, in mere buffer, a single and / or the only step of such a method can consist, if desired, of an inventive cleaning component as the only active cleaning component Laccase is brought into contact with the soiling, preferably in a buffer solution or in water. This represents a further embodiment of this subject matter of the invention.
Alternative Ausführungsformen dieses Erfindungsgegenstandes stellen auch Verfahren zur Behandlung von Textilrohstoffen oder zur Textilpflege dar, bei denen in wenigstens einem Verfahrensschritt eine erfindungsgemäße Laccase aktiv wird. Hierunter sind Verfahren für Textilrohstoffe, Fasern oder Textilien mit natürlichen Bestandteilen bevorzugt, und ganz besonders für solche mit Wolle oder Seide. Alternative embodiments of this subject matter of the invention also represent methods for treating textile raw materials or for textile care, in which a laccase according to the invention becomes active in at least one method step. Among these, processes for textile raw materials, fibers or textiles with natural components are preferred, and very particularly for those with wool or silk.
In einem weiteren Aspekt bezieht sich die vorliegende Erfindung auf die Verwendung einer erfindungsgemäßen Laccase oder einer nach einem erfindungsgemäßen Verfahren erhältliche Laccase in einem Wasch- oder Reinigungsmittel zur Entfernung von stärkehaltigen Anschmutzungen. In a further aspect, the present invention relates to the use of a laccase according to the invention or a laccase obtainable by a method according to the invention in a washing or cleaning agent for removing starchy soiling.
Ein weiterer Gegenstand der Erfindung ist die Verwendung einer erfindungsgemäßen Laccase zur Verbesserung der Waschleistung eines Wasch- und Reinigungsmittels, insbesondere bei der Entfernung farbiger Flecken und Anschmutzungen, besonders bevorzugt bei der Entfernung anthocyanhaltiger Anschmutzungen. Another object of the invention is the use of a laccase according to the invention to improve the washing performance of a washing and cleaning agent, in particular when removing colored stains and soiling, particularly preferably when removing soiling containing anthocyanins.
Alle Sachverhalte, Gegenstände und Ausführungsformen, die für erfindungsgemäße Laccase und sie enthaltende Mittel beschrieben sind, sind auch auf die beschriebenen Verfahren und Verwendungen anwendbar. Daher wird an dieser Stelle ausdrücklich auf die Offenbarung an entsprechender Stelle verwiesen mit dem Hinweis, dass diese Offenbarung auch für die vorstehenden erfindungsgemäßen Verwendungen und Verfahren gilt. All facts, objects and embodiments, which are described for laccase according to the invention and agents containing it, are also applicable to the described methods and uses. Therefore, reference is expressly made at this point to the disclosure at the appropriate point with the note that this disclosure also applies to the above-mentioned uses and methods according to the invention.
In einem weiteren Aspekt bezieht sich die vorliegende Erfindung auf die Verwendung einer erfindungsgemäßen Laccase oder einer nach einem erfindungsgemäßen Verfahren erhältliche Laccase oder einer wie in den beschriebenen Mitteln der Erfindung eingesetzten Laccase in einem Wasch- oder Reinigungsmittel zur Entfernung von anthocyanhaltigen Anschmutzungen. Alle Sachverhalte, Gegenstände und Ausführungsformen, die für erfindungsgemäße Laccase und sie enthaltende Mittel beschrieben sind, sind auch auf diesen Erfindungsgegenstand anwendbar.
Beispiele: In a further aspect, the present invention relates to the use of a laccase according to the invention or a laccase obtainable by a method according to the invention or a laccase as used in the agents of the invention described in a washing or cleaning agent for removing anthocyanin-containing soiling. All facts, objects and embodiments that are described for laccase according to the invention and agents containing it can also be applied to this object of the invention. Examples:
Die folgenden Beispiele erläutern die Erfindung, ohne sie jedoch darauf einzuschränken. The following examples illustrate the invention without, however, restricting it thereto.
Beispiel 1 : Identifizierung der Laccase Example 1: Identification of the laccase
Es wurde in Basidiomyceten nach anthocyanabbauenden Enzymen gescreent. Dabei wurde ein Wildtyp-Enzym, annotiert als Laccase, aus Marasmiellus palmivorus (Mpa) entdeckt. Diese Laccase zeigte eine positive Waschleistung auf anthocyanhaltigen Anschmutzungen, ohne dass es zu einer Verdunklung auf anderen Anschmutzungen kam, was bei früheren bereits getesteten Enzyme dieser Klasse vorkam (was natürlich unerwünscht ist und zum Ausschluss dieser Enzyme aus dem Screening führte). Sie eröffnet dadurch viele Möglichkeiten, die genetische und biochemische Vielfalt im Bereich der in Reinigungsmitteln eingesetzten Enzymen zu erhöhen. It was screened in Basidiomycetes for anthocyanin-degrading enzymes. A wild-type enzyme, annotated as laccase, was discovered from Marasmiellus palmivorus (Mpa). This laccase showed a positive wash performance on soils containing anthocyanin without darkening on other soils, which was the case with previously tested enzymes of this class (which is of course undesirable and led to the exclusion of these enzymes from the screening). It opens up many opportunities to increase the genetic and biochemical diversity in the area of enzymes used in detergents.
Beispiel 2: Kultivierung Example 2: Cultivation
Alle Basidiomyceten wurden in einem flüssigen Standard-Nährstoff-(SNL)-Medium kultiviert. Eine Vorkultur wurde zunächst in SNL-Medium für eine Woche bei 24 °C und 150 rpm kultiviert. Danach wurde ein standardisiertes Inokulum in die Hauptkultur (SNL) überführt. Die Kultivierung wurde bei 24 °C und 150 rpm für vier Tage in einem Reaktorsystem durchgeführt. All basidiomycetes were grown in a standard liquid nutrient (SNL) medium. A preculture was first cultivated in SNL medium for one week at 24 ° C and 150 rpm. A standardized inoculum was then transferred to the main culture (SNL). The cultivation was carried out at 24 ° C. and 150 rpm for four days in a reactor system.
Eine Trennung der Wildtyp-Mpa-Laccase mittels AEX-Zentrifugensäulenchromatographie wurde durchgeführt. 19 ml Kulturüberstand wurden auf Pierce® Strang Anion Exchange Spin Column (Maxi, äquilibriert mit 10 ml 50 mM Natriumacetatpuffer, pH 5) gegeben. Danach wurden die Säulen zweimal mit 10 ml 50 mM Natriumacetatpuffer (pH 5) gewaschen. Die Laccase wurde schrittweise mit 10 ml von 2, 4, 6, 8 und 100 % 50 mM Natriumacetatpuffer (pH 5) mit 2 M NaCI eluiert. Die resultierenden Fraktionen wurden hinsichtlich ihrer Laccaseaktivität und ihres Bleicheffektes auf eingefärbte Textilien analysiert. The wild-type Mpa laccase was separated by means of AEX centrifuge column chromatography. 19 ml of culture supernatant was added to the Pierce® strand anion exchange spin column (Maxi, equilibrated with 10 ml of 50 mM sodium acetate buffer, pH 5). The columns were then washed twice with 10 ml of 50 mM sodium acetate buffer (pH 5). The laccase was gradually eluted with 10 ml of 2, 4, 6, 8 and 100% 50 mM sodium acetate buffer (pH 5) with 2 M NaCl. The resulting fractions were analyzed for their laccase activity and their bleaching effect on colored textiles.
Beispiel 3: Aktivitätsassav Example 3: Activity ass
Die Aktivität der Laccase wurde mit einem ABTS-Assay in der Mikrotiterplatte bestimmt. The activity of the laccase was determined using an ABTS assay in the microtiter plate.
Das Gesamtvolumen beträgt 300 pl. Es werden 245 mI 50 mM Na-Acetat Puffer (pH 4,5) vermischt mit 30 mI einer 5 mM ABTS-Lösung und 10 mI einer 2 mM H202-Lösung. The total volume is 300 pl. 245 ml of 50 mM Na acetate buffer (pH 4.5) are mixed with 30 ml of a 5 mM ABTS solution and 10 ml of a 2 mM H 2 O 2 solution.
Dazu werden 15 mI Probe in geeigneter Verdünnung gegeben, bzw. 15 mI 50 mM Na-Acetat-Puffer als Blank. For this, 15 ml of sample are added in a suitable dilution, or 15 ml of 50 mM Na acetate buffer as a blank.
Es folgt eine kinetische Messung bei 420 nm für 10 min bei 30°C. This is followed by a kinetic measurement at 420 nm for 10 min at 30 ° C.
Die Aktivität in Unit wird über folgende Formel berechnet: The activity in units is calculated using the following formula:
Testvolumen = 0,3 ml Test volume = 0.3 ml
Probenvolumen = 0,015 ml Sample volume = 0.015 ml
ABTS = 0,0368 cm2*pmo|·1 , bei 405-420 nm
Über den molaren Extinktionskoeffizienten für ABTS lässt sich dann die Aktivität in mitioI freigesetzte ABTS-Radikale pro Minute und ml berechnen: ABTS = 0.0368 cm 2 * pmo | · 1 , at 405-420 nm The activity in mitioI-released ABTS radicals per minute and ml can then be calculated using the molar extinction coefficient for ABTS:
Aktivität [pmol*min 1*ml 1] = (((DE/minprobe - AE/minBiank)*n*r2)/(8ABTs*VT es 0)*(VT est/Vprobe)*Fverdg. wobei Activity [pmol * min 1 * ml 1 ] = (((DE / minprobe - AE / minBiank) * n * r 2 ) / (8ABTs * VT es 0) * (VT est / Vprobe) * Fverdg. Whereby
DE/m inprobe der Extinktionsänderung der Probe pro Minute, DE / m inprobe of the absorbance change of the sample per minute,
AE/mineiank der Extinktionsänderung des Blanks pro Minute, AE / mineian k the extinction change of the blank per minute,
R dem Radius des MTP-wells, R the radius of the MTP well,
e ABTS dem Extinktionskoeffizienten von ABTS entspricht (0,0368 cm2*pmol 1 , bei 405-420 nm), e ABTS corresponds to the extinction coefficient of ABTS (0.0368 cm 2 * pmol 1 , at 405-420 nm),
Viest dem Testvolumen, Viest the test volume,
Vprobe dem Probenvolumen und Vprobe the sample volume and
Fverdg dem Verdünnungsfaktor Fverdg the dilution factor
entspricht. equivalent.
Man erhält die Aktivität der Laccase gegenüber ABTS in U/ml. Eine Unit ist definiert als 1 pmol Substrat oxidiert pro Minute unter definierten Bedingungen. The activity of the laccase against ABTS is obtained in U / ml. One unit is defined as 1 pmol substrate oxidized per minute under defined conditions.
Beispiel 4: Waschtest Example 4: Wash test
Ein Mini-Waschtest erfolgte mit dem aufgereinigten Wildtyp-Überstand aus Marasmiellus palmivorus , in dem die Laccase mit der Aminosäuresequenz SEQ ID NO: 1 oder SEQ ID NO:2 vorliegt. A mini-wash test was carried out with the purified wild-type supernatant from Marasmiellus palmivorus, in which the laccase with the amino acid sequence SEQ ID NO: 1 or SEQ ID NO: 2 is present.
Bedingungen: 40 °C, 16°dH Wasser, 1 h, Conditions: 40 ° C, 16 ° dH water, 1 h,
Laccasekonzentration: 25 mU/ml Laccase concentration: 25 mU / ml
Anschmutzungen: stains:
1 . C-S-15 Blaubeere von CFT 1 . C-S-15 blueberry from CFT
2. C-S-72 Forrest Fruit Ice Cream von CFT 2. C-S-72 Forrest Fruit Ice Cream from CFT
Durchführung: Execution:
• Ausgestanzte Gewebe (Durchmesser = 10 mm) in Mikrotiterplatte vorlegen, Waschlauge auf 40 °C vortemperieren, Endkonzentration 3, 18 g/l, • Place punched tissue (diameter = 10 mm) in the microtiter plate, preheat the wash liquor to 40 ° C, final concentration 3, 18 g / l,
• Lauge und Enzym auf die Anschmutzung geben, für 1 h bei 40 °C und 600 rpm inkubieren, • Apply lye and enzyme to the soiling, incubate for 1 h at 40 ° C and 600 rpm,
• anschließend die Anschmutzung mehrmals mit klarem Wasser spülen, trocken lassen und mit einem Farbmessgerät die Helligkeit bestimmen.
Je heller das Gewebe wird, desto besser ist die Reinigungsleistung. Gemessen wird hier der L-Wert = Helligkeit, je höher desto heller. • then rinse the soiling several times with clear water, let it dry and determine the brightness with a color measuring device. The lighter the fabric, the better the cleaning performance. The L value = brightness is measured here, the higher the brighter.
Es wird mit einem gängigen Flüssigwaschmittel ohne Enzyme gewaschen. It is washed with a common liquid detergent without enzymes.
Probe 1 : nur Waschmittel als Benchmark Sample 1: only detergent as a benchmark
Probe 2: Waschmittel plus Laccase aus Mpa Sample 2: Detergent plus laccase from Mpa
Man erkennt also deutlich, dass die Laccase auf diesen Anschmutzungen eine gute Leistung zeigt. Von einer signifikanten Leistungsverbesserung spricht man schon ab 1 Einheit. Als Negativkontrolle wurde der abgekochte, aufgereinigte Überstand aus Mpa mitgewaschen (99 °C für 30 min), der keinerlei Waschleistung zeigt (nicht gezeigt). So you can clearly see that the laccase performs well on these stains. One speaks of a significant improvement in performance from just 1 unit. As a negative control, the boiled, purified supernatant from Mpa was washed (99 ° C. for 30 min), which shows no washing performance (not shown).
Beispiel 4: Waschmittelformulierunq Example 4: Detergent formulation
Claims
1. Laccase, umfassend eine Aminosäuresequenz, die mindestens 70 % Sequenzidentität mit der in SEQ ID NO:1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist. 1. Laccase comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length.
2. Laccase oder Varianten davon, wobei diese Varianten dadurch gekennzeichnet sind, dass2. Laccase or variants thereof, these variants being characterized in that
(a) sie aus einer Laccase nach Anspruch 1 als Ausgangsmolekül erhältlich sind durch ein- oder mehrfache konservative Aminosäuresubstitution; und/oder (a) they are obtainable from a laccase according to claim 1 as the starting molecule by single or multiple conservative amino acid substitution; and or
(b) sie aus einer Laccase nach Anspruch 1 als Ausgangsmolekül erhältlich sind durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese und eine Aminosäuresequenz umfassen, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit dem Ausgangsmolekül übereinstimmt. (b) they are obtainable from a laccase according to claim 1 as a starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprise an amino acid sequence which is at least 345, 350, 360, 370, 380, 390, 400, 410 in length , 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 related amino acids matches the starting molecule.
3. Verfahren zur Herstellung einer Laccase nach Anspruch 1 oder 2, umfassend das Bereitstellen einer Ausgangs-Laccase, die mindestens 70 % Sequenzidentität zu der in SEQ ID NO: 1 oder SEQ ID NO:2 angegebenen Aminosäuresequenz über deren Gesamtlänge aufweist. 3. A method for producing a laccase according to claim 1 or 2, comprising providing a starting laccase which has at least 70% sequence identity to the amino acid sequence given in SEQ ID NO: 1 or SEQ ID NO: 2 over its entire length.
4. Verfahren nach Anspruch 3, ferner umfassend einen oder beide der folgenden Verfahrensschritte: 4. The method of claim 3, further comprising one or both of the following method steps:
(a) Einbringen einer ein- oder mehrfachen konservativen Aminosäuresubstitution in die Ausgangs-Laccase; (a) introducing a single or multiple conservative amino acid substitution into the starting laccase;
(b) Veränderung der Aminosäuresequenz der Ausgangs-Laccase durch Fragmentierung, Deletions-, Insertions- oder Substitutionsmutagenese derart, dass die veränderte Laccase eine Aminosäuresequenz umfasst, die über eine Länge von mindestens 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491 , 492, 493, 494 oder 495 zusammenhängenden Aminosäuren mit der Ausgangslaccase übereinstimmt. (b) altering the amino acid sequence of the starting laccase by fragmentation, deletion, insertion or substitution mutagenesis such that the modified laccase comprises an amino acid sequence which is at least 345, 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494 or 495 contiguous amino acids corresponds to the starting succase.
5. Nukleinsäure, codierend für eine Laccase nach Anspruch 1 oder 2 oder codierend für eine nach einem Verfahren nach Anspruch 3 oder 4 erhaltene Laccase. 5. Nucleic acid coding for a laccase according to claim 1 or 2 or coding for a laccase obtained by a method according to claim 3 or 4.
6. Vektor, enthaltend eine Nukleinsäure nach Anspruch 5, insbesondere ein Klonierungsvektor oder ein Expressionsvektor. 6. Vector containing a nucleic acid according to claim 5, in particular a cloning vector or an expression vector.
7. Nicht menschliche Wirtszelle, die eine Nukleinsäure nach Anspruch 5 oder einen Vektor nach Anspruch 6 beinhaltet, oder die eine Laccase nach Anspruch 1 oder 2 beinhaltet, oder die eine
nach einem Verfahren nach Anspruch 3 oder 4 erhaltene Laccase beinhaltet, insbesondere eine, die die Laccase in das die Wirtszelle umgebende Medium sezerniert. 7. A non-human host cell which contains a nucleic acid according to claim 5 or a vector according to claim 6, or which contains a laccase according to claim 1 or 2, or which one laccase obtained by a method according to claim 3 or 4, in particular one which secretes the laccase into the medium surrounding the host cell.
8. Verfahren zur Herstellung einer Laccase umfassend 8. A method for producing a laccase comprising
(a) Kultivieren einer Wirtszelle gemäß Anspruch 7; und (a) culturing a host cell according to claim 7; and
(b) Isolieren der Laccase aus dem Kulturmedium oder aus der Wirtszelle. (b) isolating the laccase from the culture medium or from the host cell.
9. Mittel, insbesondere ein Wasch- und Reinigungsmittel, enthaltend mindestens eine Laccase nach Anspruch 1 oder 2 oder eine nach einem Verfahren nach Anspruch 3 oder 4 erhaltene Laccase, wobei die Konzentration der mindestens einen Laccase insbesondere von 0,00005 bis 15 Gew.-%, vorzugsweise von 0,0001 bis 5 Gew.-%, weiter bevorzugt von 0,001 bis 1 Gew.-% und besonders bevorzugt von 0,001 bis 0,1 Gew.-%, bezogen auf aktives Protein, beträgt. 9. Agent, in particular a washing and cleaning agent, containing at least one laccase according to claim 1 or 2 or a laccase obtained by a method according to claim 3 or 4, the concentration of the at least one laccase being in particular from 0.00005 to 15% by weight. %, preferably from 0.0001 to 5% by weight, more preferably from 0.001 to 1% by weight and particularly preferably from 0.001 to 0.1% by weight, based on active protein.
10. Mittel nach Anspruch 9, dadurch gekennzeichnet, dass es mindestens einen zusätzlichen Mediator enthält, der aus der aus 2,2,6,6-Tetramethyl-1-Piperidinyloxy, 1-Hydroxybenzotriazol, 2,2'-Azinobis-3-Ethylbenzthiazol-6-Sulphonat, N-Hydroxy-Acetanilid, 2,5-Xylidin, Ethanol, Kupfer, 4-Methylcatechol, N-Hydroxyphthalimid, Gallussäure, Gerbsäure, Quercetin, Syringasäure, Guaiacol, Dimethoxybenzyl alcohol, Phenol, Violursäure, Phenolrot, Bromphenolblau, Cellulose, p-Kumarinsäure, Rooibos, o-Kresol, Dichloroindophenol, Hydroxybenzotriazol, Cycloheximid oder Vanillin bestehenden Gruppe ausgewählt ist. 10. Composition according to claim 9, characterized in that it contains at least one additional mediator consisting of 2,2,6,6-tetramethyl-1-piperidinyloxy, 1-hydroxybenzotriazole, 2,2'-azinobis-3-ethylbenzothiazole -6-sulphonate, N-hydroxyacetanilide, 2,5-xylidine, ethanol, copper, 4-methylcatechol, N-hydroxyphthalimide, gallic acid, tannic acid, quercetin, syringic acid, guaiacol, dimethoxybenzyl alcohol, phenol, violuric acid, phenol red, bromophenol blue, Cellulose, p-coumaric acid, rooibos, o-cresol, dichloroindophenol, hydroxybenzotriazole, cycloheximide or vanillin group is selected.
1 1. Verfahren zur Reinigung von Textilien oder harten Oberflächen, dadurch gekennzeichnet, dass in mindestens einem Verfahrensschritt ein Mittel nach Anspruch 9 oder 10 angewendet wird, oder dass in mindestens einem Verfahrensschritt eine Laccase nach Anspruch 1 oder 2 oder eine nach einem Verfahren nach Anspruch 3 oder 4 erhaltene Laccase katalytisch aktiv wird. 1 1. A method for cleaning textiles or hard surfaces, characterized in that in at least one process step, an agent according to claim 9 or 10 is used, or that in at least one process step a laccase according to claim 1 or 2 or one according to a method according to claim 3 or 4 obtained laccase becomes catalytically active.
12. Verwendung einer Laccase nach Anspruch 1 oder 2 oder einer nach einem Verfahren nach Anspruch 3 oder 4 erhaltenen Laccase in einem Wasch- oder Reinigungsmittel zur Entfernung fahriger Flecken und Anschmutzungen, insbesondere von anthocyanhaltigen Anschmutzungen.
12. Use of a laccase according to claim 1 or 2 or a laccase obtained by a process according to claim 3 or 4 in a washing or cleaning agent for removing moving stains and soiling, in particular anthocyanin-containing soiling.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102018210570.7 | 2018-06-28 | ||
DE102018210570.7A DE102018210570A1 (en) | 2018-06-28 | 2018-06-28 | Laccase detergent with improved cleaning performance |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020002187A1 true WO2020002187A1 (en) | 2020-01-02 |
Family
ID=67070825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2019/066589 WO2020002187A1 (en) | 2018-06-28 | 2019-06-24 | Laccase-containing detergent having improved cleaning power |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102018210570A1 (en) |
WO (1) | WO2020002187A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4385491A1 (en) | 2022-12-14 | 2024-06-19 | SkyLab AG | Ph-stable biotechnology composition based on laccase for targeted degradation of coloured melanoidines and/or phenolic organic compounds on dense surfaces |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009121725A1 (en) | 2008-04-02 | 2009-10-08 | Henkel Ag & Co. Kgaa | Detergents and cleaners comprising proteases from xanthomonas |
CN104818257A (en) * | 2015-04-22 | 2015-08-05 | 华南理工大学 | Moniliophthora perniciosa laccase and engineering bacteria, recombinant laccase as well as application thereof |
WO2016151656A1 (en) * | 2015-03-20 | 2016-09-29 | 株式会社大地クリア | Aromatic chlorine compound degradation agent, and method for degrading aromatic chlorine compound using same |
-
2018
- 2018-06-28 DE DE102018210570.7A patent/DE102018210570A1/en not_active Withdrawn
-
2019
- 2019-06-24 WO PCT/EP2019/066589 patent/WO2020002187A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009121725A1 (en) | 2008-04-02 | 2009-10-08 | Henkel Ag & Co. Kgaa | Detergents and cleaners comprising proteases from xanthomonas |
WO2016151656A1 (en) * | 2015-03-20 | 2016-09-29 | 株式会社大地クリア | Aromatic chlorine compound degradation agent, and method for degrading aromatic chlorine compound using same |
CN104818257A (en) * | 2015-04-22 | 2015-08-05 | 华南理工大学 | Moniliophthora perniciosa laccase and engineering bacteria, recombinant laccase as well as application thereof |
Non-Patent Citations (13)
Title |
---|
ALTSCHUL ET AL.: "Basic local alignment search tool", J. MOL. BIOL., vol. 215, 1990, pages 403 - 410, XP002949123, DOI: doi:10.1006/jmbi.1990.9999 |
ALTSCHUL ET AL.: "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402, XP002905950, DOI: doi:10.1093/nar/25.17.3389 |
BENDER ET AL., J. AM. CHEM. SOC., vol. 88, no. 24, 1966, pages 5890 - 5913 |
BOURBONNAISPAICE, FEBS LETT., vol. 267, no. 1, 1990, pages 99 - 102 |
CAMILA CANTELE ET AL: "Synthetic dye decolorization by Marasmiellus palmivorus : Simultaneous cultivation and high laccase-crude broth treatment", BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, vol. 12, 1 October 2017 (2017-10-01), pages 314 - 322, XP055607916, ISSN: 1878-8181, DOI: 10.1016/j.bcab.2017.10.025 * |
CANAS ET AL.: "Laccases and their natural mediators", BIOTECHNOL. ADVANCES, vol. 28, 2010, pages 694 - 705, XP027331809 |
CHENNA ET AL.: "Multiple sequence alignment with the Clustal series of programs", NUCLEIC ACIDS RES., vol. 31, 2003, pages 3497 - 3500, XP002316493, DOI: doi:10.1093/nar/gkg500 |
DATABASE UniProt [online] 16 March 2016 (2016-03-16), "SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:KTB44067.1};", XP002793138, retrieved from EBI accession no. UNIPROT:A0A0W0G682 Database accession no. A0A0W0G682 * |
FRASCONI ET AL.: "Kinetic and biochemical properties of high and low redox potential laccases from fungal and plant origin", BIOCHEMICA ET BIOPHYSICA ACTA, vol. 1804, 2009, pages 899 - 908, XP026921426, DOI: doi:10.1016/j.bbapap.2009.12.018 |
GORNALL ET AL., J. BIOL. CHEM., vol. 177, 1948, pages 751 - 766 |
HAHN SCHNEIDER WILLIAN DANIEL ET AL: "High level production of laccases and peroxidases from the newly isolated white-rot basidiomycete Marasmiellus palmivorus VE111 in a stirred-tank bioreactor in response to different carbon and nitrogen sources", PROCESS BIOCHEMISTRY, vol. 69, 15 March 2018 (2018-03-15), pages 1 - 11, XP055607918 * |
NOTREDAME ET AL.: "T-Coffee: A novel method for multiple sequence alignments", J. MOL. BIOL., vol. 302, 2000, pages 205 - 217, XP004469125, DOI: doi:10.1006/jmbi.2000.4042 |
SAMBROOK, J.FRITSCH, E.F.MANIATIS, T.: "Molecular cloning: a laboratory manual", 2001, COLD SPRING LABORATORY PRESS |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4385491A1 (en) | 2022-12-14 | 2024-06-19 | SkyLab AG | Ph-stable biotechnology composition based on laccase for targeted degradation of coloured melanoidines and/or phenolic organic compounds on dense surfaces |
WO2024126636A1 (en) | 2022-12-14 | 2024-06-20 | SkyLab AG | Ph-stable biotechnology composition based on laccase for targeted degradation of coloured melanoidines and/or phenolic organic compounds on dense surfaces |
Also Published As
Publication number | Publication date |
---|---|
DE102018210570A1 (en) | 2020-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3660151B1 (en) | Variant proteases having improved performance and storage stability | |
WO2021175697A1 (en) | Performance-enhanced protease variants vii | |
EP3299457A1 (en) | New lipase | |
EP3679131B1 (en) | Performance-enhanced protease variants ii | |
EP3660146B1 (en) | Storage stable protease variants with improved performance | |
EP2683808B1 (en) | Performance-enhanced protease variants | |
EP3458583B1 (en) | Improved-performance proteases | |
WO2016037992A1 (en) | Peroxidases having activity for carotenoids | |
WO2020002187A1 (en) | Laccase-containing detergent having improved cleaning power | |
EP3458580A1 (en) | Improved washing performance using a novel n alpha-amylase from ausrhizoctonia solani | |
DE102017202034A1 (en) | Lipases with increased thermostability | |
EP3303572B1 (en) | Detergents with improved detergent power, containing at least one laccase | |
EP2999782B1 (en) | Peroxidases having activity for carotenoids | |
DE102018208446A1 (en) | Improved washing performance with a new alpha-amylase from Fomes fomentarius (Ffo) | |
WO2019228877A1 (en) | Improved washing performance using a novel alpha-amylase from fomitopsis pinicola (fpi) | |
DE102018208443A1 (en) | Improved washing performance with a new alpha-amylase Irpex lacteus (IIa) | |
WO2019101417A1 (en) | Amylase and washing or cleaning agent containing same | |
WO2024037685A1 (en) | Performance-enhanced protease variants ix | |
DE102018208444A1 (en) | Improved washing performance with a new alpha-amylase from Trametes hirsuta (Thi) | |
DE102022209245A1 (en) | DETERGENT AND CLEANING PRODUCT CONTAINING TANNASE I | |
DE102022209246A1 (en) | DETERGENT AND CLEANING PRODUCT CONTAINING TANNASE II | |
DE102017220670A1 (en) | Glucosidase and detergents and cleaners containing such | |
DE102021207704A1 (en) | Performance-enhanced protease variants VIII | |
EP3464577A1 (en) | Novel amylases | |
WO2016096393A1 (en) | Bilirubin oxidases as dye transfer inhibitors in detergent and cleaning agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19733725 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19733725 Country of ref document: EP Kind code of ref document: A1 |